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Abstract 
 
Many DNA repair pathways have been documented in Trypanosoma brucei 
but less attention has been paid to damage tolerance, a reaction in which lesion 
bypass is needed, in particular to ensure continued genome replication. Such 
bypass is promoted by translesion DNA polymerases (TLS Pols). T. brucei has ~15 
TLS polymerases candidate genes, only two of which have been functionally 
examined to date. Understanding the roles provided by TLS Pols could reveal 
new aspects of T. brucei biology. Here, I examine the activities of TLS Pol Nu 
(PolN), TbPolZ and TbPolQ (HelQ) in bloodstream cells.  
 
RNAi against TbPolN results in slowed growth after ~24 hours, which is 
associated with altered DNA content, changed cell morphology and sensitivity to 
DNA damage. Surprisingly, growth and morphology defects are reduced after ~48 
hours, without apparent RNAi reversion. In addition, depletion of the protein 
seems to lead to an aberrant distribution of the chromosomes, as visualised by 
telomere fluorescent in situ hybridization. TbPolN epitope tagging demonstrates 
a discrete localisation of the protein at the periphery of the nucleus in the 
absence of damage, with a more widespread, but non-uniform localisation after 
damage. EdU labelling and γH2A analysis after TbPolN knockdown reveal a 
decrease in proliferating cells, which accumulate nuclear DNA damage. Finally, 
we show that TbPolN interacts with a nuclear putative non-canonical PolyA 
polymerase. Taken together, these data suggest TbPolN may be involved in T. 
brucei nuclear DNA maintenance. 
 
RNAi of TbPolZ (zeta) did not impair growth but resulted in increased 
sensitivity to methyl methanesulphonate (MMS) damage and UV radiation, 
suggesting a possible role in the response against both genotoxic agents. 
Generation of TbPolZ null mutants confirmed that the protein is non-essential 
and plays a role in genotoxic damage repair. Surprisingly, TbPolZ epitope tagging 
not only showed a nuclear signal, but a mitochondrial signal was also detected. 
These data were supported by immunoprecipitation, where mitochondrial 
proteins were obtained as potential interaction partners. These data suggest a 
contribution of TbPolZ to both nuclear and kinetoplast genome maintenance.    
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Targeted RNAi of the third putative TLS-related factor, TbHelQ, was 
unsuccessful. Despite this, sequence analysis of the protein indicates that its 
current annotation as a PolQ homologue is inaccurate, since the predicted 
protein is not a joint polymerase-helicase like in other eukaryotes, but only a 
putative helicase. Hence, it is suggested it should be renamed TbHelQ. 
Immunoprecipitation and colocalisation analyses indicate a possible role of 
TbHelQ in homologous recombination, given the potential interaction of the 
factor with BRCA2 and other factors involved in this repair process. Notably, the 
predicted interactome of TbHelQ differs from that of TbPolN, suggesting 
discrete functions in T. brucei. 
 
Taken together, these data reveal widespread and variant functions of 
three putative TLS DNA polymerases in the parasite genome biology, suggesting a 
possible role in the maintenance of genome integrity in T. brucei.   
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1.1 Kinetoplastids 
Kinetoplastids (class Kinetoplastae) are flagellated protozoans, which belong 
to the phylum Euglenozoa (Moreira, López-García and Vickerman, 2004). The 
members of this group are characterised by the presence of a unique organelle 
known as kinetoplast, which is the single copy mitochondrion and contains a 
genome composed of a concatenated network of two classes of circular DNA 
(Moreira et al. 2004). This is not the only biological peculiarity that 
differentiates these organisms from other eukaryotes. The ability to edit their 
mitochondria RNA, their organisation of nearly all genes as multigene 
transcription units, near universal trans-splicing to generate mature mRNA, and 
the compartmentation of glycolysis are a few of the characteristics that make 
kinetoplastids unusual among the eukaryote domain (Simpson, Stevens and 
Lukeš, 2006).  
 
The class Kinetoplastae is divided into two subclasses known as the 
Prokinetoplastina and Metakinetoplastina, the latter of which is subdivided in 
four clades: the Parabodonida, Eubodonida, Neobodonida and Trypanosomatida 
(Lukeš et al., 2014). The Trypanosomatida clade consists of uniflagellar obligate 
parasites, which are associated with pathogenic infections in humans and 
animals. This grouping includes Trypanosoma brucei, T. cruzi and Leishmania 
spp (Simpson, Stevens and Lukeš, 2006; Kaufer et al., 2017). T. brucei is the 
etiological agent of African trypanosomiasis, which is a parasitic disease of 
humans (sleeping sickness) and cattle (Nagana disease). T. cruzi infection 
provokes American trypanosomiasis, which is known as Chagas disease and is 
found mainly in south and central America (Simpson, Stevens and Lukeš, 2006; 
Kaufer et al., 2017). On the other hand, Leishmania spp. are responsible for a 
range of pathologies collectively referred to as the disease leishmaniasis, which 
is divided into cutaneous, mucocutaneous and visceral leishmaniasis (Murray et 
al., 2005). Leishmaniasis is endemic to the tropics, subtropics and Mediterranean 
basin  (Simpson, Stevens and Lukeš, 2006; Oryan and Akbari, 2016).  
 
1.2 Human African Trypanosomiasis  
African trypanosomiasis affects humans and animals in sub-Saharan Africa 
(Franco et al., 2014) (Figure 1-1). In humans, Human African trypanosomiasis 
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(HAT), or sleeping sickness, is frequently fatal if untreated. Furthermore, the 
disease also has a wider impact on the economy, since sleeping sickness 
contributes to the reduction of labour resources (Simarro, Jannin and Cattand, 
2008). Meanwhile, animal infection, or Nagana, greatly impacts food sources 
(Simarro, Jannin and Cattand, 2008) since it affects cattle, which are normally 
used for farming activities (Steverding, 2008). The infected animals develop a 
range of symptoms like fever, discharge from the eye, anaemia and paralysis, 
subsequently generating weakness in the animal rendering it unable to work 
(Steverding, 2008). Due to these effects, African trypanosomiasis is a public 
health problem which affects not only the economy but the cultural 
development of rural communities (Steverding, 2008). 
 
 
 
Figure 1-1. Map showing the distribution of sleeping sickness across the 
African continent. Adapted from (Simarro et al., 2010). 
 
The causative agent of trypanosomiasis, in humans, is the flagellate 
parasite Trypanosoma brucei, of the class Kinetoplastida, order 
Trypanosomatidae (Rotureau and Van Den Abbeele, 2013). The parasite is 
transmitted by the bite of the flies from the genus Glossina (Diptera; 
Glossinidae) (Rotureau and Van Den Abbeele, 2013; Franco et al., 2014). This 
parasite is divided in three subspecies, Trypanosoma brucei brucei, T.b. 
gambiense, and T.b. rhodesiense. T.b. gambiense and T.b. rhodesiense are 
21 
 
human infective and responsible for HAT (Rotureau and Van Den Abbeele, 2013; 
Franco et al., 2014). T.b. brucei is not human infective but instead is 
responsible for causing Nagana disease, though two further species, T. vivax and 
T. congolense, are a much greater source of the animal disease (Steverding, 
2008). 
 
HAT has two stages. The first stage is called the haemolymphatic stage, 
where parasites are found in the lymph and the blood system. During this stage 
the symptoms that manifest include fever, headache, pruritus lymphadenopathy, 
weakness, asthenia, anaemia and hepato-splenomegaly (Franco et al., 2014). 
However, considering that these symptoms are usually not severe, patients do 
not typically seek medical care (WHO, 2013). In the second, or 
meningoencephalitic stage, the parasites cross the blood brain barrier and 
invade the central nervous system, producing neurological disorders (Franco et 
al., 2014). The common symptoms in this stage include confusion, tremors, 
fasciculation, motor weakness, akinesia or dyskinesia, sensory disturbances, 
abnormal movements and speech disorders (Malvy and Chappuis, 2011; Franco et 
al., 2014). Early sleeping sickness symptoms are general and variable, making it 
possible to confuse this disease with others such as malaria, enteric fever, 
tubercular meningitis and HIV (Wastling and Welburn, 2011). Depending on the 
parasite subspecies, the progression of the disease can vary. T.b. gambiense 
(responsible of 90% of HAT cases) results in a chronic infection, in which the 
patients may be infected for months, even years, without presenting any 
neurological symptoms (Simarro, Jannin and Cattand, 2008). By the time 
infected individuals display specific HAT symptoms (headaches, fever, sleep 
disturbances, alteration of mental state and other neurological disorders), the 
disease is already in the meningoencephalitic stage (Simarro, Jannin and 
Cattand, 2008; Franco et al., 2014).  In contrast, T.b. rhodesiense causes an 
acute infection where neurological symptoms can manifest a few weeks or 
months after the infection and subsequently progress rapidly to the 
meningoencephalitic stage (Simarro, Jannin and Cattand, 2008; Franco et al., 
2014). 
 
Recent studies have shown that T. brucei parasites are found outside the 
vasculature in the adipose tissue, suggesting this location may provide a 
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significant reservoir for T. brucei, where the parasites use fatty acids as a 
carbon source. Parasite localisation in this tissue could be beneficial for parasite 
survival, hindering the action of the immune system (Trindade et al., 2016). 
Though it is still uncertain if T. brucei has the capability to undergo VSG 
switching in the adipose tissue, if this is the case it would be an advantage 
during blood repopulation (Trindade et al., 2016). However, further studies are 
needed in order to determine if the insect vector, the tsetse fly, is able to ingest 
parasites from the subcutaneous fats in order to continue the infection cycle 
(Trindade et al., 2016).  In further work, the skin has also been recently 
identified as a similar extravascular reservoir for T. brucei. In the same way as 
adipose tissue, parasites localised in the skin may play an important role during 
blood repopulation and transmission (Capewell et al., 2016).  
 
 Treatment 1.2.1
The treatment for HAT involves highly toxic drugs, whose administration 
depends upon the phase of the disease. In the case of infections with T.b. 
gambiense, early stage disease is treated with pentamidine, while a combination 
of eflornithine and nifurtimox is used for the late stage (Kennedy, 2013). In the 
case of infections with T.b. rhodesiense the early stage of the disease is treated 
with suramin, and the late stage disease with melarsoprol (Kennedy, 2013). The 
problem with these drugs is the severe side-effects for the patient and 
difficulties during administration of the drug, since nifurtimox is the only drug 
administered by the oral route (Kennedy, 2013).  
 
1.3 Life Cycle 
The life cycle of T. brucei involves two hosts, an insect (tsetse fly) and a 
mammal (Figure 1-2). The cycle begins when an infected fly feeds on a mammal 
and inoculates metacyclic trypomastigotes, which invade the bloodstream from 
the bite site via the lymphatic system. In the bloodstream the metacyclic form 
cells differentiate into long slender bloodstream form trypomastigotes, and start 
to replicate by binary fission (Rotureau and Van Den Abbeele, 2013). This form 
of the parasite can also differentiate into short stumpy trypomastigote forms, 
which are non-dividing and are pre-adapted for inhabiting the vector, where 
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replicative bloodstream form cells do not survive. When a fly feeds on an 
infected mammal, short stumpy form parasites are able to differentiate into 
procyclic form cells in the midgut of the fly (Rotureau and Van Den Abbeele, 
2013). Short stumpy form cells therefore have a crucial role in perpetuating the 
trypanosome life cycle. These forms are also associated with infection chronicity 
since they contribute, along with antigenic variation (see below), to the 
regulation of parasitemia (Matthews and Gull, 1994; Rico et al., 2013). 
 
Procyclic form cells establish an infection in the midgut by resuming cell 
replication and undergoing a major change in the proteins displayed on the cell 
surface of the parasite. The Variant Surface Glycoprotein (VSG) ‘coat’ expressed 
on the plasma membrane of bloodstream form and metacyclic form cells is 
replaced by expression of procyclin. Each coat is required for survival in the 
different host environments (Rotureau et al., 2012). In bloodstream forms, the 
VSG coat has an important function evading the mammalian host immune system 
(Sheader et al., 2005; Taylor and Rudenko, 2006). The role of the procyclin coat 
is still uncertain, but it is believed to have a similar role to the VSG coat in 
bloodstream forms (Ruepp et al., 1997; Acosta-Serrano et al., 2001). It has been 
proposed that the coat in procyclic form cells is essential for the establishment 
of infection in the fly, probably by contributing to the evasion of the fly immune 
system and protecting the cells from lysis in the midgut environment (Ruepp et 
al., 1997; Acosta-Serrano et al., 2001; Sheader et al., 2005).  The next stage in 
the life cycle begins when procyclic form cells differentiate into mesocyclic 
forms, which migrate from the midgut and then differentiate into epimastigotes. 
In the salivary glands, epimastigote cells multiply and differentiate into 
metacyclic trypomastigotes and, in this way, the cycle starts all over again 
(Rotureau & Van Den Abbeele, 2013)  
 
Previous studies have analysed mRNA expression levels of pleomorphic 
slender forms, in vivo generated stumpy forms and cells undergoing synchronous 
differentiation (from stumpy to procyclic forms); in order to compare gene 
expression in different  life cycle stages (Jensen et al., 2009; Kabani et al., 
2009; Nilsson et al., 2010). Despite the different techniques used for the 
analysis, microarrays (Jensen et al., 2009; Kabani et al., 2009) and splice leader 
trapping (Nilsson et al., 2010), the results were comparable. Expression of 
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distinct genes was seen depending on the life cycle stage, at least some of which 
might be related with the requirement for diverse proteins for the adaptation to 
a new environment, or growth and survival within that environment (Jensen et 
al., 2009; Kabani et al., 2009; Nilsson et al., 2010; Rico et al., 2013).Significant 
changes in transcripts levels involved in metabolism, cell division, protein 
transport, cell structure, proteolysis and translation, were detected in slender 
and stumpy forms. For example, in the slender forms an up-regulation of 
expression site-associated genes (ESAG), histones, DNA replication/repair and 
translation transcripts was detected (Jensen et al., 2009; Kabani et al., 2009). 
On the other hand, in the stumpy form, there was an up-regulation of procyclins 
and proteins associated with differentiation (PAD) (Jensen et al., 2009; Kabani 
et al., 2009). In the case of the procyclic forms, there was a down-regulation of 
ESAG transcripts and an up-regulation of procyclin transcripts (Jensen et al., 
2009; Kabani et al., 2009; Nilsson et al., 2010).  
 
 
 
Figure 1-2. Life cycle of T. brucei. Simplified diagram of the life cycle of the 
parasite inside the fly and mammal host. Adapted from (Langousis and Hill, 
2014). 
 
1.4 Trypanosoma brucei architecture  
T. brucei is an elongated unicellular organism with a single flagellum. The 
parasite contains a network of sub-pellicular microtubules that gives shape and 
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polarity to the cell (Matthews, 2005). The flagellum is essential for  parasite 
survival as it facilitates motility and attachment to the salivary glands in the 
insect vector (Matthews, 2005; Ooi and Bastin, 2013). This structure is attached 
laterally along the cytoskeleton of the cell by the flagellar attachment zone 
(FAZ) (Ooi and Bastin, 2013). The flagellum is organised as two main structures: 
the axoneme and paraflagellar rod, which arise from the flagellar pocket that is 
linked to the basal body. The flagellar pocket is the only region in the parasite 
where endo- and exocytosis occurs (Matthews, 2005). The basal body consists of 
a 9+0 microtubule configuration (Ooi and Bastin, 2013), which is connected to 
the kinetoplast by the tripartite attachment complex (Matthews, 2005; Field and 
Carrington, 2009). The T. brucei cell contains  a number of single copy 
organelles, including a nucleus, mitochondrion and Golgi apparatus, all being 
localised towards the posterior end of the cell (Matthews, 2005; Hammarton, 
2007) (Figure 1-3). However, the parasite cell presents morphological 
differences depending on the life cycle. The reorganization of the kinetoplast 
and the basal body with respect to the nucleus is one of the main alterations 
that the cell undergoes during their transition from epimastigotes to 
trypomastigotes (Matthews, 2005). In the case of the epimastigotes, the 
kinetoplast and the basal body lie anterior to the nucleus. In the case of the 
trypomastigotes, the kinetoplast and the basal body are positioned posterior to 
the nucleus (Matthews, 2005; Ooi and Bastin, 2013).  
 
 
 
Figure 1-3. Cell architecture. Internal structure of T. brucei; for details refer 
to the legend. Adapted from (Matthews, 2005). 
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1.5 Cell Cycle 
 Cell cycle in eukaryotes 1.5.1
The cell cycle of eukaryotes consists of four stages, separated by 
checkpoints, which ensure the integrity of the cell (see below). The diverse 
checkpoints are essential for the regulation of different mechanisms such as cell 
growth, replication and chromosome segregation during mitosis (Barnum and 
O’Connell, 2014). Cyclin-dependent kinases (CDKs), which are serine/threonine 
protein kinases, play an important role during cell cycle progression. These 
protein kinases are not only involved in cell cycle regulation, but also have a 
critical role during transcription, autophagy and differentiation (Hisanaga and 
Endo, 2010; Yang et al., 2010; Malumbres, 2014).  
 
Like all kinases, CDKs structure consists of two lobes: a C-terminal lobe 
containing α- helix, and an N-terminal lobe containing β-sheets.  Between these 
structures the active site is localised (Malumbres, 2014). CDK activation is 
regulated by two events, the binding of a cyclin subunit and the phosphorylation 
by CDK-activating kinase (CAK) (Malumbres, 2014). The cyclin subunit binds to 
the C-terminal lobe. In the absence of the subunit, the active site is blocked by 
a flexible loop, also known as T-loop, impeding the binding of ATP (Malumbres, 
2014). The binding of the cyclin reorders the α-helix, facilitating the 
phosphorylation of Thr161, localised in the active site, by CAK (Malumbres, 
2014). Once the cyclin-CDK complex is activated, it has the capacity to 
phosphorylate several substrates, including substrates which promote new DNA 
synthesis and mitotic progression (Harashima, Dissmeyer and Schnittger, 2013; 
Barnum and O’Connell, 2014).  
 
The activated form of CDK is regulated during the cell cycle by the 
interaction with cyclin-dependent kinase inhibitor proteins (Wee1 or Myt1). 
These proteins phosphorylate the Thr14 and Tyr15 residues in the N-terminal 
lobe, reducing the affinity of the cyclin-CDK complex for its substrate 
(Malumbres, 2014). Cdc25 phosphatase is able to reverse the inactive state by 
cleaving the phosphate group of the Thr14 and Tyr15 residues (Malumbres, 
2014).   
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Cell cycle progression is regulated by the action of various cyclin-CDK 
complexes. In each step of the cell cycle, a different cyclin is required, leading 
to a continuous process of synthesis and degradation of the proteins. On the 
other hand, CDK synthesis remains constant during the cycle (Harashima, 
Dissmeyer and Schnittger, 2013). In mammalian cells there are four CDKs that 
are involved in cell cycle progression. The first stage of the cell cycle is gap1 
(G1), in which the cell increases its size preparing for replication, ensuring the 
accessibility of nutrients and cell integrity (Harashima, Dissmeyer and 
Schnittger, 2013; Barnum and O’Connell, 2014). Once the cell is ready for 
replication, CDK4 or CDK6 binds with cyclin D; followed by phosphorylation by 
CAK. This will result in the progression to S phase (Malumbres, 2014). The 
retinoblastoma protein (Rb) is inactivated during this process, as a consequence 
of phosphorylation by CDK4 or CDK6 activated kinase. Rb is associated with the 
repression of genes that encode for proteins involved in DNA synthesis 
(Malumbres, 2014). In S phase, cyclin E binds to CDK2; the activation of this 
complex promotes replication during S-phase. During this process there is the 
presence of two checkpoints, which are activated in the case of DNA damage. 
The checkpoints are regulated by the Chk1 (G1/S) and Chk2 (G2/M) kinases, and 
by ATM and ATR (serine/threonine kinases) (Harashima, Dissmeyer and 
Schnittger, 2013; Barnum and O’Connell, 2014). ATM and ATR are activated by 
DNA damage, phosphorylating ChK1 and Chk2, which subsequently phosphorylate 
Cdc25, impeding the activation of the cyclin-CDK complex (Harashima, 
Dissmeyer and Schnittger, 2013; Barnum and O’Connell, 2014). 
 
The transition to mitosis is regulated by the binding of cyclin A and B to 
CDK1. The cyclin-CDK complex is essential during this stage, promoting mitotic 
entry, chromosome condensation and spindle maturation and migration 
(Malumbres, 2014). The transition from metaphase to anaphase is regulated by 
the Anaphase promoting complex or Cyclosome (AP/C) (Manchado, Eguren and 
Malumbres, 2010; Barnum and O’Connell, 2014), which is an E3 ligase that 
consists of approximately 12 subunits and is regulated by the cofactors Cdc20 
(cell division cycle 20) and Cdh1. When sister chromatids and kinetochores are 
properly attached to the poles of the mitotic spindle, the cyclin A- or B-CDK1 
complex phosphorylates AP/C, promoting the binding with Cdc20 (Manchado, 
Eguren and Malumbres, 2010; Barnum and O’Connell, 2014).  AP/CCdc20 degrades 
28 
 
securin and cyclin A and B, promoting the release of separase (cysteine 
protease), whose role is to cleave the kleisin protein of the cohesin complex 
(Figure 1-4)(Manchado, Eguren and Malumbres, 2010). The cohesin complex is a 
multiple subunit complex, composed of  proteins that are members of the 
Structural Maintenance of Chromosomes (SMC) family (SMC1, SMC3), a α-kleisin 
protein (Scc1), and Scc3 (Peters, Tedeschi and Schmitz, 2008). Scc1’s N-terminal 
domain binds to SMC3 and the C-terminus binds with SMC1, forming a ring 
structure, which is followed by the binding of Scc3 with Scc1 (Figure 1-4)(Peters, 
Tedeschi and Schmitz, 2008). In the case of unattached kinetochores, the 
mitotic checkpoint proteins, known as Bub1R (serine/threonine kinase) in 
mammals and Bub1 in yeast, inhibit the action of Cdc20, impeding the activation 
of the AP/C complex (Barnum and O’Connell, 2014). Cdh1 is also involved in the 
regulation of AP/C complex activity. The association of AP/CCdh1 promotes 
mitotic exit by degrading cyclins A and B and other molecules, such as Aurora 
kinase and Plk1, which are involved in the removal of bulky cohesin during 
prophase (Peters, Tedeschi and Schmitz, 2008; Barnum and O’Connell, 2014).  
 
 
 
 
Figure 1-4. Diagram representing the cohesin complex and metaphase-
anaphase transition. Cohesin subunit Smc1 is in light grey and purple, Smc3 in 
dark grey and yellow, Scc1 and Scc3 in pink. Representation of the cleavage of 
the cohesion complex, inducing the transition from metaphase to anaphase.  
 
1.5.1.1 Mitosis     
Mitosis is an important process during cell division, permitting equal 
distribution of genomic material into two daughter cells. In eukaryotes there two 
types of mitosis: ‘open’ and ‘closed’. The first is characterised by the 
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breakdown of the nuclear membrane before chromosome segregation, and in the 
latter the nuclear envelope remains intact during chromosome distribution 
(Boettcher and Barral, 2012). Plants and animals are known to have an ‘open’ 
mitosis, while the members of the Excavata subgroup, which includes 
trypanosomes, are characterised by having a ‘closed’ mitosis. Interestingly, 
organisms such as fungi and amoeboid protists may go through ‘closed’ to ‘semi-
open’ and ‘open’ mitosis (Boettcher and Barral, 2012).   
 
Mitosis is subdivided into four stages: prophase, metaphase, anaphase and 
telophase (Figure 1-5). During each stage, the cell undergoes diverse changes. In 
a typical prophase, chromatin condensation occurs by formation of distinct 
visible chromosomes.  This event is driven by the condensin complex, which 
consist of two SMC proteins and three non-SMC proteins. This complex forms a 
ring, encircling two strands of DNA (Mitchison and Salmon, 2001; Antonin and 
Neumann, 2016).  The sister chromatids are joined by the centromere, the 
microtubule spindle is connected to the centromere via the kinetochore, and 
with the poles of the cell by the centrosome structure (Mitchison and Salmon, 
2001). Another main change during prophase is the disappearance of the nuclear 
membrane (Mitchison and Salmon, 2001), though, as mentioned above, not all 
eukaryotes undergo this event (Boettcher and Barral, 2012). In the case of 
‘closed’ mitosis, the chromosomes tend to localise close to the nuclear 
membrane (Ebrahimi and Cooper, 2012).  
 
In metaphase, the chromosomes line up along the centre of the nucleus, 
which is a consequence of the opposing forces generated by the microtubules 
(Mitchison and Salmon, 2001). On the other hand, during anaphase there is the 
separation of the sister chromatids, which start to migrate to the poles of the 
cell (Barnum and O’Connell, 2014). The transition between metaphase-anaphase 
is regulated by the AP/C complex, as described above.  
 
During the final stage of the cell cycle, termed telophase, the spindles 
disappear, there is a redistribution of the chromosomes and the formation of a 
new nuclear membrane (Salic and Mitchison, 2008). Mitosis is then followed by 
cytokinesis, which completes cell division by cytoplasm separation, normally 
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resulting in two identical daughter cells (Harashima, Dissmeyer and Schnittger, 
2013).   
 
 
 
 
Figure 1-5. Stages of mitosis. Diagram describing the different stages of 
mitosis. Prophase shows the condensation of the chromatin by the formation of 
distinct visible chromosomes. In metaphase the chromosomes align to the centre 
of the nucleus, while in anaphase the sister chromatids are separated and start 
migration to opposite poles. The last stage is telophase in which there is a 
reorganisation of the chromosomes.  
 
 Cell cycle in Trypanosoma brucei 1.5.2
 
The parasite T. brucei follows the typical route of the eukaryotic cell 
cycle, but with certain peculiarities. A prominent variation relative to a 
canonical eukaryote is the lack of chromatin condensation or dissolution of the 
nuclear membrane during mitosis, though these are also observed in other 
eukaryotes. As it was previously mentioned the organisms belonging to the 
Excavata subgroup are characterised by having a ‘closed’ mitosis, maintaining 
the nucleus envelope (Boettcher and Barral, 2012). On the other hand, the lack 
of chromatin condensation is not unique for T. brucei (Belli, 2000; Hammarton, 
2007), with the absence of chromatin compaction also detected in T. cruzi and 
Leishmania (Belli, 2000). 
   
The cell cycle progression in T. brucei, as in other eukaryotes, is regulated 
by cyclin-kinase complexes. In the parasite, 11 cyclin related kinases (CRK1-4, 
CRK6-12) and ten cyclins (CYC2-11) have been identified. Of these the roles of 
just two kinases and two cyclins have been elucidated (Monnerat et al., 2013). 
Depletion of CRK1 and CRK3 by RNAi has shown these proteins to have an 
important role during G1/S and G2/M progression (Tu and Wang, 2004). On the 
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other hand, depletion of cyclin CYC2 by RNAi results in the accumulation of cells 
in G1/S phase in procyclic forms (Li and Wang, 2003; Hammarton, Engstler and 
Mottram, 2004), and the depletion of CYC6 blocks mitosis in procyclic and in 
bloodstream forms (Hammarton et al., 2003).  In vivo analysis have confirmed 
the interaction of CRK3 with CYC2 and CYC6 in T. brucei and their role in the 
regulation of G1/S and G2/M transition (Van Hellemond et al., 2000; Hammarton 
et al., 2003; Monnerat et al., 2013), though it is still uncertain with which 
cyclins CRK1 is interacting in the parasite. It is known that in yeast CRK1 
interacts with cyclins CYC2, CYC4 and CYC5, but whether this is conserved  in T. 
brucei remains to be tested (Monnerat et al., 2013). A role for the CYC9-CRK12 
complex has also been demonstrated in bloodstream cell proliferation, though in 
procyclic forms the depletion of the cyclin-kinase complex does not affect the 
cell cycle  (Monnerat et al., 2013). 
 
As mentioned above (section 1.4), the parasite has single copy organelles 
and structures, which must be correctly replicated. Such replication includes the 
unusual genome composition of both the nucleus (which has many more 
chromosomes than most eukaryotes) and the mitochondrion (the unusual 
kinetoplast network)(Hammarton, 2007). For this reason, replication and 
segregation of the organelles maintain a specific order during the different 
phases of the cycle, assuring a viable progeny (Hammarton, 2007).  
 
During the G1 phase, duplication of the basal body and elongation of the 
new flagellum can be observed (Hammarton, 2007). It has been shown that polo-
like kinase (PLK) plays an important role during basal body duplication 
(Hammarton, 2007). PLK is a serine-threonine kinase that has been shown to 
have an important role in the context of cell progression in all eukaryotes 
(Harashima, Dissmeyer and Schnittger, 2013; Barnum and O’Connell, 2014). The 
depletion of PLK in procyclic T. brucei cells by RNAi results in cells with two 
nuclei but one kinetoplast, one basal body and one flagellum (reviewed by 
Hammarton 2007). The elongation of the new flagellum is followed by 
duplication of the Golgi apparatus, but the signals that initiate duplication are 
still uncertain (Hammarton, 2007). The Golgi apparatus is positioned alongside 
the basal body and kinetoplast, and Vps34 kinase is involved during this process 
(Hall et al., 2006; Hammarton, 2007).  
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The replication of the kinetoplast and nuclear DNA occurs during S phase, 
though completion of kinetoplast replication and division occurs  prior to 
completion of nuclear DNA replication (Hammarton, 2007; Li, 2012). It has been 
shown that the nucleus and the kinetoplast possess their own, distinct 
replication machinery (Hammarton, 2007). In the case of the nucleus, replication 
initiation is regulated by a divergent origin recognition complex (ORC), 
containing at least two proteins related to other eukaryotic ORC subunits, 
TbORC1/CDC6 and TbORC4, as well as further more diverged factors (De Melo 
Godoy et al., 2009; Tiengwe et al., 2012; Marques et al., 2016). How ORC 
activity is regulated is unclear, since no protein kinases that act on TbORC have 
been described. Indeed, the recruitment of one ORC-like protein, TbORC1B, to 
the nucleus only occurs during S phase, which may suggest very unusual 
regulation, since conventionally ORC is thought to be loaded to replication 
initiation sites during G1 phase (Dang and Li, 2011; Marques et al., 2016). It was 
suggested that kDNA replication is regulated by the abundance of TbPIF2, though 
the detailed regulation processes in this organelle are still uncertain (Li, 2012), 
at least in part because the kinetoplast recruits many novel replication or repair 
factors, including DNA polymerases, DNA ligases and further DNA helicases that 
appear either to have no counterparts in the nucleus or are exclusively found in 
the kinetoplast (Engel and Ray, 1999; Grams et al., 2002; Downey et al., 2005; 
Onn et al., 2006; David F Bruhn, Sammartino and Klingbeil, 2011). 
 
During the G2 phase, another checkpoint is present to ensure the integrity 
of the cell prior to mitosis. The transition from G2 to mitosis is regulated by the 
kinase CRK3 and the cyclin CYC6 (Hammarton et al., 2003). Mitosis in T. brucei 
is a complex process due to the number of chromosomes (~200) that are 
redistributed within the nucleus (Hammarton, 2007). Minichromosome and 
megabase chromosome segregation occur by different mechanisms: the 11 
diploid megabase chromosomes are segregated by a kinetochore-centromere 
dependent mechanism (Gull, Alsford and Ersfeld, 1998; Akiyoshi and Gull, 2014; 
D’Archivio and Wickstead, 2017), whereas the ~100 minichromosomes are 
segregated before the megabase chromosomes along pole-to-pole microtubules 
(Gull, Alsford and Ersfeld, 1998; Echeverry et al., 2012; Li, 2012). As shown in 
other eukaryotes, the transition from metaphase to anaphase is regulated by the 
APC/C complex. Tandem affinity purification and mass spectrometry analysis 
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was used to identify 10 subunits of T. brucei APC/C complex, including APC1, 
APC2, APC10/DOC1, APC11, CDC16, CDC23, CDC27, AP2, AP3 and APC4 (Kumar 
and Wang, 2005; Bessat et al., 2013). Although the general structure of AP/C is 
closely related to that observed in the rest of eukaryotes, it was possible to 
detect certain peculiarities, such as the absence of a securin homologue in the 
parasite, the lack of interaction between CDC20 and APC/C, as well as the lack 
of association of APC/C with mitotic checkpoint proteins (Bessat et al., 2013). 
Taken together, these data may suggest that T. brucei APC/C regulation differs 
from the rest of the eukaryotes (Bessat et al., 2013). The depletion of the 
subunits APC1, APC2 and CDC27 in procyclic cells results in an arrest in 
metaphase, suggesting that, despite the differences, T. brucei APC/C complex is 
involved in metaphase-anaphase transition (Kumar and Wang, 2005; Li, 2012; 
Bessat et al., 2013) 
 
The culmination of mitosis gives rise to cytokinesis, which occurs along the 
longitudinal axis of the cell (Zhou et al., 2016). A furrow forms initially in the 
anterior end of the new flagellum, and ingression of the furrow divides the 
cellular organelles and structures equally between progeny, resulting in two 
viable cells (Hammarton, 2007; Zhou et al., 2016). Cytokinesis in T. brucei is 
regulated by three proteins, CIF1 (Cytokinesis Initiation Factor1), which is also 
called TOEFAZ1 (Tip Of The Extending FAZ 1), Aurora B kinase (TbAuK) and Polo-
like kinase (TbPLK). CIF1 works like a substrate for both kinases (Zhou et al., 
2016). Although TbAuK and TbPLK have an important role during this process, 
these two proteins never interact during the cell cycle (Zhou et al., 2016). In S 
phase, TbPLK phosphorylates and recruits CIF1 to the tip of the new FAZ.  TbAUK 
concentrates to the kinetochore and central spindle during G2 and early 
anaphase, while TbPLK and CIF1 remain in the FAZ tip. During late anaphase, 
CIF1 recruits TbAUK to the new FAZ tip, while TbPLK diffuses into the cytoplasm 
(Li et al., 2010; Zhou et al., 2016). The recruitment of TbAUK initiates a cascade 
of signals that result in the formation of  the initial cleavage furrow (actomyosin 
contractile ring) (Minoshima et al., 2003; Li, Umeyama and Wang, 2009). 
Interestingly, depletion of CIF1 results in a ‘back-up’ cytokinesis, where the 
furrow ingression is originated in the posterior region (Sinclair-Davis, 2013; Zhou 
and Li, 2016).    
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1.6 Variant Surface Glycoprotein Coat and Immune 
evasion 
Certain microorganisms, including species of viruses, bacteria, fungi and 
protozoa, have evolved a strategy to avoid the host immune system by changing 
their surface molecules; this strategy is collectively known as antigenic variation 
(Deitsch, Lukehart and Stringer, 2009; Duraisingh and Horn, 2016; Palmer, 
Bankhead and Seifert, 2016). During the infection process, the host generates 
idiotypic antibodies to eliminate the pathogen and the pathogen changes the 
surface coat to temporarily avoid being recognized. Therefore, there is a 
constant coevolution between the host and infectious organism in which the 
most competent will survive (Barry, Hall and Plenderleith, 2012; Sironi et al., 
2015). Though the strategy of antigenic variation is a common route for surviving 
the host immune attack, the underlying molecular mechanisms and machinery in 
the different organisms are highly variable, suggesting independent evolutionary 
events. African trypanosomes are remarkable in that they utilise two commonly 
observed mechanisms for antigenic variation (transcription-based and 
recombination-based antigen switching), whereas most other organisms employ 
a single strategy (McCulloch, 2004; Horn, 2014; Duraisingh and Horn, 2016).  
 
In the mammalian bloodstream, each T. brucei cell is covered with 
approximately five million dimers of one type of variant surface glycoprotein 
(VSG), which is thought to form a protective coat that shields invariant surface 
antigens from immune recognition (Pays, Vanhamme and Pérez-Morga, 2004; 
Smith et al., 2009; Stijlemans et al., 2016; Bartossek et al., 2017), though this 
view has been challenged due to the discovery of an invariant surface 
glycoprotein that may project beyond the VSG coat (Overath et al., 1994; 
Schwede and Carrington, 2010). A VSG monomer is composed of a C-terminal 
domain and an N-terminal domain, with the C-terminus arranged towards the 
cell surface, where it is anchored by GPI, and the N-terminal domain 
predominantly exposed to the host immune system (Hall, Wang and Barry, 2013). 
During an infection, the parasites have the capacity to express different VSG 
coats; as the host immune system recognizes the currently expressed surface 
VSG and eliminates the infecting parasites, a population of cells that have 
switched to express a new VSG variant coat allow part of the infectious 
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population to survive, proliferate and continue the infection (Jackson et al., 
2012). The success of this strategy appears to rely on a number of features, in 
common with antigenic variation in all organisms that use this strategy. First, 
trypanosomes have an ‘archive’ of new surface antigen genes, ready to be 
expressed (Jackson et al., 2012).  Second, trypanosomes ensure that only a 
single VSG coat is expressed in a single cell at one time, a control termed 
monoallelic expression. Third, trypanosomes have mechanisms to execute a 
switch in the expressed VSG (Hovel-Miner et al., 2015). 
 
 Organization of VSG genes 1.6.1
T. brucei has >1000 silent VSG genes, which are distributed among the 
chromosome subtelomeres of all types of chromosome in the genome (Berriman 
et al., 2005), including the 11 large, diploid megabase chromosome (MBC) and 
specialised, aneuploid intermediate and minichromosomes, which seem to have 
evolved to provide a reservoir of new VSGs (Barry et al., 2003; Morrison, 
Marcello and McCulloch, 2009). The vast majority of the VSG archive is found in 
silent, subtelomeric arrays in the megabase chromosomes (Marcello and Barry, 
2007), and variations in these parts of the chromosome appear to underlie the 
observed flexibility in the chromosome (and perhaps genome) size amongst 
strains of T. brucei (Callejas et al., 2006). However, most of the silent VSG 
archive is not composed of intact VSGs, with ~85%  found to be either 
pseudogenes or gene fragments (Berriman et al., 2005). The requirement that 
only a single VSG gene is expressed in one cell at any given time is achieved by 
VSG expression in the mammal being limited to specialised bloodstream form 
expression sites (BES) that are located in the telomeres of the MBCs and some 
intermediate chromosomes. BES consist of a defined structural organisation 
(Figure 1-6) (Vanhamme et al., 2001). During transcription, the active VSG-ES 
promoter recruits RNA Polymerase I within a putative subnuclear structure 
known as the expression-site body (ESB) (López-Farfán et al., 2014; Glover et 
al., 2016). In this site, a single VSG gene, in combination with expression site 
associated genes (ESAGs), is transcribed (Günzl et al., 2015). This contrasts with 
metacyclic forms, where one VSG gene is transcribed in a metacyclic expression 
site that does not encode ESAGs (Ginger et al., 2002).   
 
36 
 
 
 
Figure 1-6. Schematic representation of BES architecture. 50 bp repeats 
(yellow), whose function is unknown, is localised upstream of the promoter 
(black arrow). Downstream of the promotor are localised multiple ESAG genes 
(purple), the 70 bp repeat sequence (pink) and the VSG (green), which is located 
proximal to the telomere. Not to scale. 
 
 Monoallelic expression  1.6.2
Surprisingly, approximately 20-40 ES have been estimated in the T. brucei 
genome, and 15 have been documented and sequenced in the strain Lister 427 
(Chapter5, Figure 5-17) (Borst and Ulbert, 2001; Hertz-Fowler et al., 2008; 
Landeira et al., 2009). However, only one BES is active at a time, ensuring 
singular VSG expression, though the details of how such ‘monoallelic expression’ 
is achieved are still being determined (Nguyen et al., 2014).  Chromatin 
structure is an important factor in the regulation of monoallelic expression. 
Studies have demonstrated that the active BES contains a reduced number of 
nucleosomes relative to the silent BES, suggesting that this event may be 
regulating Pol I transcription and monoallelic expression (Figueiredo and Cross, 
2010; Hovel-Miner et al., 2015). Moreover, histone deposition proteins are also 
associated with BES promoter silencing. Depletion of these proteins (FACT, NLP, 
Asf1A or Caf-19), results in an increase in transcription of silenced BES 
(Narayanan et al., 2011; Alsford and Horn, 2012). Another factor involved is the 
histone modifier DOT1B,  depletion of this factor delays the active to silent 
transition, resulting in parasites expressing two VSGs for a prolonged time period 
(Figueiredo, Janzen and Cross, 2008). Recent studies have shown a novel factor, 
VEX1, as a positive and negative regulator of BES that appears to co-localise with 
the ESB (Glover et al., 2016). The origin recognition complex, or at least 
ORC1/CDC6, has also been associated with the maintenance of monoallelic 
expression (Benmerzouga et al., 2013).  
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 VSG switching 1.6.3
T. brucei has two switching strategies: transcriptional switching, and 
recombination. In the first strategy, often called in situ switching, an activated 
BES is silenced and a silent BES is activated. This mechanism may predominantly 
occur during the early infection stage, since only the VSG genes that are already 
located in the BES can participate in this switching process (Figure 1-7 A) 
(McCulloch and Barry, 1999; Vanhamme et al., 2001; Taylor and Rudenko, 2006). 
Recombination is the more common switching mechanism, allowing the parasite 
to move a silent VSG into a BES and thereby become expressed. A number of 
mechanisms have been described that account for VSG recombination switching. 
The most common is a gene conversion mechanism, sometimes called duplicative 
transposition (Figure 1-7 B), where the VSG gene that is located in the active BES 
is deleted and replaced by a copy of a silent gene. Gene conversion can use 
functionally intact silent VSGs, which are able to be translated and form a VSG 
coat(Horn, 2014). Alternatively, the VSG pseudogenes and fragments can be 
recombined by segmental gene conversion reactions, using multiple silent genes 
to form novel VSG ‘mosaics’(Figure 1-7 C)(Marcello and Barry, 2007; Hall, Wang 
and Barry, 2013). A final form of recombination is termed reciprocal 
recombination (Figure 1-7 D), where there is a telomere exchange, moving a 
silent gene into the active BES and the transcribed VSG gene to the silent 
telomere (Horn, 2014). It is suggested that recombination-based VSG switching 
takes advantage of the parasite’s homologous recombination (HR) pathway, 
which is a general strategy for repair of genome damage or replication stalling 
(McCulloch and Barry, 1999; Vanhamme et al., 2001). Whether or not parasite-
specific factors or processes direct such recombination events during VSG 
switching, and whether mosaic VSG formation also uses HR, is largely unclear. 
For instance, it has been suggested that DNA breaks within the BES initiate 
recombination, but how these form and whether they are sequence-specific 
remains undetermined (Boothroyd et al., 2009; Glover et al., 2013). Recent 
studies have alternatively suggested that replicative lesions may trigger VSG 
switching in the parasite (Devlin et al., 2016). VSG switching is essential for the 
survival of the parasite, allowing it to change its coat and avoid the host immune 
system, and indeed some further work suggests that expression of the VSG itself 
is essential, since RNAi ablation of VSG is lethal in vitro (Sheader et al., 2005). 
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The switching rate of laboratory-adapted lines is 10-6 cells per generation, but it 
can occur at much higher rates (10-2-10-5) if the cells have been recently 
recovered from field isolates (Vanhamme et al., 2001). Switching is not induced 
by antibodies, and is largely stochastic, though some order of VSG expression is 
seen during infections (Morrison et al., 2005), and it may have an important 
functional relationship with long slender to short-stumpy form differentiation 
(Batram et al., 2014).  
 
 
 
Figure 1-7. VSG switching strategies. A. In the transcriptional switching, the 
telomere of the ‘active’ BES (green ) is exchanged for a ‘silent’ VSG (grey). B. A 
silent VSG is duplicated to the active ‘BES’ replacing the active VSG. C. A new 
VSG is generated by segments of other VSG genes, resulting from a segmental 
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gene conversion.  D. Telomere exchange, result in the replacement of the active 
VSG by another telomeric VSG. 
 
1.7 DNA Polymerases  
DNA Polymerases (Pols) play important roles in all organisms, both during 
genome replication and repair. These enzymes are divided into four families 
based on sequence homology: A, B, X and Y (Table 1-1). Despite the differences 
between members of these diverse families, the catalytic reaction is conserved, 
with few exceptions. DNA Pols have the capacity to add nucleotides in order to 
synthesise a DNA strand. For DNA synthesis, the polymerases normally require a 
single-stranded DNA template and a primer (a short DNA or RNA molecule), 
which anneals to the template and provides  a 3’-OH group that is the starting 
point for new synthesis (Cotterill & Kearsey, 2002; Rothwell & Waksman, 2005). 
Apart from these elements, the Pols require four deoxyribonucleotide 
triphosphates (dATP, dTTP, dGTP and dCTP) that are incorporated into the new 
strand,  following  Watson and Crick pairing rules (A•T and G•C), in a 5’-
3’direction (Cotterill & Kearsey, 2002). Mg2+ ions have an important function in 
this process, facilitating the bond between the 3’-OH group of the primer and 
the α-phosphate of the dNTP (Cotterill and Kearsey, 2002). In the case of repair 
DNA Pols, they have the capacity to extend the sequence using mismatched 
primers, and new synthesis does not necessarily follow the Watson and Crick 
pairing rules (Cotterill and Kearsey, 2002). 
 
 
Table 1-1.Eukaryotic DNA polymerases. Members of the A, B, X and Y family of 
polymerases and their proposed role in the cell. Table based on (Cotterill and 
Kearsey, 2002). 
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 Polymerase families 1.7.1
1.7.1.1 A family 
A family of DNA Polymerases (Pols) are involved in replication and repair 
processes and are known for their high fidelity due to their 3’-5’ exonuclease 
activity, which allows the excision of incorrectly inserted nucleotides. In 
bacteria, polymerase I (Pol I) is a member of the A family and was the first DNA 
Pol ever described (Bebenek and Kunkel, 2004; Johansson and Dixon, 2013), with 
a total of five bacterial DNA Pols subsequently described (I, II, III, IV and V) 
(Bebenek and Kunkel, 2004).  Bacterial DNA PolI is involved in repair and the 
maturation of Okazaki fragments during DNA replication (Rothwell and 
Waksman, 2005; Garcia-Diaz and Bebenek, 2007). In eukaryotes, the A family is 
composed of DNA polymerases gamma (Pol ɣ), theta (Pol θ) and nu (Pol N), with 
Pol ɣ being associated with mitochondrial replication, base excision repair (BER) 
and non-homologous end joining (NHEJ) (Bebenek and Kunkel, 2004; Garcia-Diaz 
and Bebenek, 2007). On the other hand, Pol θ and Pol N are characterised by the 
absence of the 3’-5’  proofreading activity, suggesting roles in translesion DNA 
synthesis (TLS) (Garcia-Diaz and Bebenek, 2007)(discussed below).  
 
1.7.1.2 B family 
In eukaryotes, the B family is formed by polymerase alpha (Pol α), 
polymerase delta (Pol δ), polymerase epsilon (Pol ε) and polymerase zeta (PolZ). 
Pol δ and  Pol ε are high fidelity polymerases with the ability to excise 
incorrectly inserted nucleotides due to their 3’-5’ proofreading activity 
(Rothwell and Waksman, 2005). Polδ and Polε are directly involved in the 
synthesis of the leading and lagging strands during DNA replication 
(Shcherbakova, Bebenek and Kunkel, 2003; Bebenek and Kunkel, 2004). 
Polymerase α and polymerase zeta (PolZ) lack  proofreading activity. The former 
is involved in the initiation of DNA synthesis due to its ability to elongate  RNA 
primers at replication origins and in the lagging DNA strand  (Bebenek and 
Kunkel, 2004; Garcia-Diaz and Bebenek, 2007). The latter is suggested to be 
involved in translesion synthesis (Goodman, 2002; Garcia-Diaz and Bebenek, 
2007). E. coli Pol II is also a member of the B family of polymerases, harbouring 
a 3’-5’ proofreading activity, associated with replication restart and TLS 
(Bebenek and Kunkel, 2004). 
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1.7.1.3 X family 
The members of the X family, which includes polymerase beta (Pol β), 
polymerase sigma (Pol σ), polymerase mu (Pol µ) and polymerase lambda (Pol λ), 
operate in the context of DNA repair (Rothwell and Waksman, 2005; Garcia-Diaz 
and Bebenek, 2007). Pol β is known to participate in the nuclear base excision 
repair pathway (Garcia-Diaz and Bebenek, 2007)(see below). In T. brucei, Polβ 
and Polβ-PAK are localised to the mitochondrion, showing nonredundant roles.  
Polβ has an active role during the maturation of the Okazaki fragments and Polβ-
PAK is associated with gap filling during the final stage of minicircle replication 
(Saxowsky et al., 2003; David F Bruhn, Sammartino and Klingbeil, 2011). Studies 
in T. cruzi have demonstrated a potential role of Polβ in BER of oxidative 
damage, since the overexpression of Tc Polβ increased the survival rate of 
epimastigotes in the presence of H2O2 (Schamber-Reis et al., 2012). This 
contrasts with L. infantum, where Pol β has a nuclear localisation, like higher 
eukaryotes, thus suggesting an important role for Pol β in nuclear BER (Alonso et 
al., 2006). Pol µ and Pol λ participate in non-homologous end-joining, and Pol λ  
has also been implicated in BER (Bebenek and Kunkel, 2004; Garcia-Diaz and 
Bebenek, 2007). Finally, studies in S. cerevisiae indicate Pol σ has a  role in 
sister chromatid cohesion, assuring equal chromosomal segregation (Edwards et 
al., 2003a). 
 
1.7.1.4 Y family 
All members of the Y family  are known as translesion polymerases (TLS 
pol), though the same activity is found in a few members of the A (Polν, Polθ) 
and B (PolZ) families (Garcia-Diaz and Bebenek, 2007). These polymerases have 
an important role in the survival of the cell, permitting the cell to tolerate 
damage during replication. Even though the replicative machinery is known to be 
highly efficient, this process can be interrupted by unresolved lesions, resulting 
in replication fork stalling (Sale, Lehmann and Woodgate, 2012). TLS Pols are 
involved in the bypass of unrepaired lesions by replacing the replicative 
polymerases and extending through the damage (Garcia-Diaz and Bebenek, 2007; 
Sale, Lehmann and Woodgate, 2012; Vaisman and Woodgate, 2017). During this 
process, they are prone to insert mutations due to their lack of 3’-5’ 
proofreading activity (Garcia-Diaz & Bebenek, 2007; Sale et al., 2012; Vaisman & 
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Woodgate, 2017). The average rate of mutation is between 10-2-10-4 errors per 
base replicated (Rothwell and Waksman, 2005), of which some mutations will be 
lethal for the cell (Sale, Lehmann and Woodgate, 2012). In humans, seven 
polymerases are suggested to have TLS activity: PolZ, Polν, Polθ, Polι, Polη, PolƘ 
and Rev1 . On the other hand, S. cerevisiae only harbour three TLS Pols, PolZ, 
Polη and Rev1. These polymerases are not restricted to eukaryotes (Bebenek and 
Kunkel, 2004). E. coli contains three TLS pols: two Y family members (Pol IV 
(DinB) and Pol V (UmuD2C)), and one B family member (Pol II), which are known 
to be involved in the SOS repair pathway (Goodman, 2002; Bebenek and Kunkel, 
2004). 
 
 Polymerase Structure 1.7.2
The general structure of DNA polymerases is highly conserved among the 
different families, though with certain variations. The overall structure 
resembles a right hand, containing palm, finger and thumb subdomains (Figure 
1-8). The palm domain harbours the catalytic carboxylate-metal ion complex, 
whereas the finger and the thumb grasp the template and the primer, creating 
an active site (Rothwell and Waksman, 2005). In the case of the Y family DNA 
pols, the finger and thumb are smaller, thus facilitating the binding of DNA 
lesions (Chun and Jin, 2010). In addition, Y family DNA pols have an extra 
structure called the little finger, wrist or polymerase-associated domain (Figure 
1-8); this domain may be involved in the substrate specificity of these Pols 
(Garcia-Diaz and Bebenek, 2007; Sale, Lehmann and Woodgate, 2012). 
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Figure 1-8. Structural similarities of DNA polymerases. Comparison between 
the general DNA polymerase structure and the structure of Y- family 
polymerases. Diagram showing the different subdomains: palm (purple), thumb 
(pink), finger (yellow) and little finger (grey), in the particular case of the Y-
family polymerases.   
 
1.8 Damage repair pathways 
DNA damage originates from many sources such as UV or gamma 
radiation, chemical agents and reactive oxygen species, some generated within 
the cell (Waters et al. 2009). Several mechanisms to repair these lesions have 
been described and are conserved across all domains of cellular life: nucleotide 
excision repair, base excision repair, mismatch repair, homologous 
recombination, non-homologous end joining and microhomology-mediated end 
joining (Figure 1-9)(García-Díaz and Bebenek, 2007; Waters et al. 2009). Despite 
the abundance and diversity of these repair mechanisms, a tolerance pathway is 
also needed under circumstances where the lesion cannot be eliminated, 
thereby preventing the collapse of cell integrity and function (L S Waters et al., 
2009). 
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Figure 1-9. DNA damage and possible DNA repair pathways. Figure shows 
mechanisms of DNA repair such as base excision repair (BER), homologous 
recombination (HR), non-homologous end joining (NHEJ), nucleotide excision 
repair (NER) and mismatch repair (MMR). Figure adapted from (Cervelli et al. 
2012). 
 
 Base excision repair (BER) 1.8.1
The BER pathway commonly repairs lesions generated by oxidation, 
alkylation and deamination of bases (Krokan and Bjørås, 2013) by removing the 
damaged base(s), and thus preventing the insertion of mutations or possible 
breaks during DNA replication (Krokan and Bjørås, 2013). DNA glycosylases are 
critical for recognizing and removing the incorrect base, thus leaving an 
apurinic/apyrimidinic site(AP) site. AP endonucleases then cleave the AP site, 
generating a 3’hydroxyl end and a 5’ deoxyribosephosphate, which will facilitate 
new DNA synthesis, most commonly catalysed by Pol β (Krokan and Bjørås, 
2013). In Leishmania spp (Passos-Silva et al., 2010; Genois et al., 2014) Polβ is 
localised in the nucleus and a BER activity has been demonstrated. It has been 
proposed that Polβ BER activity is critical especially during the amastigote stage, 
where the parasite has to survive the hostile environment of the macrophages 
(Taladriz et al., 2001). In the case of T. cruzi and T. brucei, Polβ and Pol β-PAK 
have a mitochondrial localisation, suggesting a role during the maintenance of 
the kinetoplast (Saxowsky et al., 2003; Lopes et al., 2008; Genois et al., 2014). 
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Why there is such a putative BER functional dichotomy within the kinetoplastids 
has not been explored. 
 Nucleotide excision repair (NER) 1.8.2
The NER mechanism is divided in two pathways, global genome NER (GG-
NER) and the transcription coupled NER (TC-NER). GG-NER is associated with 
repair throughout the genome, and TC-NER is associated with repair of lesions 
that block transcription (Compe and Egly, 2012). NER is involved in the repair of 
helix distorting lesions, including those caused by UV radiation, which results in 
DNA adducts including thymidine dimers and 6,4 photoproducts (Schärer, 2013). 
This repair pathway acts by removing short oligonucleotides containing the 
lesion, leaving a 3’ hydroxyl end and 5’ deoxyribosephosphate. Gap synthesis is 
catalysed by Pol δ, Pol ε or Polκ, and DNA is rejoined by DNA ligase III (Schärer, 
2013). T. brucei, T. cruzi and Leishmania lack ligase III, suggesting that this 
enzyme is replaced by the activity of DNA ligase I (Passos-Silva et al., 2010). It is 
known that the general transcription factor TFIIH, together with XPG, is 
necessary for the cleavage of the 3’ site, and XPF is involved in the cleavage of 
the 5’ site. XPD and XPB, which are part of TFIIH, unwind the DNA strands 
(Compe and Egly, 2012). 
 
The transcription factor complex, TFIIH, has a critical role during NER. 
This complex consists of two subcomplexes, the first formed by two helicases 
(XPB and XPD) and five associated proteins (p62, p52, p44, p34 and p8/TTD-A), 
and the second by the kinase activating complex, CAK. Helicases XPA, XPC, XPE, 
XPF and XPG also participate in the NER pathway (Compe and Egly, 2012). In T. 
brucei, two genes have been identified that encode for two XPB proteins, one of 
105 kDa (XPB) and a second one of 89 kDa (XPBz) (Badjatia et al., 2013). 
Deletion of T. brucei XPBz has demonstrated that the protein is non-essential 
and that its loss increases the sensitivity of the cells to UV radiation and 
cisplatin (Badjatia et al., 2013). Therefore TbXPBz has been associated with the 
TC-NER pathway (Machado et al., 2014). RNAi studies targeting XPG, XPD and 
XPB have also been performed, suggesting that NER activity is uniquely 
associated with XPG, which shows a similar effect to RNAi against CSB, which 
initiates TC-NER. Thus, only CSB, XPBz and XPG appear to act in NER, suggesting 
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that the TC-NER mechanism seems to  predominate in the parasite (Machado et 
al., 2014). 
 
  Mismatch repair (MMR) 1.8.3
The MMR pathway is  highly conserved in all kingdoms and is required 
during the repair of erroneous base insertions produced by DNA synthesis or 
homologous recombination (HR) (Marinus, 2012). T. brucei and T. cruzi express 
many proteins involved in this process, including MSH2 and MLH1, suggesting that 
these organisms are fully capable of repairing lesions requiring the MMR pathway 
(Augusto-Pinto and Bartholomeu, 2001; Bell et al., 2004; Passos-Silva et al., 
2010).  
 
 Non-homologous end joining (NHEJ) 1.8.4
The NHEJ pathway is involved in the repair of DNA double-strand breaks 
(DSBs) by promoting the re-ligation of the lesion, without relying on a template 
(Schärer, 2013). T. brucei, T.cruzi and L. major harbour several proteins known 
to be involved in this pathway, such as Mre11, Rad50, KU70 and KU80. In spite of 
the presence of the proteins, studies suggest that each of the parasites lacked 
NHEJ activity and, instead an alternative repair pathway, termed 
microhomology-mediated joining (MMEJ) predominates  (Burton et al., 2007; 
Glover, Jun and Horn, 2011; Genois et al., 2014). MMEJ is another repair 
pathway that is considered a non-homologous mechanism, though in this case it 
requires between 5-25 bases of imperfect homology in order to promote re-
ligation of a DSB (Truong et al., 2013). This mechanism is associated with 
chromosome aberrations such as translocation, deletion and inversions (Truong 
et al., 2013) and is readily detected in kinetoplastids, perhaps due to the lack of 
NHEJ (Burton et al., 2007; Peng et al., 2015). 
 
 Homologous recombination (HR) 1.8.5
The HR repair pathway is involved in the repair of  DSBs and the restart of 
stalled replication forks (Costes and Lambert, 2013). The repair of DSB lesions 
involves the activity of a group of proteins which lead the recombination steps 
(Figure 1-10). The first step is the recognition of the DSB by the MRN complex 
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(Mre11-Rad50-NBS1) in humans, or the MRX (Mre11-Rad50-Xrs2) complex in S. 
cerevisiae. This is followed by the binding of replication protein A (RPA; SSB in 
bacteria) and recombination mediators such as RAD52 and RAD54 to the ssDNA, 
stimulating RAD51 (Renkawitz, Lademann and Jentsch, 2014). The loading of 
Rad51 to ssDNA depends of BRCA2 and Rad51 paralogs (RAD51B, RAD51C, 
RAD51D, XRCC2 and XRCC3) (Sung and Klein, 2006; Suwaki, Klare and Tarsounas, 
2011; Costes and Lambert, 2013). It is known that Rad51 interacts with BRCA2 
via BRC repeat motifs present in the latter protein (Lord and Ashworth, 2007). 
The precise role of Rad51 paralogs during this process is still uncertain, but it 
has been demonstrated that in the absence of these proteins there is an 
inefficient HR process (Suwaki, Klare and Tarsounas, 2011). It has also been 
proposed that Rad51C and XRCC3 play a role during branch migration (Badie et 
al., 2009; Suwaki, Klare and Tarsounas, 2011). Moreover, it has been suggested 
that Rad51C, XRCC2 and XRCC3 are involved in chromosome segregation and 
centrosome integrity (Griffin et al., 2000; Renglin Lindh et al., 2007).   
 
Once Rad51 binds onto ssDNA, it forms a helical protein filament known as 
presynaptic filament (Sung and Klein, 2006; Costes and Lambert, 2013). Rad51 is 
universally conserved, with close homologues in bacteria and archaea called 
RecA and RadA, respectively. The presynaptic filament next binds to the DNA 
duplex (synaptic complex), initiating the search for homology along the duplex 
(Sung and Klein, 2006). The strand invasion is promoted by the action of 
accessory factors (including Rad54, Rad54B), forming a DNA joint known as a 
displacement (D)-loop (Sung and Klein, 2006; Costes and Lambert, 2013). DNA 
synthesis starts from the 3’ broken end, using the homologous sequence as a 
template and the invaded ssDNA as a primer. This process commonly results in 
the formation of a recombination intermediate known as the Holliday junction 
(HJ). The dissolution of the HJ is performed by branch migration (Renkawitz, 
Lademann and Jentsch, 2014). There is an alternative pathway known as 
synthesis-dependent strand annealing (SDSA), where the HJ is not formed due to 
the migration of the DNA strand after DNA synthesis (Renkawitz, Lademann and 
Jentsch, 2014). 
 
In kinetoplastids, HR is the main mechanism involved in the repair of 
DSBs. T. brucei, T. cruzi and L. major encode for the main HR proteins, BRCA2 
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and Rad51 (Passos-Silva et al., 2010). Rad51 has been characterised amongst the 
three species, demonstrating a role during this repair mechanism (Passos-Silva et 
al., 2010). As in other eukaryotes, Rad51 interacts with the BRC repeat motifs of 
BRCA2. Interestingly the parasite has evolved an expansion of BRC repeats, with 
15 predicted BRC repeats (Hartley and McCulloch, 2008), which contrasts with 
mammals that have eight BRC repeats, and T. cruzi and L. major, where BRCA2 
harbours two BRC repeats (Hartley and McCulloch, 2008; Carreira and 
Kowalczykowski, 2011; Genois et al., 2012). Unlike other organisms, such as 
Leishmania and mammals, it is proposed that BRCA2 in T. brucei is not solely 
involved in the recruitment of Rad51. Instead, it is suggested that is associated 
with the subnuclear redistribution of Rad51 (Genois et al., 2012; Trenaman et 
al., 2013; Lord and Ashworth, 2016). BRCA2 also contributes to VSG switching, 
since its loss impedes the reaction (Hartley and McCulloch, 2008).  
 
Rad51 paralogues also play an important role in T.brucei HR.  Six Rad51- 
like proteins were identified in the parasite. Mutants have been made in all the 
proteins, demonstrating they all act in repair, presumably through  HR 
(Proudfoot and McCulloch, 2005; Dobson et al., 2011). Interestingly, the 
disruption of Rad51-3 also results in a decrease of VSG switching rate (Proudfoot 
and McCulloch, 2005), like RAD51, reaffirming  an association of HR and VSG 
switching in the parasite (McCulloch and Barry, 1999; Proudfoot and McCulloch, 
2005). 
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Figure 1-10. Activity of Rad51 during homologous recombination. Diagram 
detailing the homologous recombination pathway. In yellow is represented the 
MRN complex, in grey  replication protein A (RPA) and in pink Rad51. 
 
 Translesion synthesis (TLS) 1.8.6
It is thought that when the replicative DNA pols α, ε and δ, encounter 
replication fork-blocking lesions, all or some of the replicative DNA pols are 
replaced by a TLS polymerase (Garcia-Diaz and Bebenek, 2007). TLS pols have 
the ability to insert nucleotides opposite to damage and, in this way, permit the 
replication process to continue. Depending on the lesion, TLS synthesis can be 
performed by one TLS pol or by the collaboration of two TLS pols (Bebenek and 
Kunkel, 2004) (Figure 1-11). This process is known as a tolerance mechanism, 
since the damage may not be corrected (L S Waters et al., 2009). When TLS pols 
synthesize DNA on a damaged template, the error rate can be as high as 1 
incorrect nucleotide for every 10 bases replicated (L S Waters et al., 2009). 
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Recent studies have demonstrated that TLS pols can replace each other since,  
when a specific TLS Pol is not present, other Pols can be recruited and 
synthesise on the template. This may result in an increased probability of 
generating mutations (Friedberg, Lehmann and Fuchs, 2005). An example 
includes Xeroderma pigmentosum (XPV) syndrome, which is a type of skin cancer 
caused by the incapacity of the cells to repair UV lesions (Kannouche and Stary, 
2003). XPV can be the result of a mutation in the XPV gene, impeding the 
activation of Polη, interrupting the repair of UV lesions. It has been proposed 
that in the absence of Polη, an alternative TLS pol acts to bypass the damage, 
increasing the mutation probability and  leading to the development of the 
disorder (Kannouche and Stary, 2003; Jansen et al., 2014). Studies suggest that 
Polι may be one of the Pols able to compensate for the absence of Polη (Jansen 
et al., 2014). 
 
 
 
 
Figure 1-11. Schematic representation of DNA damage repair by translesion 
synthesis. A. Translesion synthesis by a single TLS pol, showing the replacement 
of the replication polymerase (green) by the translesion polymerase (purple), 
the one that is subsequently replaced by the replicative polymerase B. 
Translesion synthesis by two TLS pols. Showing two subsequent switches 
between two different TLS pols, the first inserts the nucleotide and the latter 
extends the strand. As in the first mechanism the TLS pol is replaced by the 
replicative polymerase.   
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But TLS pols may have multiple functions. In S. cerevisiae Pol Z is able to 
synthesise through UV damage-associated lesions, such as TT dimers (an activity 
also seen in PolH) and is also capable of elongating mismatched primers (Rattray 
and Strathern, 2003; L S Waters et al., 2009), thereby increasing its capacity to 
retain mutations in the genome. In yeast, Pol Z is the cause of 50-70% of 
spontaneous mutations (Goodman, 2002). While in mammals this enzyme has an 
essential role during embryogenesis; experiments performed in mice show that a 
knockout of PolZ causes death during embryonic development (Esposito et al., 
2000; Gómez-Llorente et al., 2013), suggesting the Pol Z might have an 
important role during cell division (Esposito et al., 2000). In mammals, PolQ 
(Polθ) has a helicase domain and a polymerase domain (Li, Gao and Wang, 2011). 
This polymerase has been associated with several repair pathways apart from 
TLS, including MMEJ, BER and HR (Beagan et al., 2017).  Studies performed on 
PolN in humans, suggest that this polymerase is involved in cross-link repair and 
HR (Moldovan et al., 2010) . A notable feature of these two enzymes is that the 
polymerase domain of mammalian PolN is similar to the polymerase domain of 
mammalian PolQ (Marini et al., 2003). Studies in the fly, Drosophila 
melanogaster, show a close relation between HEL308 (ortholog of human PolQ) 
and PolN due to an ancient gene duplication event; it was also shown that 
expression of both genes overlaps, which suggests that these two polymerases 
might function together in the cell (Marini et al., 2003). 
 
1.8.6.1 Recruitment of translesion polymerases 
The proliferating cell nuclear antigen (PCNA) is a homotrimeric protein 
whose role is to encircle the DNA and orchestrate the recruitment of proteins 
involved in DNA damage repair, DNA replication and chromatin structure 
maintenance (Andersen, Xu and Xiao, 2008). It has been demonstrated that TLS 
Pols are able to interact with PCNA through a motif known as the PIP box 
(Boehm, Spies and Washington, 2016). The interaction between the polymerase 
and the PCNA clamp increases the processivity of the polymerase, which can be 
described as the number of nucleotides that are incorporated by the polymerase 
in a single association (Zhuang and Ai, 2010). Furthermore, mono-ubiquitination 
(MUB) of PCNA promotes the switch between the replicative polymerase and the 
translesion polymerase, while polyubiquitination (POLYUB) is linked with an 
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error-free repair pathway (Lehmann et al., 2007; Boehm, Spies and Washington, 
2016).  
 
Blockage of the replication fork leads to a prolonged single-stranded DNA 
(ssDNA), followed by the association of the RPA with the ssDNA. This event 
triggers MONOUB of the PCNA by the RAD18-RAD6 complex (Mailand, Gibbs-
Seymour and Bekker-Jensen, 2013; Boehm, Spies and Washington, 2016). This 
then leads the switch of the replicative polymerase with the TLS pol, facilitating 
the bypass of the lesion. MUB of the PCNA can be reversed by the 
deubiquitylating enzyme known as ubiquitin-specific processing protease 1 
(USP1) (Mailand, Gibbs-Seymour and Bekker-Jensen, 2013). The PCNA can also 
undergo POLYUB, and this event is driven by the E3 ligase Rad5 in association 
with the MMS2-UBC13E2 ubiquitin-conjugating enzyme complex (Mailand, Gibbs-
Seymour and Bekker-Jensen, 2013; Boehm, Spies and Washington, 2016). 
POLYUB in higher eukaryotes leads to the recruitment of the helicase-nuclease 
ZRANBR3, suggesting that this molecule facilitates the binding of the PCNA to 
the stalled replication fork (Mailand, Gibbs-Seymour and Bekker-Jensen, 2013). 
Studies have shown that certain genotoxic agents, such as UV irradiation, methyl 
methanesulfonate, cisplatin and benzo[α]-diolepoxide are more prone to cause 
MONOUB of PCNA (Stelter and Ulrich, 2003; Solomon, Cardoso and Knudsen, 
2004; Lehmann et al., 2007). In mammalian cells, UV irradiation mainly causes 
mono-ubiquitination (Stelter and Ulrich, 2003; Kannouche, Wing and Lehmann, 
2004; Lehmann et al., 2007). 
 
 Translesion Polymerases in kinetoplastids 1.8.7
Studies to date on TLS Pols in kinetoplastids are relatively limited. Recent 
work in L. infantum demonstrated TLS activity of LiPolθ, which is capable of 
bypassing oxidative damage (Fernández-Orgiler et al., 2016). Moreover, T. cruzi 
Polη is linked with the bypass of oxidative and UV damage. In addition, this 
polymerase has been shown to have an active role during HR (De Moura et al., 
2009). TcPolƘ has also been shown to possess TLS activity, with the capability to 
bypass 8-oxoG, a lesion commonly generated by oxidative agents (Rajão et al., 
2009).  Studies performed in T. brucei have demonstrated the presence of two 
primase-polymerase-like proteins (PPL), TbPPL1 and TbPPl2 (of which the second 
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protein has been shown to be essential for cell survival). TbPPl2 was shown to 
have translesion synthesis activity, and depletion of the protein leads to a G2 
arrest, perhaps because of unrepaired DNA gaps (Rudd et al. 2013). Although 
these findings have given us a better understanding of the TLS pathway in 
kinetoplastids, essentially nothing is known about the functions of the ~14 
conventional TLS gene candidates of T. brucei (Table 1-2). In this context, 
whether or not these orthologs are involved in the TLS synthesis, in repair 
pathways, or in parasite-specific reactions is unknown.  
 
 
 
Table 1-2. Predicted translesion DNA polymerases in T. brucei. 
 
1.9 Project objectives 
To date, most of our understanding of TLS Pols is based on studies in 
bacteria, mammals and model eukaryotes. Therefore investigating the roles of 
these polymerases in T. brucei will address questions as to whether they 
conform to these predictions, or if they harbour T. brucei specific functions. 
Given the large number of translesion polymerases present in the parasite, three 
candidates, which belong to the A and B family of polymerases, were selected 
for further studies. 
The main aim of this research was to understand the functions of 
polymerase nu (TbPolN), polymerase theta helicase domain (TbPolQ) and 
polymerase zeta (TbPolZ) during genome maintenance in the bloodstream form 
of T. brucei. The study tried to address the importance of the three TLS pols in 
the parasite survival, analysing a potential contribution in DNA damage repair.  
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2 Material and Methods 
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2.1 General Bioinformatics 
 Sequence retrieval and analysis 2.1.1
T. brucei gene and protein sequences were retrieved from TriTrypDB 
version 33  (http://tritrypdb.org/tritrypdb/) (Aslett et al., 2009). Sequences 
from other organisms were retrieved from NCBI database 
(http://www.ncbi.nlm.nih.gov/). CLC genomic Workbench, version 7.5.1 
(Qiagen) was used for sequence alignments, plasmid map construction and 
primer design. 
 
2.2 Protein homology search and domain prediction 
The protein homology searches were performed using the  NCBI database 
Basic Local Alignment Tool (BLASTp) (https://blast.ncbi.nlm.nih.gov/Blast.cgi) 
(Altschul et al., 1990). Smart BLAST 
(http://blast.ncbi.nlm.nih.gov/smartblast/smartBlast.cgi?CMD=Web&PAGE_TYPE
=BlastDocs) was used for further analysis of the sequences. For protein domain 
analysis two web-based programs were used: InterPro 64.0 
(https://www.ebi.ac.uk/interpro/) and Pfam 31.0 (http://pfam.xfam.org/). 
 
2.3 General Molecular Techniques  
 Genomic DNA extraction 2.3.1
Genomic DNA was extracted by harvesting 2x106 cells and processed 
through the Qiagen Blood and Tissue kit (Qiagen), according to the 
manufacturer’s instructions. Genomic DNA was eluted in 50 µl of Buffer AE and 
stored at 4°C. 
 Primer design 2.3.2
Primers were designed based on T. brucei reference strain TREU927, using 
the CLC genomic Workbench 7.0 and synthesised by Eurofins Genomics 
(http://www.eurofins.com/). The lyophilised DNA was reconstituted in ddH2O to 
give a final concentration of 100 pmol/µl. The primer working concentration was 
of 10 pm/μl.  
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 Polymerase Chain Reaction (PCR) 2.3.3
For general fragment amplification NEB Taq DNA polymerase was used, in 
the case of cloning fragment amplification Phusion® high fidelity polymerase 
(NEB) was used.  
 
For the amplification of the different DNA fragments, specific primers 
were used (Error! Reference source not found.). The amplification reaction 
was performed in a final volume of 50 µl containing:  1x Phusion Buffer (NEB) or 
10 x ThermoPol® Buffer (NEB; Taq), 0.2 mM dNTPs mix, 10 ng of genomic DNA 
from Lister 427 T. brucei, 2 µl of each primer (10 pmol/µl stock) and 20 U/ml of 
Phusion® (NEB) or Taq DNA polymerase (NEB) and ddH2O to obtain a final volume 
of 50 µl.  The amplification was carried out as follows: initial denaturation step 
of 5 min at 98°C, 30 cycles of 30 s-1 min at 98°C, the annealing temperature 
varied depending of the pair of primers but in general was 30s between 52°C-
60°C and an extension of 30 s-1min at 72°C (Phusion®) or 68°C (Taq) ; with a 
final extension step of 10 min at 72°C. The resulting products were analysed in 
agarose gel electrophoresis (Section 2.3.5).  
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Table 2-1. Primer sequences. List of primer sequences used for gene deletion (KO), endogenous tagging and Gateway cloning. 
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 RT-qPCR 2.3.4
 Gene knockdown was tested by quantitative reverse transcriptase 
polymerase chain reaction (RT-qPCR). For this, 4x106 cells were harvested by 
centrifugation (405 g for 10 minutes). RNA was isolated by using the Qiagen 
RNeasy kit, following the manufacturer’s protocol entitled “Purification of Total 
RNA from Animal Cells using Spin Technology”.  
 
For the RT-qPCR primers were designed by using the software ‘Primers 
Express 3.0’ (Table 2-2).  For the amplification, the One Step SYBR® Prime 
Script™ RT PCR kit (TAKARA) was used. The amplification reaction was 
performed in a final volume of 20 µl containing:  10 µl of Buffer4, 0.8 µl of each 
primer (10 µM), 0.4 µl OF ReoxdyeII, 5.2 µl of H2O and 2 µl of RNA.  Actin primers 
were used as the endogenous control (Table 2-2) and ddH2O as a negative 
control. Each sample set was performed as a technical triplicate. 
 
For testing the RNA levels of silent VSGs, first the RNA of each sample was 
converted to complementary DNA. 1 µg of total RNA from each sample was 
converted into complementary DNA. For this process the SuperScript™ III Reverse 
Transcript Kit (Invitrogen™, Life Technologies) was used, following the 
manufacturer’s protocol entitled ‘First Strand cDNA Synthesis’. Random primers 
were used. The cDNA was stored at -20 °C until analysis. For the RT-qPCR, 
specific primers were used (Table 2-2). Prior to the RT-qPCR, cDNA was 
extracted. The master mix was prepared at 4°C (but not in direct contact with 
ice) as follows: 12.5 µl SYBR® Green PCR Master Mix (Applied Biosystems), 5 µl 
RNase free ddH20 (Qiagen), 2.5 µl of each primer (300 nM stock) and 2.5 µl of 
the appropriate cDNA. The master mix was pipetted into a MicroAmp® Optical 
96-well reaction plate (Thermo Fisher). As mentioned above, actin was used as 
endogenous control and ddH2O as negative control. 
 
The AB 7500 RT PCR system thermocycler conditions for all reactions were 
50 oC for 2 min (x 1), 95 oC for 10 min (x 1), 95 oC for 15 sec followed by 60 oC 
for 1 min (x 40) then a dissociation step was added as follows, 95 oC for 15 secs, 
60 oC for 1 min, 95 oC for 15 secs and finally 60 oC for 15 secs (x 1). Analysis of 
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the amplification and dissociation curves was performed as described in the 
Applied Biosystems® manual. The fluorescence intensity was quantified by 
calculated by using the ∆∆Ct method (Livak and Schmittgen, 2001). 
 
 
 
Table 2-2. Primers used for RT-qPCR. 
 
 Agarose Gel 2.3.5
 
1% agarose gels were performed by melting UltraPureTM Agarose 
(Invitrogen) in 1x TAE (40 mM Tris Base, 19 mM acetic acid, 1 mM EDTA). SYBR® 
Safe DNA Stain (Life technologies) was added in a proportion of 1:20,000 for DNA 
visualization under ultraviolet light.  The PCR product, which was pre-mixed 
with 4x NuPAGE® LDS Sample Buffer in a final concentration of 1x, was loaded 
onto the gel along with the 1 Kb Plus ladder (Invitrogen™, Life Technologies). 
The gel was left running at 100 V for 50 minutes on a Mini-Sub® Cell GT Cell tank 
(Bio Rad). DNA was visualized by using a GelDocTM XR+ system (BioRad). 
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 DNA fragment purification 2.3.6
For the DNA purification, the gels were visualised under a Dark Reader 
blue Transilluminator (Clare Chemical Research) and the fragment of interest 
was excised from the agarose gel using a sterile scalpel blade.  The QIAquick Gel 
purification kit (Qiagen) was used for the DNA purification following the 
manufacturer’s instructions. 
 
 Restriction Enzyme digestion 2.3.7
         
The purified PCR fragment and vector backbone used for cloning 
(excluding Gateway Cloning) were digested with the appropriate restriction 
enzymes. The reaction was performed as follows: 5 µl of 10x buffer, 20 units of 
the restriction enzyme, 20 µl of the PCR product or 10 µl of the vector (~5 µg) 
and made up to a final volume of 50 µl with ultra-pure water. In the case of a 
double digestion, it was determined the best buffer for the optimal function of 
both enzymes. The reaction was incubated for 2 h at the temperature 
recommended by the manufacturer (NEB).  Once the incubation period 
concluded, the product was separated in a 1% agarose gel (Section 2.3.4) and 
purified with the QIAquick Gel purification kit (Section 2.3.6).  
 
 Fragment ligation 2.3.8
 
The fragment was ligated into the appropriate vector using 1 µl (400 
units) of T4 ligase (NEB), 1 µl of 10x buffer, 2 µl of digested vector and 6 µl of 
the digested product (1:3 ratio; vector: PCR product). Reactions were left 
overnight at room temperature. In the case of the KO plasmids, the ligation of 
the inserts was performed in two ligation steps:  in the first step, one of the 
inserts was ligated to the vector and, after confirmation, the next insert was 
ligated to the same vector.  
 
 Transformation of competent cells 2.3.9
 
Chemically competent DH5α E. coli (in house) bacteria were thawed on 
ice for 5 minutes. Next, 50 µl of bacteria were added to 10 µl of ligation product 
and incubated on ice for 30 minutes. The cells were ‘heat shocked’ at 42 °C for 
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45 seconds and immediately placed on ice for 5 minutes. Next, 250 µl of SOC 
media (5 g yeast extract, 20 g tryptone, 0.5 g NaCl, 10 ml 1M MgCl2, 10 ml 2M 
glucose, 10 ml 1M MgS04 /L) was added and left for shaking at 37 °C for 1 h. The 
cells were pelleted at 7000x g for 1 minute and re-suspended in ~50 µl of the 
remaining supernatant. The cells were plated onto LB broth (5 g yeast extract, 
10 g tryptone, 10 g NaCl /1L ddH20; pH 7.0 and 20 g agar) agar plates 
supplemented with 100 µg/ml ampicillin and incubated overnight at 37 °C.  
 
 Plasmid extraction  2.3.10
A colony containing the required plasmid was inoculated into 5 ml of 
liquid LB supplemented with 100 μg.ml-1 of Ampicillin and incubated overnight at 
37 °C, with agitation. 800 µl of the culture was stored in 50:50 ‘peptone-
glycerol’ mix for long term storage at -80 °C. The rest of the liquid culture was 
centrifuged for 10 minutes at 2000x g and the pellet was used for plasmid 
purification.  
In order to purify the plasmid from the pellet of the transformed E. coli 
DH5α bacteria, the QIAprep Spin Miniprep Kit (Qiagen) was used according to the 
manufacturer’s instructions. The plasmid concentration was measured by using 
the NanoDrop 1000™ Spectrophotometer (Thermo Scientific).  To test if the 
plasmid has successfully recombined, 5 µg of the plasmid was digested with the 
appropriate restriction enzymes. The product was loaded o n a 1% agarose gel to 
visualize the digestion pattern. Once the correct digestion pattern was achieved, 
the plasmid was sent for sequencing (Eurofins Genomics, Germany) to confirm 
that the product was free of mutations. Primers used for the sequencing are in 
Table 2-3. The resulting chromatogram files were analysed using CLC 
Workbench, version 7 (QIAGEN), by assembling the sequence peaks to the 
reference file.  
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Table 2-3. Primers used for the confirmation of insert integration. 
 
 Plasmid preparation prior to transfection 2.3.11
 
10 µg of plasmid was linearised with appropriate restriction enzyme (Table 
2-1) for 4 hours. The digested product was purified using the DNA Clean and 
Concentrator™ -25 kit (ZYMO). 1 µl of the purified product was loaded onto a 1% 
agarose gel, alongside the undigested plasmid for confirmation. If correct, 10 µg 
of the product was used for transfection (Section 2.6.4).  
 
2.4 Gateway Cloning 
The RNAi constructs for bloodstream form cells (BSF) were generated as 
described in (Jones et al., 2014). The primers were designed to include the site- 
specific attachement sites (attB) (ggggacaatttgtacaaaaaagcaggct/ggggaccactt 
tgtacaagaaagctgggt) The primer sequence was identified using TrypanoFAN RNAit 
software (http://trypanofan.bioc.cam.ac.uk/software/RNAit.html).The PCR 
amplification was performed using Phusion® High fidelity DNA polymerase, as 
described in section 2.3.3. The PCR product was tested on a 1% agarose gel 
(Section 2.3.5); the expected band was extracted and purified as described in 
section 2.3.6.  
 
 The insert was cloned into the plasmid by using the Gateway Cloning 
Technology. Which consist of a BP reaction, catalysed by the bacteriophage λ 
integrase and E. coli integration host factor proteins, which promote the 
recombination between the attB sites of the PCR product and the attP sites of 
the pGL2084 vector (Katzen, 2007). The pGL2084 vector consist of two sets of 
attP sites, which flank a counter selectable marker (ccdB), and are separated by 
a 150 bp stuffer (Figure 3-6). Resulting in the insertion of the gene-specific 
63 
 
fragment in a ‘tail to tail’ orientation, separated by the ‘stuffer’. Allowing the 
expression of a dsRNA hairpin loop, which is under the control of the PRNA 
promoter, regulated by a tetracycline operator (Jones et al., 2014) 
   
The BP reaction (section 3.3) was performed by using the Gateway® BP 
Clonase® II Enzyme mix by adding 5 µl attB-PCR product, 1 µl pGL2084, 3.75 µl 
TE buffer and 0.25 µl of the BP enzyme. The reaction was incubated for 1 h at 
room temperature; after the incubation 1 µl of proteinase K (2 μg/μl) was 
added. The 10 µl BP reaction was added to 50 µl of E. coli MAX Efficiency® 
DH5α™ competent cells (Life Technologies), which were transformed as 
described in section 2.3.9. The plasmid was purified as described in section 
2.3.10. The verification of the plasmid was performed by enzymatic digestion 
using the following enzymes: BamHI/XbaI (excise both inserts), StuI (sense 
insert), ClaI (anti-sense insert) and AscI (linearisation site). The enzymatic 
reaction was prepared as follow:  2 μl of Buffer 4 with BSA or CutSmart™ buffer 
(NEB), 0.25 μl of restriction enzyme (NEB), 3 μl of plasmid and 14.75 μl of ddH2O 
(final volume 20 µl); and incubated for 1 h at 37 °C. The digestion product was 
separated on a 1% agarose gel for plasmid confirmation.   
 
2.5 Construct design 
 C-terminal endogenous tagging 2.5.1
The pNAT12myc or pNAT6HA vector (Alsford and Horn, 2008) was used. 
The construct integrates into the gene of interest through single-crossover 
recombination, guided by the 3’ ORF region present in the vector. Resulting in 
the incorporation of the tag (Myc or HA) into the 3’ end of the gene’s ORF, 
together with the T. brucei βα tubulin, the drug resistance marker gene and the 
T.brucei actin. Tubulin and actin are necessary for the expression of the drug 
resistance gene by regulating trans-splicing. There is also a duplication of the 
target sequence downstream of the tagged locus. The duplicated sequence lacks 
the start codon, suggesting an inactive ORF, not compromising the gene 
(McCulloch et al., 2004)  (Figure 2-1).  
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The primers used in this assay, amplify a 3’ region of the ORF excluding 
the stop codon (Table 2-1). The cloning was performed as described above 
(Section 2.3.7 - 2.3.10.) 
 
 
 
Figure 2-1. C-terminal endogenous tagging strategy. Integration of the 
linearised construct via a single recombination (black cross) using the 
homologous regions (white lines), within the 3’ region of the endogenous locus. 
Not to scale.  
 
 Knockout construct 2.5.2
The knockout mutant cell lines were generated by the replacement of the 
endogenous locus with an antibiotic selection marker (blasticidin or neomycin) 
by homologous recombination (HR) (section 4.3). For this approach the pmtl23 
vector was used (Devlin et al., 2016). There are two modified versions, 
containing either the blasticidin (ΔORF::BSD) or the neomycin (ΔORF::NEO) 
antibiotic cassette. The NEO and BSD vectors contain T. brucei Actin and T. 
brucei β/αTubulin, which facilitate the trans-splicing and polyadenylation 
required for mRNA processing. Primers were designed to amplify the 3’ region of 
the 5’ UTR upstream, and the 5’ region of the 3’ UTR downstream. The 
amplification of the fragments was performed as described in section 2.3.3. The 
cloning strategy is described in sections 2.3.7-2.3.10. 10 µg of the plasmid 
(ΔORF::BSD or ΔORF::NEO) was linearised and concentrated as described in 
section 2.3.11.  
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2.6  In vitro cultivation of bloodstream forms of 
Trypanosoma brucei  
 Strains 2.6.1
The monomorphic bloodstream strain, Lister 427, was used for gene 
deletion and protein tagging assays. Lister 427 is a laboratory adapted strain, 
frequently used for genetic manipulation (McCulloch et al., 2004).  
 
For the RNAi interference assays the genetically modified Lister 427 cell 
line (2T1) was used. The 2T1 cell line contains a modification in chromosome 2a. 
For the construction of the RNA interference (RNAi) cell lines, an RNAi cassette 
integrates in the ribosomal locus of chromosome 2a in the 2T1 parental cell line. 
Permitting the expression of a RNA stem loop, which is under the control of the 
RNA polymerase I promoter, regulated by a tetracycline operator  (Alsford and 
Horn, 2008). Facilitating the knockdown of the gene of interest by RNAi.  The 
procedure is explained in detail in section 3.3.  
 
 Maintenance of cultures  2.6.2
Lister 427 (WT) cells were grown in HMI-9 (Gibco®) (Hirumi and Hirumi, 
1989), supplemented with 20% (v/v) heat inactivated fetal bovine serum (FBS; 
Sigma Aldrich) and 1% penicillin-streptomycin solution (stock at 10,000 U/ml) 
(Gibco®). In the case of the 2T1 cell line, the cells were grown in HMI-11 
thymidine-free media, consisting of Iscove’s Modified Dulbecco’s Medium (IMDM) 
(Gibco®), 10% (v/v) of FBS (Gibco®,tetracycline free), 1% of penicillin- 
streptomycin solution (10.000 U.ml-1)(Gibco®). 
 
 For the RNAi cell lines used for the replication assays with EdU (Section 
2.8), the cells were grown in HMI-11 thymidine free media, consisting of Iscove’s 
Modified Dulbecco’s Medium (IMDM) (Gibco®), 10% (v/v) of FBS (Gibco®, 
tetracycline free), 1% of penicillin-streptomycin solution (10,000 U.ml-1; 
Gibco®),4% (v/v) of HMI-9 mix (0.05 mM of bathocuproine disulphonic acid, 1 mM 
of sodium pyruvate, and 1.5 mM of L-cysteine (Sigma Aldrich), 1 mM of 
hypoxanthine (Sigma Aldrich) and 0.0014% of 2-mercaptoethanol (Sigma Aldrich). 
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For Lister 427 (WT) no drugs were added to the media. The selective 
drugs used for 2T1 cells were puromycin and phleomycin and for RNAi cell lines 
phleomycin and hygromycin. For the tagged lines the drug depends on the 
plasmid (blasticidin or phleomycin) and for the knockout cell lines blasticidin 
and neomycin (G418).  The concentrations are detailed in Table 2-4. For culture 
maintenance the cells were seeded at ~1x104 and were cultured up to a 
maximum of 2x106 cells.ml-1. The cells were grown in vented flasks at 37°C in a 
5% CO2 humidified incubator.   
 
 
 
Table 2-4. Antibiotic concentration used for cell maintenance and 
transfection in bloodstream forms. 
 
 Cryopreservation of bloodstream forms 2.6.3
For cryopreservation of the cells, 800 µl of a mid-log phase culture was 
added to 200 µl of 50:50 solution of glycerol and HMI-9 media. The samples were 
wrapped in cotton wool and stored at -80 °C for 24 hours. Subsequently, the 
cells were transferred to liquid nitrogen tanks. The respective information of 
each stabilate was submitted to the Wellcome Trust Centre for Molecular 
Parasitology (WTCMP) Freeze works samples management database 
(http://www.freezerworks.com/). 
For the revival of the cells, the cells were thawed at room temperature 
and added to 9 ml of HMI-9 (lacking drugs). If required, selective drugs were 
added 24 hours later. The cells were maintained as described in section 2.6.2 
 
 Transfection  2.6.4
3x107 cells were harvested by centrifugation at 405x g for 10 minutes.  The 
pellet was re-suspended in remaining media and transferred to a 1.5 ml tube. 
Manufacturer Drug Concentration
InvivoGen Hygromycin 5 µg/ml
InvivoGen  Neomycin (G418) 2.5µg/ml
InvivoGen Blasticidin 10µ/gml
InvivoGen Phleomycin 2.5µg/ml
Calbiochem Puromycin 0.2µg/ml
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The cells werere centrifuged at 665x g for 2 minutes. The pellet was re-
suspended in 100 µl of Amaxa Human T Cell Nucelofactor kit solution (Lonza) and 
transferred to an electroporation cuvette (Lonza), containing 10 µg of linearised 
plasmid (Section 2.3.11). The cells were electroporated using the programme X-
100, pre-programmed into the Amaxa Nucleofector II machine (Lonza). The cells 
were transferred into a conical tube containing 27 ml of HMI-9 medium in the 
absence of selective drugs. Two further serial dilutions were performed, adding 
3 ml of the cells to a new conical tube containing 27 ml, resulting in three tubes 
with the following concentrations: 1x106 cells.ml-1, 1x105 cells.ml-1 and 1x104 
cells.ml-1. One ml of the cell suspension was plated into 24 well plates and 
incubated overnight at 37 °C with 5% CO2. The following day, 1 ml of medium 
containing double the required concentration of drugs was added to each well 
(Table 2-4). The plates were incubated with 5% CO2 for 5 to 7 days. The surviving 
clones were confirmed by PCR (Section 2.3.3) or Western blot analysis (Section 
2.12.1). 
 
2.7 Cell growth assays  
 Growth analysis after RNA interferance induction 2.7.1
The cell lines with inducible RNAi were used to test the gene essentiality 
in T. brucei survival. In order to test the importance of the different genes in 
the parasite growth, on the  day before of the experiment, the parental cell line 
2T1 (untransformed cell line) and the RNAi cell lines (transformed cell lines) 
were set up at a concentration of 1x105 cells.ml-1 in 10ml of HMI-11 thymidine-
free medium (Section 2.6.2). Containing puromycin and phleomycin for the 2T1 
(untransformed) and phleomycin and hygromycin for the RNAi cell lines (Table 
2-4). The following day, the culture (2T1and RNAi cell lines) was diluted to 5x104 
cells.ml-1 in HMI-11 medium with the selective drugs and devided into two flasks. 
Resulting in two flasks containing 2T1 cells (used as a control cell line) and two 
flasks containing the RNAi inducible cell line. Tetracycline (1µg/ml) was added 
to one flask (Tet+) containing 2T1 cells and to one flask containing the RNAi 
inducible cell line. In the case of the RNAi inducible cell line, the tetracycline  
controls the expression of the dsRNA hairpin loop, permitting the knockdown of 
the gene. After the addition of the tetracycline 1 ml of each of the four flasks 
was pipetted into 24 well plates. The cells were left to grow at 37 °C for 48-72 
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hr. Growth was monitored every 24  hours: 10 µl of each culture was loaded onto 
the Neubauer improved hemocytometer for parasite counting. The concentration 
was plotted using Prism 6 (GraphPad software Inc.), where the y-axis represents 
the number of parasites in a Log10 scale and the x-axis the days post induction.  
 
The growth of the cells was also assessed after genotoxic stress, using 
methyl methanesulfonate (MMS) (0%, 0.001%, 0.0002%, 0.0003%) and UV 
radiation (0 J/m2, 500 J/m2, 750 J/m2, 1000 J/m2 and 1500 J/m2). The 
experiment was set up as described above. The appropriate concentration of 
MMS was added to each well of Tet- and Tet+ cells. In the case of UV exposure, 
Tet- and Tet+ cells were UV irradiated 24 hour post induction using a Stratagene 
Stratalinker UV Crosslinker 2400 and left to grow for 72 h.  
 
 
 Growth analysis of knockout cells 2.7.2
 
The day before the experiment, cells were set up at a concentration of 
1x105 cells.ml-1 in 10 of HMI-9 medium (Section 2.6.2), containing blasticidin for 
the heterozygous and null mutants. G418 was slowing the growth of the cells, 
and so it was not added to the medium containing null mutants. In the case of 
the WT (Lister 427), no drugs were added to the medium. The following day, the 
culture was diluted to 5x104 cells.ml-1 in HMI-9 medium with the respective 
drugs and 1 ml of each flask (WT and KO cells) was pipetted to 24 wells plate. 
Different concentrations of MMS (0%, 0.0001%, 0.0002% and 0.0003%) was added 
to each well. As no induction was required, cells were exposed to UV (0 J/m2, 
500 J/m2, 750 J/m2, 1000 J/m2 and 1500 J/m2) immediately. 
 
The cells were left to grow at 37 °C for 48-72 hr. Growth was monitored 
every 24 h hours post treatment. 10 µl of each culture was loaded onto the 
Neubauer improved hemocytometer for parasite counting. The concentration 
was plotted using Prism 6 (GraphPad software Inc.), in where the y-axis 
represents the number of parasites in a Log10 scale and the x-axis the days post 
induction. As described the growth was monitored every 24 hours.   
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 Cell Cycle analysis  2.7.3
The day before the experiment, RNAi cell lines and 2T1 cells were set up 
at a concentration of 1x105 cells.ml-1 in 10 ml of HMI-11 thymidine-free media 
(2.6.2), containing the selective drugs. The following day, the culture (2T1 and 
RNAi cells) was diluted to 5x104 cells.ml-1 in HMI-11 media with the selective 
drugs and divided into two flasks. Tetracycline (1µg/ml) was added to one flask 
(Tet+). Every 24 hours the cells were counted and harvested by centrifugation 
(405xg for 10 minutes at room temperature). Cells were stained with DAPI as 
described in section 2.10.1.  
 
 Flow cytometry 2.7.4
 
For the assay, 5x106 cells were harvested by centrifugation (405xg for 10 
minutes) and washed once with 1x PBS. Cells were re-suspended in the residual 
supernatant before adding 200 µl of 1% paraformaldehyde (PFA; diluted in 
1xPBS) for 10 minutes at room temperature. Fixed cells can be stored at 4 °C 
before harvesting. Next, the cells were centrifuged at 1620x g for 10 minutes 
and washed once in 1x PBS. The cells were then re-suspended in 1ml 1x PBS 
containing 10 µg/ml of propidium iodide (PI; Sigma Aldrich) and 10 µg/ml of 
RNAse A (Sigma Aldrich), and incubated at 37 °C for 45 minutes in the dark. 
Samples were filtered through a fine mesh gauze prior analysis using a FACS 
Calibur (BD Biosciences). Data was acquired from the FL2-A channel and 
analysed using Flow Jo software (TreeStar).  
 
2.8 Replication assay 
Cells were grown in thymidine free media for 24 h. The following day, 4 ml 
with 1x105 cells were transferred to a vented flask, one with tetracycline and 
other without tetracycline. After 20 hours, 32 hours and 44 hours the cells were 
incubated with EdU (Click-iT® EdU Alexa Fluor® 555 Imaging Kit – Life 
Technologies) for 4 hours at 37 °C with 5% CO2. Next, the cells were centrifuged 
at 1000x g for 5 minutes and washed with 1x PBS. The pellet was re-suspended 
in 20 µl of 1x PBS and the cell suspension was pipetted onto a 12 well slide, pre-
treated with poly-L-lysine, and left to settle for 5 minutes. The supernatant was 
removed and 25 µl of 3.7% paraformaldehyde was added and left for 4 minutes, 
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followed by a wash with 3% BSA in 1x PBS. The cells were permeabilised by 
adding 20 μl of 0.2% Triton X-100 (Promega) in 1x PBS for 10 minutes at room 
temperature. The wells were washed twice with 3% BSA in 1x PBS. The 
supernatant was removed and 25 µl of the Click-iT reaction was added (Life 
Technologies) (21.25 µl of 1x Reaction Buffer, 1 µl of CuSO4, 0.25 µl Alexa Fluor 
555 Azide and 2.5 µl of 1x Reaction Buffer) for 1 hour at room temperature. The 
solution was removed and the cells were washed six times with 3% BSA in 1x PBS. 
The cells were stained with DAPI as described in section 2.10.1. 
2.9 Telo FISH analysis 
For the Telo-FISH analysis, 5x106 cells were harvested (405x g for 10 
minutes) and washed in 1x PBS at 660x g for 3 minutes. The supernatant was 
removed and the pellet re-suspended in 4% FA in 1x PBS for 20 minutes at room 
temperature. The cells were washed and re-suspended in 65 µl of 1xPBS and 
spread onto a pre-treated poly-L-lysine (Sigma Aldrich) slide (left to settle for 20 
minutes). The supernatant was removed and the cells permeabilised with 0.1 % 
TritonX-100 in 1x PBS for 3 minutes. The cells were washed and dehydrated with 
pre-chilled ethanol in ascending concentration (70-90-100%) for 5 minutes each 
concentration. The slide was left to dry.  
In the meantime, the probe (10 µl) in the hybridization solution (60 µl) (50 
% Formamide, 10% Dextran, 2x SSPE buffer [1x SSPE: 0.18 M NaCl, 10 mM 
NaH2P04, 1 mM EDTA, pH 7.7: use buffer at pH 7.9]) was heated at 85 °C in a 
water bath for 7 minutes and added to the slide. The slide was sealed and 
incubated at 95 °C for 5 minutes (water bath), followed by a 16 hours incubation 
at 37 °C. The telomeric probe recognizes the TTAGGG repeats. Then, the slide 
was washed for 30 minutes with 2x SSC (Thermo Fisher)/50% Formamide solution 
at 37 °C (incubator), 60 minutes with 0.2x SCC at 50 °C and a final wash with 4x 
SSC at room temperature for 10 minutes. Cells were stained for DAPI as 
described in section 2.10.1. 
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2.10  Microscopy protocols 
 DAPI staining  2.10.1
For DAPI staining, 2x106 cells were harvested by centrifugation at 405x g 
for 10 minutes. The pellet was washed in 1x PBS at 405x g for 3 minutes and the 
supernatant was removed, leaving ~25 µl in which the cells were re-suspended. 
The cell suspension was settled on a pre-treated poly-l-lysine (Sigma Aldrich) 
slide (Menzel-Gläser) for 5 minutes at room temperature. A hydrophobic circle 
was drawn on the slide by using a PAP pen (Life Technologies). The supernatant 
was removed and 25 µl of 4% PFA was added for 4 minutes. The PFA was 
removed and the cells were washed three times in 50 µl of 1xPBS for 5 minutes. 
5 µl of DAPI (SouthernBiotech) was added to each well and left at room 
temperature for 5 minutes. The slide was covered with a coverslip and sealed 
with nail varnish. Slides were stored at 4 °C.      
 
 Immunofluorescence analysis   2.10.2
The cells were prepared as described above (Section 2.10.1). After the 
fixation step, the cells were permeabilised with 25 µl 1x PBS/Triton X-100 
(Thermo Scientific) for 10 minutes. Free-aldehyde groups were neutralised by 
the addition of 100 mM glycine for 20 minutes. The glycine binds the free 
aldehyde groups, impeding its binding with the primary and secondary antibody, 
minimizing the background in the immunofluorescence.   The wells were washed 
three times with 1x PBS for 5 minutes. To each well, 25 µl of blocking solution (1 
% BSA [Sigma], 0.2 % Tween-20 in 1 x PBS) was added for 1 hour (wet chamber). 
The blocking solution was removed and 25 µl of the primary antibody diluted in 
blocking solution was added and incubated for 1 hour in a wet chamber 
(antibody concentration Table 2-5). The wells were washed two times and the 
secondary antibody was added and incubated for one hour. The cells were 
washed and DAPI stained as described in section 2.10.1. In the case of the 
fluorophore-conjugated antibody, the incubation with the secondary antibody 
was not necessary. The rest of the protocol was followed as described above. 
  
Double immunofluorescence using primary antibodies from the same host 
specie was performed. For this assay, the samples were incubated with the first 
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primary and secondary antibody, following the protocol described above with 
the exception of the DAPI staining. Sequentially the cells were incubated with 
the blocking solution for a second occasion, followed by the incubation with the 
fluorophore-conjugated antibody and DAPI staining.  
  
 
Table 2-5. Antibody concentration used for immunofluorescence assay. 
 
 Measurement of fluorescence intensity 2.10.3
The software Fiji (ImageJ) was used for the measurement of the 
fluorescence intensity. For the fluorescence analysis, the image has to be in 
grayscale and the background must be subtracted. The cell of interest was 
selected by using the drawing/selection tool (circle). A circle of 2.1 x 2.1 pixel 
region of interest (ROI) was drawn around the cell. The option ‘measure’ was 
selected from the ‘analyse’ menu. This provides, for the area, integrated 
density (area and the mean gray value) and mean fluorescence value of each 
cell. For each image a region that has no fluorescence was selected, which 
corresponds to the background control. The fluorescence was obtained by 
calculating the corrected total cell fluorescence (CTCF) using the following 
formula: 
𝐶𝑇𝐶𝐹 = 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 − (𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑙𝑒𝑐𝑡𝑒𝑑 𝑐𝑒𝑙𝑙 x 𝑚𝑒𝑎𝑛 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝑟𝑒𝑎𝑑𝑖𝑛𝑔𝑠) 
The fluorescence was plotted onto a vertical scatter plot using Prism 6 
(GraphPad software Inc.). 
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2.11 Electron microscopy protocols (EM) 
 
Fixation and imaging of the cells was performed by L.Lemgruber-Soares. 
 
 Scanning Electron Microscopy (SEM) 2.11.1
Cells (5x106) were fixed in a solution containing 2.5% glutaraldehyde and 
4% PFA in 0.1 M phosphate buffer. Samples were stored at 4 °C until used. The 
cells were settled on a pre-treated poly-L-lysine cover slip and washed with 0.1 
M phosphate buffer. The cells were dehydrated with ethanol in ascending 
concentration (from 30% to 100%). The cover slip was left to dry and metal 
coated (gold/palladium). The samples were visualized on a Jeol 6400 scanning 
electron microscope (Jeol, Japan). 
 
 Transmission Electron Microscopy (TEM) 2.11.2
For the TEM 5x106 cells were fixed in a solution containing 2.5% 
glutaraldehyde and 4% PFA in 0.1 M cacodylate buffer (pH 7.2). The post-fixation 
was performed for 45 minutes by adding 1 % osmium tetroxide and 2.5 % 
potassium ferrocyanide (pH7.3) in 0.1 M sodium cacodylate buffer (in the dark). 
The cells were washed several times with 0.1 M cacodilate buffer. Next, they 
were stained with 2 % aqueous uranyl acetate and dehydrated in acetone 
solutions (30, 50, 70, 90 and 100 %). The samples were embedded in Epon resin 
and sectioned. The visualisation of the sample was performed on a Tecnai T20 
transmission electron microscope (FEI, Netherlands). 
 
 Image analysis 2.11.3
For images captured on the Axiscope 2 (Zeiss) fluorescence microscope, 
the 63 x DC magnification lens was used. The images were acquired using the 
ZEN software package (Zeiss; http://www.zeiss.com/corporate/en_de/home.html). 
For images captured in the Deltavision RT deconvolution fluorescence 
microscope, the 1.4/63 x lens was used. Z-stacks were acquired and images de-
convolved using SoftWoRx suite 2.0 (Applied Precision, GE). High resolution 
images were captured on an Elyra PS.1 super resolution microscope (Zeiss) using 
the 1.4/63 x lens. The images were acquired using the ZEN software. 
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2.12  Protein analysis 
 Western blot 2.12.1
2.5x106 cells were harvested by centrifugation at 1620x g for 10 minutes 
and washed with 1x PBS by centrifugation (405x g). The pellet was re-suspended 
in 10 µl of 2x NuPAGE® LDS sample buffer (Invitrogen) and denaturated at 100 
°C for 10 minutes. Samples were loaded in a NuPAGE 10% Bis-tris protein gel 
1.0mm (Life Technology), along with a NovexSharp prestained Standard (Life 
Technology) that was used as a protein size marker, and 5% NuPAGE MOPS SDS 
Run buffer (Life Technology). The gel was left to run for 50 minutes at 200 V in a 
XCell SureLock™ Mini-Cell Electrophoresis System (Life Technologies).  
 
For the protein transfer a PVDF (Amersham Bio) membrane, activated with 
methanol (GE Healthcare Life Science) was used. The transfer was performed by 
electrophoresis at 100 V for 1 hour, in a Mini Trans-Blot Electrophoretic Transfer 
Cell tank (Bio Rad) containing 1x transfer buffer (25 mM Tris pH 8.3, 192 mM 
Glycine, and 20% (v/v) methanol). After the transfer the membrane was 
incubated in Ponceau-S solution (Sigma) for one minute, in order to confirm a 
successful transfer of proteins.  
 
 The membrane was washed in 1xPBS-Tween for 5 minutes and incubated 
in blocking solution (1x PBS, 0.01% Tween and 5% milk) for 1 hour, preventing 
nonspecific antibody binding.  The membrane was incubated with agitation with 
the primary antibody (Table 2-6), diluted in blocking solution for 1 hour.  The 
membrane was washed twice with agitation for 10 minutes with 1x PBS with 
0.001% Tween. After the washes, the membrane was incubated for 1 hour with 
the blocking solution containing the secondary antibody (Table 2-6). Next, the 
membrane was washed three times in 1x PBS with 0.001% Tween, in order to 
reduce the background. For the developing, the membrane was incubated for 1 
minute with SuperSignal WestPico Chemi-luminescent Substrate (Thermo 
Scientific) and exposed onto X-rayfilm (Kodak). In the cases that protein 
detection failed, the membrane was incubated in ECL Prime western blotting 
Development Reagents (GE Healthcare Life Sciences) and exposed onto the 
Hyperfilm ECL film (GE Healthcare Life Sciences). 
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Table 2-6. Antibody concentrations used for Western Blot. 
 
 Immunoprecipitation 2.12.2
2.12.2.1 Preparation of magnetic beads 
Approximately 50 µl of Dynabeads® M-28 Sheep α-mouse IgG (Novex®, Life 
Technologires) magnetic beads were washed twice in cold blocking solution 
(0.5% BSA in 1x PBS, pH 7.2)  for 1 minute, vortexed gently and placed on a 
DynaMag™-2 magnet (Life Technologies). The supernatant was discarded and the 
beads were re-suspended in 125 µl of blocking solution containing 5 µg of mouse 
α-Myc clone 4A6 antiserum (Milipore) or α-HA antiserum (Sigma Aldrich). Due to 
the lack of polymerase specific antibodies, it was necessary to tag the proteins 
rather with Myc tag or HA tag, in order to perform the immunoprecipitation. The 
beads were left overnight on mixing rotor at 4°C.  
2.12.2.2 Cell lysis 
A total of 5x108 cells were harvested by centrifugation at 1620x g for 10 
minutes (two flasks were set up for each cell line). The cells were washed once 
in 1x PBS by centrifugation. Approximately 2.5 x 106 cells were re-suspended in 
4x NuPAGE® LDS Sample Buffer (pre-lysis sample).  The rest of the sample was 
re-suspended in 1 ml of whole extract buffer (WCE; 50 mM of HEPES pH 7.55,100 
mM NaCl, 1 mM EDTA pH 8, 1 mM EGTA pH 8, 10% Glycerol, 1%Triton X-100, 1 
mM DTT, and 2x complete protease inhibitor cocktail - Roche) and lysed at 4°C 
for 30 minutes. Next, the sample was centrifuged at 15000x g for 30 minutes at 
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4°C. From the supernatant 30 µl was re-suspended in 4x NuPAGE® LDS Sample 
Buffer (Input sample) and the remaining 900 µl were saved for the 
immunoprecipitation. 
 
2.12.2.3 Immunoprecipitation and Elution  
The remaining 900 µl was added to the 50 µl of magnetic beads, which 
were pre-washed three times in blocking solution, and left at 4 °C for 2 hours. 
The sample was placed on the magnet and 30 µl of supernatant was re-
suspended in sample buffer (Flowthrough sample). The remaining supernatant 
was discarded and the beads were washed five times with washing buffer (50 mM 
Hepes pH 7.55, 100 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, 10 % 
glycerol, 0.1 % Triton X-100, and 2x complete protease and phosphatase inhibitor 
cocktail; Roche). For this step the washing buffer was added to the beads, the 
beads were gently shaken and placed on the mixing rotor for 5 minutes. After 
the last wash, the supernatant was discarded and the beads were centrifuged at 
1000x g for 3 minutes. The beads were placed on the magnet, in order to discard 
the supernatant, and the beads were re-suspended in 15 µl of 1x NuPAGE® LDS 
Sample Buffer (gently vortexed). The beads were incubated at 70 °C for 10 
minutes, then the beads were placed on the magnet and the supernatant 
collected (Eluate sample). 1 µl of the eluate sample was added to 1 µl of 1x 
NuPAGE® LDS Sample Buffer for Western blot analysis (Section 2.12.1)The 
remaining 14 µl were saved for SYPRO® Ruby staining and for mass spectrometry 
analysis (Glasgow Polyomics).  For this reason two samples were set up for each 
cell line.  
 
2.13 SYPRO® Ruby staining 
After electrophoresis, the gel was placed in a clean polypropylene 
container with fixation solution (100 ml 7 % (v/v) acetic acid and 50 % (v/v) 
methanol diluted in MilliQ water) and left to agitate for 30 minutes. The fixation 
solution was discarded and 60 ml SYPRO® Ruby gel stain (Molecular ProbesTM, 
Life Technologies) was added and left agitating overnight. Next, the gel was 
transferred to a clean container with wash solution (7 % (v/v) acetic acid and 
10% (v/v) methanol diluted in MilliQ water) and left to agitate for 30 minutes. 
The wash solution was discarded and the gel washed twice with MilliQ water for 
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5 minutes on agitation. The gel was imaged using a Typhoon 8600 Variable Mode 
Imager (Amersham Biosciences) using the 457 mm Blue I and Blue II emission 
filters. 
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3 The importance of Translesion DNA Polymerases 
in Trypanosoma brucei 
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3.1 Introduction 
 Translesion DNA synthesis pathway in Eukaryotes 3.1.1
 
DNA replication is a high fidelity mechanism, with an error incidence of 
10-7 to 10-8 in Escherichia coli (Kunkel, 2004). It is suggested that, in eukaryotes, 
A and B family DNA polymerases (Pols) have an error incidence of 10-7 to 10-8 
during DNA synthesis (Kunkel, 2004). This pathway is extremely efficient in part 
because of the capacity of the replicative DNA Pols to recruit the correct 
nucleotide, allied to the proofreading activity of the DNA Pols permitting the 
excision of incorrectly inserted nucleotides. In addition, the overall error rate of 
replication is reduced further by post-replicative repair strategies to remove 
mispaired bases (Sale, 2013). Even though these characteristics are required for 
efficient replication, the replication machinery can be unstable in the presence 
of damage, provoking a stall of the replication fork (Sale 2013). For this reason, 
the cells have evolved diverse repair mechanisms to maintain the integrity of 
the genome (Iyama and Wilson, 2013; Gao et al., 2017) 
 
Several DNA repair pathways can be found in eukaryotes, including base 
excision repair (BER), mismatch repair (MMR), nucleotide excision repair (NER), 
homologous recombination (HR) and non-homologous end joining (NHEJ). In 
addition, there is a damage tolerance pathway, termed translesion synthesis 
(TLS) (Iyama and Wilson, 2013; Gao et al., 2017). The first three repair 
mechanisms directly remove lesions from the DNA template before the 
replication fork encounters them, ensuring synthesis on a damage free template. 
Unfortunately, these repair mechanisms can fail, risking the integrity of the cell 
(Iyama and Wilson, 2013; Gao et al., 2017).  
 
When replicative DNA Pols encounter an unrepaired lesion, this can result 
in the replication fork stalling and the subsequent death of the cell if the 
blockade is not tackled (Sale, 2013). Therefore, the presence of HR, NHEJ and 
and TLS are necessary to ensure cell survival (Iyama and Wilson, 2013; Sale, 
2013).The difference between the three mechanisms is the ability to tackle the 
lesions in ‘error free’ or ‘error prone’ manners (Gao et al., 2017).  HR is 
generally considered error-free, since it relies on copying sequence from an 
intact template. NHEJ is frequently error-prone, since DNA breaks are processed 
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to allow rejoining. However, NHEJ normally occurs during G0/G1, meaning 
lesions in S-phase are normally tackled by HR (Karanam et al., 2012; Iyama and 
Wilson, 2013). 
 
The TLS pathway has the ability to insert nucleotides opposite DNA lesions, 
meaning the lesion is not immediately repaired. In addition, this pathway is 
notable for its low fidelity, due to the lack of proofreading activity in most of 
the translesion DNA pols (TLS pols) involved in this process (Li, Gao and Wang, 
2011; Sale, 2013). Such lack of proofreading activity may increase the 
probability of spontaneous mutations but, despite this, TLS has been conserved 
throughout evolution, revealing its importance for cell viability (Friedberg, 
Wagner and Radman, 2002; Sale, 2013). In fact, mutations generated during TLS 
can have a role in evolution or adaptation, an effect that has been demonstrated 
in bacteria, showing that genome sequence changes generated by the TLS 
pathway can have important functions during population diversification, which is 
a decisive event during adaptive evolution (Taddei et al., 1997; Rosenberg, 
2001; Friedberg, Wagner and Radman, 2002). Moreover, TLS pols in human cells 
are involved in somatic hypermutation, increasing the diversification of 
immunoglobulin genes by the insertion of mutations within the variable region 
(Friedberg, Wagner and Radman, 2002; Saribasak et al., 2012). An example of 
this positive function was confirmed in experiments showing that inhibition of 
DNA PolZ provokes a decrease in somatic hypermutation (Friedberg, Wagner and 
Radman, 2002; Saribasak et al., 2012). Although the activity of the TLS pathway 
can be beneficial, it can also represent a risk for the cells (Friedberg, Wagner 
and Radman, 2002). For instance, in organisms such as humans, these mutations 
increase the probability of cancer (Friedberg, Wagner and Radman, 2002). For 
this reason, cells have efficient mechanisms to regulate the intervention of TLS 
pols during replication (Friedberg, Wagner and Radman, 2002). 
 
 Translesion DNA synthesis pathway in trypanosomes 3.1.2
 
In trypanosomes, many DNA repair pathways have been documented, but 
less attention has been paid to the TLS pathway (Passos-Silva et al., 2010; 
Genois et al., 2014). In T. brucei, T. cruzi and L. major, several TLS pols have 
been reported to be present in the parasites including Polymerase kappa (Pol κ), 
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Polymerase eta (Polη), Polymerase zeta (PolZ), Rev1 and two PrimPol-like 
proteins (PPL1 and PPL2) (Passos-Silva et al., 2010; Rudd et al., 2013) .  
 
The overexpression of Polκ and Polη in T. cruzi results in an increase in 
tolerance to H2O2, suggesting that these enzymes are capable of inserting 
nucleotides opposite oxidative lesions (Rajão et al., 2009; Passos-Silva et al., 
2010).  The ability of the cells to tolerate oxidative stress is of high importance, 
given that T. cruzi  parasite cells, especially amastigotes, have to deal with 
reactive oxygen species (ROS) inside the host cell (Passos-Silva et al., 2010) .  
 
It has been hypothesized that the TLS pathway in T. cruzi, T. brucei and 
Leishmania, may have an important role during genetic diversification of surface 
protein genes (Passos-Silva et al., 2010), due to its capacity to insert mutations 
during lesion bypass (Passos-Silva et al., 2010). If correct, this might increase 
the efficiency of the evasion mechanism of the parasite when confronted by the 
immune system of the host  (Passos-Silva et al., 2010). However, to date 
concrete evidence of a role of any TLS pol, or the wider pathway, in immune 
tolerance is lacking. Indeed, experimental evaluation of the importance of the 
range of TLS Pols in parasite biology, and their modes of action, is notably 
absent. 
 
Little research has been conducted to investigate the tolerance repair 
pathway in T. brucei, beyond two Primase-Polymerase (Prim Pol) putative 
proteins, PPL1 and PPL2 (Rudd et al., 2013). Prim Pol proteins belong to the 
archaeo-eukaryotic primase (AEP) superfamily. In archaea and prokaryotes, AEP 
proteins are known to have a nucleotidyltransferase activity (Iyer et al., 2005). 
In certain bacteria, such as Mycobacterium tuberculosis, is known to be involved 
in DNA repair (Della et al., 2004).  In T. brucei, TLS activity of PPL1 and PPL2 
have been confirmed; revealing their capacity to insert nucleotides opposite T-T 
6-4 photoproducts (Rudd et al., 2013). As such, there is a lack of information 
about the range of function of TLS pols in the parasite. Three TLS pols were 
chosen for this study: Polymerase Zeta catalytic subunit (TbRev3), Polymerase 
Nu (also known as Polymerase Theta polymerase domain; TbPolN) and 
Polymerase Theta helicase domain (TbHelQ). TbPolZ was obtained as a hit in an 
RNAi screen which demonstrated that depletion of the protein generates an 
82 
 
increase in cell sensitivity towards the alkylating agent Methyl methanesulfonate 
(MMS) (Stortz et al., 2017). The same study suggested a similar effect following 
loss of Pol κ, but as this is encoded from a multicopy gene family (Berriman et 
al., 2005; Passos-Silva et al., 2010), it was more problematic to evaluate. 
Unpublished studies conducted in procyclic T. brucei cells demonstrated the 
possible interaction of TbHelQ with proteins involved in HR (Marko Prorocic, 
unpublished). TbPolN was chosen due to its potential interaction with TbHelQ, 
as has been proposed in other organisms (Marini et al., 2003).  
 
The aim of this chapter was to study the effect of depletion by RNAi of 
three putative TLS pols, TbPolN, TbHelQ and TbPolZ (Rev3), on BSF parasite 
growth in vitro. These data will contribute to understanding if these proteins are 
involved in the survival of the cells.  
 
3.2 Bioinformatics Analysis 
 Blast Analysis 3.2.1
Due to the lack of information about TLS pols in T. brucei, it was 
important to search for homologues in other species, with the aim of elucidating 
if the function of these proteins resemble the functions described in other 
organisms. Available information for the three TLS pols of interest is shown in 
Table 3-1, which summarises the product annotation of each gene in tritrypDB, 
plus chromosome and predicted protein size. To evaluate if the annotations are 
accurate, the predicted polypeptides were used firstly in standard protein-
protein Basic Local Search Tool (Blastp) searches 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi).  
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Table 3-1-General information of TbPolN, TbHelQ and TbRev3. Gene ID of the 
specific gene that encodes for each particular protein, the chromosome 
localization and the expected protein size (data obtained from TriTrypdb.org; 
correct as of June 2017).  
 
The protein sequences of TbPolN, TbHelQ and TbRev3 were each used as 
query sequences against the protein non-redundant (nr) database (Li et al., 
2013), in an effort to identify homologous proteins. A second analysis of the 
protein sequences was then conducted by using the SmartBLAST 
(http://blast.ncbi.nlm.nih.gov/smartblast/) tool, whose aim is to identify 
potential matches from distantly related organisms compared to that of the 
input sequence. The top five ‘hits’ identified by Blastp and SmartBLAST are 
summarized in Table 3-2 and Table 3-3, respectively. 
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Table 3-2. Top Five Blastp ‘hits’ for TbPolN, TbHelQ and TbRev3, obtained 
from the NCBI database. Comparing the query sequence with closely related 
Trypanosome species. Blastp hits, showing the E value and the percentage of 
identity for each hit (Data recovered June, 2017).  
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Table 3-3. Top five SmartBlast ‘hits’ for TbPolN, TbHelQ and TbPolZ (Rev3), 
obtained from the NCBI database. Comparing the query sequence with distantly 
related organisms. SmartBlast five top ‘hits’, showing the E value and 
percentage of identity for each hit. Data recovered June, 2017.  
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The ‘hits’ obtained with standard Blastp indicate that TbPolN, TbHelQ and 
TbRev3 are conserved amongst the class kinetoplastida, with syntenically 
conserved genes identified in different Trypanosoma species. For T. brucei 
brucei, T. brucei gambiense and T. congolense, PolN gene is localised in 
chromosome 11. Unlike the other species, in T. cruzi PolN is found in 
chromosome 26. In the case of T. grayi, the localisation of the gene has not 
been assigned. On the other hand, HelQ gene is localised in chromosome 8 with 
exception of T. cruzi, which is found in chromosome 32. PolZ gene is found in 
chromosome 8 on T. brucei brucei, T. brucei gambiense and T. congolense. The 
localisation of PolZ gene in T. equiperdum and T. cruzi genome still unknown. 
The level of sequence homology followed predictions of phylogenetic distances 
between species, with T. cruzi always the most distantly related to the T. brucei 
subspecies. The Smart Blast analysis revealed Leishmania homologues for TbPolN 
and TbRev3  (Table 3-3).  
 
Notably, in all cases DNA PolN and PolQ were encoded from separate 
genes, suggesting that none of the kinetoplastids encode a single protein with 
both polymerase and helicase domains. PolQ with dual domain (polymerase and 
helicase domain), has so far has only been described in metazoan organisms, 
including humans, D. melanogaster and C. elegans (Wood and Doublié, 2016; 
Wyatt et al., 2016). 
 
From the SmartBLAST analyses, homologues in organisms aside from the 
kinetoplastid group were identified. One species appeared as a common ‘hit’ in 
the analysis of the three proteins; Arabidopsis thaliana, with an E value of 1e-
25, 1e-123 and 4e-132 for TbPolN, TbHelQ and TbRev3, respectively. Homo 
sapiens was one of the top ‘hits’ for TbPolN (8e-24; XP_011510656.1) and for 
TbHelQ (2e-142; XP_005262770.1). For TbPolN it was notable that the genes 
identified did not encode proteins with only a polymerase domain, but instead 
DNA Pol theta was recovered, which encodes both a helicase-like domain and a 
polymerase-like domain (Yousefzadeh and Wood, 2013). Thus, this reinforces the 
close evolutionary relationship between the dual-domain and single-domain 
proteins. Nonetheless H. sapiens helicase PolQ-like (2e-142; XP_005262770.1), 
which is just a predicted helicase, was a top ‘hit’ for TbHelQ, suggesting this 
protein may be more homologous to the parasite helicase.  
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 Protein domain predictions 3.2.2
The study of protein structure is of high relevance, permitting a better 
prediction of the functions played in the organism (Karplus and Kuriyan, 2005). 
Due to this the domain organization of TbPolN, TbHelQ and TbRev3 was 
analysed, in the attempt to comprehend their roles in the parasite. 
 
To identify potential protein domains, analysis using two software 
packages, Pfam (http://pfam.xfam.org/) and InterPro 
(https://www.ebi.ac.uk/interpro/), was performed. These software are 
databases of known protein families, which includes their domains and 
functional sites (Sonnhammer et al., 1998; Finn et al., 2017). Pfam and Interpro 
align the unknown proteins to the database, finding the conserved domains 
present in the protein of interest(Sonnhammer et al., 1998; Finn et al., 2017).     
 
The protein structures were subsequently compared to their respective 
human homologues. The structure of TbPolN and TbHelQ resemble the domain 
organization of H. sapiens PolN and HelQ, respectively. In the case of TbPolN 
(Figure 3-1 A-D), the presence of a polymerase palm domain, which is 
characteristic of A family polymerases, was seen. On the other hand, TbHelQ is 
composed of a helicase domain and a DEAD/DEAH box domain, both domains of 
which are characteristic of SF2 family helicases (Fairman-Williams, Guenther and 
Jankowsky, 2010). Thus, TbHelQ resembles the domain organization of the 
human HelQ (Figure 3-1C-D). These data confirm that neither TbPolN nor TbHelQ 
harbour both domains, as can be found in A. thaliana and H. sapiens PolQ 
(Figure 3-1 E-F). 
 
In the case of TbRev3, a polymerase domain, a multifunctional domain 
(characteristic of B family DNA polys) and an N- terminal exonuclease domain 
are conserved between T. brucei. H. sapiens and A. thaliana (Figure 3-2). The 
human PolZ catalytic Rev3 subunit has the presence of an N-terminal domain, 
with unknown function, that is absent in the other two species. There is also the 
presence of an extra C-terminal exonuclease domain and a C-terminal zinc finger 
domain in the human and the plant proteins that is not present in the T. brucei 
polymerase subunit (Figure 3-2 B-C).  
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Figure 3-1. Schematic representation of conserved domains of TbPolN and 
TbHelQ compared against human and plant homologues. A-B. Domain 
organization of TbPolN and H. sapiens PolN. C-D.Domain organization of Tb HelQ 
and H. sapiens HelQ. E-F. Domain organization of H. sapiens and A. thaliana 
PolQ. See legend for domain colour coding.  
 
 
 
 
 
 
 
 
A. 
 C. 
E. 
 B. 
    
     
D. 
F. 
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Figure 3-2. Schematic representation of conserved domains of PolZ catalytic 
subunit Rev3. Conserved domains of TbRev3, compared against H. sapiens and 
A. thaliana homologous proteins. The color-coded legend identifies the distinct 
domains constituting each protein. 
 
 Conserved Motifs 3.2.3
To identify conserved motifs in the putative T. brucei TLS pols, the 
protein sequences of TbPolN (Tb927.11.5550) and TbHelQ (Tb927.8.3350) were 
obtained from TriTrypDB v. 33 and compared against the human protein 
sequences of PolQ (XP_011510656.1), PolN (Gene ID: 353497) and HelQ 
(XP_005262770.1), for which the  protein sequences were obtained from the 
NCBI database. The alignment was carried out using the multiple sequence 
alignment software ClustalW2.  In the case of the polymerase domain, it was 
possible to observe the presence of six conserved motifs (Figure 3-3) 
characteristic of A family polymerases (Delarue et al., 1990; Yousefzadeh and 
Wood, 2013). On the other hand, TbHelQ  displayed conservation within the 
helicase domain across 7 conserved motifs characteristic of the SF2 helicase 
family (Figure 3-4) (Hall and Matson, 1999; Fairman-Williams, Guenther and 
 
A. 
B. 
C. 
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Jankowsky, 2010). The presence of sequence inserts in the polymerase domain 
of Drosophila melanogaster (Mus308) and the human dual helicase-polymerase, 
PolQ, which are absent in TbPolN, suggest the parasite protein is closer in 
function to the stand alone human polymerase, H. sapiens PolN.  
 
The same analysis was conducted for TbPolZ catalytic subunit Rev3 
(Tb927.8.3290) and compared against H. sapiens (Gene ID: 5980) and A. thaliana 
Rev3 (NP_176917.2) (Figure 3-5). In this alignment, it was possible to identify six 
conserved motifs that characterize members of the B family polymerases (Lin, 
Wu and Wang, 1999). 
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Figure 3-3.Diagram illustrating the characteristic motifs within members of A 
family polymerases. A. Conserved sequence motifs within A family polymerases. 
“()” represents an amino acid (aa) residue known to be located in a specific 
position and that is conserved in almost all four sequences; “aa” represents an 
aa known to occupy a specific position but that can be replaced by another aa; 
“•” denotes any aa can occupy that position. A family of polymerase conserved 
sequences obtained from (Delarue et al., 1990; Yousefzadeh and Wood, 2013) B. 
Characteristic motifs of the A family polymerases are labeled in yellow and, in 
purple, polymerase domain inserts in H. sapiens PolQ are labelled.   
 
 
 
 
A. 
B. 
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Figure 3-4. Diagram illustrating the characteristic motifs within members of 
SF2 Helicase family. A. Conserved sequences within SF2 helicase family 
characteristic motifs. “()” represents an amino acid residue (aa) known to be 
localized in a specific position and that is conserved in almost all three 
sequences. The “aa” represents an aa that is known to occupy a specific position 
but that can be replaced by another one; “•” denotes any aa can occupy that 
position. “+” Represents hydrophobic aa occupying a specific position and 
“◦”represents hydrophilic aa. SF2 family conserved sequences obtained from 
(Hall and Matson, 1999; Fairman-Williams, Guenther and Jankowsky, 2010)  B. 
Characteristic motifs of the SF2 helicase family are labelled in pink. 
 
A. 
B. 
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Figure 3-5. Diagram illustrating the characteristic motifs within the catalytic 
subunit of PolZ, Rev3. Yellow boxes showing the conserved sequences within 
PolZ catalytic subunit Rev3 in three different species, T. brucei. A. thaliana and 
H. sapiens.  B family of polymerases conserved sequences obtained from (Lin, 
Wu and Wang, 1999). 
  
                                                                           
3.3 Construction of TbPolN, TbHelQ and TbRev3 RNAi cell 
lines 
 
In order to generate the RNAi cell lines against TbPolN, TbHelQ and 
TbRev3, the Gateway® technology was used for the construction of the stem 
loop plasmids.  The TbHelQ RNAi cell line was kindly provided by M. Prorocic. 
 
The plasmid pGl2084 (constructed as described in (Jones et al., 2014)), 
originally modified from the pRPAiSL construct (Alsford & Horn 2008), was used 
for this assay. The RNAi target sequences were amplified using appropriate 
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primers, incorporating attachment sites (attB) which facilitates the integration 
of the fragment into the vector (Jones et al., 2014).  
 
The pGl2084 plasmid is composed of two sets of attachement sites (attP), 
which flank a counter selectable marker (ccdB), and are separated by a 150 bp 
stuffer (Figure 3 6). The attP sites are compatible with attB sites of any 
fragment of interest. The compatibility between the attP (vector) and the attB 
(fragment) sites facilitates the integration of the fragment into two specific 
regions of the vector in a single cloning step, replacing the ccdB gene (Hartley et 
al. 2000; Katzen 2007). This approach results in a final vector with the gene-
specific fragment inserted in a ‘tail to tail’ orientation separated by the ‘stuffer’ 
(Figure 3-7), which  permits the expression of a dsRNA hairpin loop, which is 
under the control of the ribosomal RNA promoter (PRRNA), regulated by a 
tetracycline operator (Jones et al., 2014). Resulting in a tetracycline inducible 
RNAi plasmid, thus facilitating knockdown of a gene of interest by RNAi (Jones et 
al., 2014). The plasmid also contains HindIII, XbaI, BamHI, ClaI and StuI 
restriction sites, which allow the verification of the correct integration of the 
fragment into the plasmid (described in N. Jones PhD thesis, 2014). On the other 
hand, an AscI restriction site allows the linearisation of the plasmid prior to 
transfection (Jones et al., 2014). Additionally, the plasmid harbours the 
remaining sequence of the HYG ORF.  
 
The pGl2084 plasmid leads the integration of a gene-specific RNAi cassette 
into the ribosomal locus of chromosome 2a in the 2T1 parental strain (Jones et 
al., 2014).  2T1 is a genetically adapted strain of T. brucei, in which the 
ribosomal spacer of chromosome 2a is modified to contain inserts consisting of a 
3’ Hygromycin (HYG) fragment (see below) and a puromycin (PUR) selectable 
marker (Alsford & Horn 2008). A detailed description of the construction of the 
cell line is found in (Alsford & Horn 2008). After transfection into 2T1 cells, the 
plasmid integrates into the ribosomal locus replacing the PUR marker and 
reconstructing the HYG ORF (Figure 3-8). The correct integration of the plasmid 
will result in cells resistant to hygromycin and sensitive to puromycin (Jones et 
al., 2014). The successful cloning will result in tetracycline-inducible RNAi gene 
knockdown cell lines.  
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Figure 3-6. RNAi plasmid pGL2084 Map.The purple arrows represent the Attp1 
and Attp2 sites; the Attp sites are separated by a 150 bp stuffer (light blue 
arrow). The RRNA promoter and the tetracycline operator, which regulates the 
activation of the expression of an RNAi insert, are represented in green. The 
dark blue arrows represent the selectable marker (ccdB). The gray arrows show 
the incomplete HYG resistance gene. The linearization sites (AscI) are localized 
next to the HYG sequence and the rRNA targeting fragment (blue arrow). The 
restriction enzyme sites used for validation (BamHI, ClaI, HindIII, StuI and XbaI) 
are shown in pink. 
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Figure 3-7. Schematic representation of the integration of PCR products into 
the RNAi vector.Graphic showing the integration of an att B flanked PCR 
product into the vector in a single cloning step, replacing the ccdB gene 
(selection marker) by recombination of the attP sites. 
 
 
 
 
Figure 3-8. Schematic representation showing the integration of linearized 
RNAi vector into the ribosomal spacer of the 2T1 cell line. Integration of the 
RNAi vector into the genome of 2T1, replacing the PUR cassette and 
reconstructing the HYG ORF.  
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 Growth analysis after the depletion of Polymerase Nu, 3.3.1
Polymerase Theta and Polymerase Zeta catalytic subunit 
Rev3 in T. brucei 
To determine the effect of TbPolN, TbHelQ and TbRev3 depletion in BSF 
T. brucei parasites, RNAi mediated tetracycline inducible knockdown of the 
three genes were performed. This will provide a better understanding of the 
essentiality of TbPolN, TbHelQ and TbPolZ in the survival of the parasite.  
 
The RNAi cell lines used for this analysis were generated as described in 
the section above (Section 3.3). To confirm the correct integration of the RNAi 
target fragment into the vector prior to transfection, a diagnostic restriction 
digest was performed using the following combination of enzymes: BamHI+XbaI, 
ClaI, StuI and AscI alone (Figure 3-9). The double digestion with BamHI and XbaI 
result in the excision of the opposite fragments and the attL sites (comprised of 
sequences from the attB and attP sites). ClaI digestion results in the excision of 
one of the PCR fragments and the attL sites. Equally to StuI digestion, which 
excises the other PCR fragment including the attL sites. AscI digestion excises 
the entire fragment including the two PCR fragments and the HYG ORF. This was 
performed for both the TbPolN and TbRev3 plasmids. This restriction digest 
analysis was not performed on the TbHelQ RNAi plasmid, as the cell line was 
kindly provided by M. Prorocic.  
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Figure 3-9. Validation of RNAi vectors and transformants for TbPolN and 
TbRev3. Enzymatic digestion confirming the insertion of the PCR fragment into 
the RNAi vector and PCR on 2T1 cells transformed with above RNAi vector 
confirming the insertion of the cassette into the genome of 2T1. A.  RNAi vector 
map for TbPolZ and confirmatory enzymatic digestion. Red arrow shows the 
band corresponding to the TbRev3 insert. Smaller gel shows PCR on 2T1 cells 
transformed with RNAi TbPolZ (Rev3) vector confirming the insertion of the 
cassette, represented by the ~600 bp band. B. RNAi vector map for TbPolN and 
confirmatory enzymatic digestion. Second gel showing a band of ~600bp 
confirming integration of TbPolN RNAi vector into the genome of 2T1. Image has 
been cropped to show the corresponding band next to the DNA molecular weight 
marker. C. Expected band size in bp after the digestion with the different 
enzyme combination is shown.  
 
A. 
B. 
C. 
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Following the diagnostic digestion, the vectors were linearised with AscI 
and transformed into the 2T1 cell line and hygromycin resistant clones were 
selected. To confirm the integration of the cassette, the transformants were 
tested for puromycin sensitivity (0.2 µg/ml). As it was mentioned above, the 
integration of the cassette replaces the PUR marker and reconstructs the HYG 
ORF. The puromycin resistant cells were discarded and the rest of transformants 
were further tested for hygromycin (5µg/ml) resistance. The integration of the 
cassette was further analysed by PCR using the primers OL4161- 
taatgccaactttgtacaaa and OL4212-taatgccaactttgtacaag, expecting a band of 
approximately 600 bp, which correspond to the insert and the attB sites (Figure 
3-9). To understand the effect of RNAi against each gene, cultures were diluted 
to 5x104 cells.ml-1 and grown with or without the addition of tetracycline at 1 
µg/ml. Cell proliferation for each cell line was monitored over 72 hours, with 
the growth analyses repeated three times.  
 
Following the putative RNAi depletion of TbRev3 and TbHelQ, no clear 
proliferative defects could be observed when compared to the uninduced 
controls (Figure 3-10 A-B). In contrast, 24 hours after the putative depletion of 
TbPolN, cell proliferation was reduced. However, growth did not cease, but 
instead was slowed from 24 hours onwards. The phenotype was confirmed by 
testing two independent clones; a similar reduction in growth was observed 
following putative TbPolN depletion in both clones (Figure 3-10 C-D). Since the 
two different clones displayed the same behavior, clone B was chosen for further 
analysis.   
 
To test for loss of TbPolN and TbHelQ after RNAi, the cell lines were 
transformed with constructs that result in the expression of each protein, from 
its own locus, as a variant fused to 12 copies of the myc tag. This manipulation 
was achieved using the 12Myc pNAT BSD vector (Alsford and Horn, 2008). The 
procedure is described in detail in Chapter 5 (section TbPolN 5.3.1; section 5.7.4 
TbHelQ), the only difference being the parental cell line used for the 
transformation. For this specific case the RNAi cell lines against TbPolN and 
TbHelQ were used instead of WT Lister427 cells. Apart from this difference, the 
same primers and procedure were performed in both assays. 
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Anti-myc antiserum was then used to test for loss of the myc-tagged 
proteins after RNAi by Western blot analysis (Figure 3-10 B,D). For TbRev3, RT-
qPCR was performed to test for loss of transcript (Figure 3-10 A) (procedure 
described in section 2.3.4), as myc-tagged clones could not be generated in the 
RNAi cells. The reasons behind this are unclear, as TbRev3 was successfully myc-
tagged in non-RNAi BSF T. brucei cells (section 4.2).  
 
RT-qPCR of TbRev3 demonstrated a 50% reduction of the RNA transcript 
relative to uninduced cells at 24 hours post RNAi induction (Figure 3-10 A), 
suggesting the RNAi was successful. western blotting of whole cells extracts to 
detect TbPolN-myc revealed the depletion of the protein from 24 hours and 
throughout the 72 hours growth post induction (Figure 3-10 D). However, In the 
case of TbHelQ, the Western blot revealed no evidence for loss of TbHelQ-myc 
(Figure 3-10 B), suggesting an inefficient RNAi cell line following tetracycline 
addition, or an unusually stable protein. No attempt was made to evaluate 
growth and protein levels over a more prolonged period of TbHelQ RNAi 
induction. Irrespective of the explanation, the lack of growth alteration after 
RNAi cannot be said to be because loss of the protein does not affect BSF T. 
brucei viability. An attempt to generate a new TbHelQ RNAi cell line was 
conducted, in case the available cell line was defective. In order to do this, a 
vector containing different TbHelQ ORF fragments was used. As it was 
mentioned above, the correct integration of the fragments into the vector was 
tested by enzymatic digestion (Figure 3-11). The plasmid was used to transform 
competent E. coli cells (DH5 α).  Unfortunately, it was not possible to recover 
transformants.  
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Figure 3-10 Effect of RNAi against the three T. brucei putative TLS Pols. Growth curves are shown of T. brucei bloodstream form cells 
over 72 hrs  in the absence (Tet-) or presence (Tet+) of tetracycline induction of RNAi against TbRev3 (A), TbHelQ (B) and TbPolN (C-D). 
Error bars represent the standard deviation of the mean of three experimental repetitions. Inserts in B and D show Western blot analysis 
using anti-myc antiserum. Ef1α was used as a loading control. Insert (A) show RT-qPCR comparing the relative amounts of TbRev3 RNA 
after 24 hours with or without addition of Tet. 
A. B. 
C. D. 
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Figure 3-11. Verification of TbHelQ RNAi vector.  A. RNAi vector map for 
TbHelQ and confirmatory enzymatic digestion. B. Expected band size in bp after 
the digestion with the different enzymes combination is shown, and size markers 
of the digest gels are shown. 
 
 Cell cycle analysis following depletion of Polymerase Nu and 3.3.2
Polymerase Zeta catalytic subunit Rev3 
As it was demonstrated in section 3.3.1 the proliferation of T. brucei cells 
was affected by the depletion of TbPolN, the cell cycle was analysed in order to 
ask if the loss altered progression. Even though the cells did not show an obvious 
phenotype after the knockdown of TbPolZ, it was important to test if the lack of 
a growth defect masked cell cycle defects.  
 
The cell cycle was analysed using the RNAi cell line against TbPolN and 
TbRev3, in the absence and presence of tetracycline induction at 24 hours, 48 
hours and 72 hours. The cells were stained with 4 ',6-diamidino-2-phenylindole 
(DAPI), allowing the visualization of the nucleus and the kinetoplast, before and 
after the depletion of the protein, allowing the characterization of the cell 
cycle. Depending on the stage of the cell cycle the DNA content will vary, 
because replication and segregation of the nucleus and kinetoplast differ in their 
timing (Siegel, Hekstra and Cross, 2008). Cells containing 1 nucleus and 1 
kinetoplast (1N1K) are predominantly in G1, though some may have entered 
A. 
B. 
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nuclear S (which can be seen by an elongated K configuration and perhaps 
increased N). Cells with 1 nucleus and 2 kinetoplasts (1N2K) are predominantly 
in G2/M; and cells that have completed mitosis and are undergoing cytokinesis 
have 2 nuclei and 2 kinetoplasts (2N2K). Changes in the distribution of these 
configurations in mutants or after RNAi indicate altered cell cycle dynamics, and 
it is frequently observed that non-standard configurations arise after mutation or 
depletion ofspecific genes (Hammarton, 2007; Monnerat et al., 2009). The 
morphology of the parasites was also observed by differential interference 
contrast (DIC) microscopy, asking if cells with an aberrant body shape arose.  
 
Following depletion of TbPolN, the DNA content distribution of the 
population and body shape at 24 hours post RNAi induction did not seem to be 
strongly affected (Figure 3-12 A). However, a minor increase in the number of 
1N2K cells could be observed, as well as a small decrease in 2N2K cells and a 
small increase in non-standard configurations (‘other’) (Figure 3-12 B). Flow 
cytometry of propidium iodide stained cells appeared to confirm this, as slightly 
decreased numbers of cells with 2N content were detected after RNAi relative to 
the control, as well as slightly increased numbers of cells with 4N content 
(Figure 3-12 C). At 48 hours post RNAi induction there was a significant decrease 
of 1N1K cells and a further loss of 2N2K cells; the numbers of 1N2K cells did not 
appear to increase relative to 24 hours, but instead there was a very significant 
accumulation of cells with aberrant DNA content (Figure 3-12 A-B). At the same 
time, the cells had lost their typical trypomastigote shape and were highly 
abnormal (Figure 3-12 A). The abnormal DNA content was hard to classify, but 
most cells had multiple kinetoplasts and abnormal, enlarged nuclei (Figure 3-12 
A-Figure 3-13). The phenotype observed after DNA characterization was 
confirmed by flow cytometry, showing a very pronounced decrease in 2N cells 
and an accumulation of >4N cells (Figure 3-12 C).    
 
The cell cycle data suggest an initial, partial arrest in G2/M, which 
explains the increase in 1N2K cells. However, it appears this stall is overridden 
and the cells progress to mitosis but cannot complete it, preventing the correct 
division of the cell and explaining the reduction of 2N2K cells, the accumulation 
of abnormal cells with increased nuclear DAPI signal, and the strong decrease of 
1N1K (G1) cells (Figure 3-12 B). 
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Remarkably, the time course revealed that the cell cycle perturbations 
following depletion of TbPolN are transient phenotypes, since at 72 hours the 
cells started to recover: in the IFA images it was possible to observe more cells 
with normal DNA content and regular body shape than at 48 hours (Figure 3-13) 
and the DNA characterisation demonstrated an increase of 1N1K cells and a 
decrease of aberrant cells relative to 48 hours. The basis for this change is 
unclear, since Western blot analysis indicated that TbPolN-myc was still absent 
at 72 hours, suggesting the RNAi depletion was still present (Figure 3-10 D). In 
addition, the cell cycle changes were not associated with increased growth, as 
the RNAi cells were still growing more slowly (Figure 3-10 C-D) than the controls. 
 
In the case of TbRev3, no differences between the control cells and the 
RNAi induced cells at 24 hours and 48 hours growth could be observed (Figure 
3-14). The DNA content and the body shape of the parasite was not affected 
following depletion of the protein (Figure 3-14 A), suggesting that TbPolZ is 
unlikely to have an essential role in bloodstream form T. brucei.  
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Figure 3-12. Analysis of the cell cycle after RNAi depletion of TbPolN. A. Cell 
cycle analysis by DAPI staining at 24 h, 48 h and 72 h in the absence (T-) and 
presence (T+) of tetracycline induction. Immunofluorescence analysis allowing 
the visualization of the DNA content. Visualization of the cell body was 
performed by differential interference contrast microscopy (DIC). B. 
Characterisation of DNA content by DAPI counting, allowing the classification 
into 1N1K (G1/S), 1N2K (G2/M) and 2N2K (mitosis) cells; other denotes cells that 
deviate from these classifications. Values depict the mean of each classification 
in the total population, and error bars represent the standard deviation of the 
mean of two biological repetitions. >200 cells were counted at each time point 
and in each experiment. C. FACS analysis: histogram profiles of cells labelled 
with propidium iodide, at 24 h and 48 h post-induction (Tet+, blue) or in 
uninduced cells (Tet-, yellow). 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. B. 
C. 
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Figure 3-13. Cell phenotype after the depletion of TbPolN in bloodstream 
forms. Immunofluorescence analysis at 24 h and 48 h in the absence (Tet-) and 
presence (Tet+) of tetracycline. First panel show DAPI staining of the nucleus 
and kinetoplast and second panel visualization of the cell body by differential 
interference contrast microscopy (DIC). Scale bar: 5 µm 
 
 
 
  
 
Figure 3-14. Analysis of the cell cycle after RNAi of TbRev3. A. Cell cycle 
analysis by DAPI staining at 24 h and 48 h in the absence (T-) and presence (T+) 
of tetracycline induction. Immunofluorescence analysis allowing the visualization 
of the DNA content. Visualization of the cell body was performed by differential 
interference contrast microscopy (DIC). B. Characterisation of DNA content by 
DAPI counting, allowing the classification into 1N1K (G1/S), 1N2K (G2/M) and 
2N2K (mitosis) cells; other denotes cells that deviate from these classifications. 
Values depict the mean of each classification in the total population of two 
biological repetitions. >200 cells were counted at each time point and in each 
experiment. 
A.
. 
 B. 
B.
. 
 B. 
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 Analysis of cell sensitivity to genotoxic agents after TLS RNAi 3.3.3
The deletion of PolN and PolZ have been linked with an increase of 
sensitivity to genotoxic agents (UV, MMS, cisplatin, etc), responsible for DNA 
cross-links and breaks, including DSBs (Ho and Schärer, 2010; Sharma, 
Helchowski and Canman, 2013a). The depletion of human PolN increases the 
sensitivity against cisplatin and mitomycin C, suggesting a role in interstrand 
cross-link repair (ICL) (Ho and Schärer, 2010). On the other hand, the depletion 
of PolZ in chicken and mammalian cells lead to an increase in the sensitivity to 
UV radiation, MMS and other cross-linkinkig agents (Sale, 2013; Sharma, 
Helchowski and Canman, 2013b). These observations indicate that these proteins 
have a role in the maintenance of genome integrity following damage (Ho and 
Schärer, 2010; Sharma, Helchowski and Canman, 2013a). For this reason, we 
next tested if the depletion of TbPolN and TbRev3 increased the sensitivity of T. 
brucei cells to exposure by the genotoxic agents UV radiation and MMS. 
  
3.3.3.1 Sensitivity of BSF cells to MMS damage after depletion of TbPolN and  
TbRev3  
Sensitivity of T. brucei BSF cells to the alkylating agent MMS was tested by 
evaluating growth of RNAi cell lines targeting TbPolN and TbRev3, in the absence 
(Tet-) and presence (Tet+) of tetracycline, over 72 hours. Growth was compared 
at three different concentrations of MMS (Figure 3-15). Depletion of either 
TbPolN or TbRev3 resulted in reduced growth in comparison to the uninduced 
cells exposed to MMS, particularly at the highest concentration (0.0003%).  
 
Depletion of TbRev3 may have had a more severe effect than depletion of 
TbPolN, since the former cells began to loose proliferation after the 24 hours 
post-induction at 0.0003% MMS and were unable to recover at 72 hours (Figure 
Figure 3-15 C-D), unlike the latter. However, this is hard to evaluate, since the 
extent of growth impairment of the TbRev3 uninduced cells was more severe 
than the uninduced TbPolN cells, perhaps due to MMS dilution variation. 
Nonetheless, these data suggest that both TLS Pols contribute to cell viability 
following exposure to MMS stress. 
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Figure 3-15. Growth of T. brucei cells in the presence of MMS and after RNAi 
depletion of TbPolN or TbRev3. Growth curves of T. brucei bloodstream form 
RNAi cell in the absence (Tet-) or presence (Tet+) of tetracycline induction, with 
or with various concentrations of MMS (0%, 0.0001%, 0.0002%, 0.0003%). A-B. 
Growth curve in the absence and presence of tetracycline RNAi induction against 
TbPolN. C-D. Growth curve in the absence and presence of tetracycline 
induction against TbRev3. Error bars represent the standard deviation of the 
mean of three biological repetitions. 
 
3.3.3.2 Sensitivity of BSF cells to UV radiation damage after depletion of 
TbPolN and TbRev3 
 The sensitivity of TbPolN and TbRev3 RNAi cell lines to UV radiation was 
tested by examining cell proliferation, following TbPolN or TbREv3 RNAi 
depletion, after exposure to five different UV intensities (0 J/m2, 500 J/m2, 750 
J/m2, 1000 J/m2 and 1500 J/m2).  
 
As seen during MMS exposure, depletion of either protein increased the 
sensitivity of the cells to UV exposure; cell proliferation in the induced cells 
(Tet+) was reduced when compared to the control, uninduced cells (Tet-) at the 
equivalent UV dose. However, the growth impediment in the presence of UV was 
more pronounced after depletion of TbPolN (Figure 3-16 A-B), with TbRev3 
depletion having only a minor effect (Figure 3-16 C-D). Due to the active role of 
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PolZ in UV lesion repair described in other organisms (Sharma, Helchowski and 
Canman, 2013a), this was unexpected. 
 
 
 Figure 3-16.Growth curve of T. brucei bloodstream RNAi cell lines against 
TbPolN and TbPolZ in the absence (Tet-) and presence (Tet+) of tetracycline  
induction, after the exposure to different intensities of UV (0 J/m2, 500 
J/m2, 750 J/m2, 1000 J/m2, 1500 J/m2). A-B. Growth curve in the absence and 
presence of tetracycline induction against TbPolN, after the exposure to 
different UV intensities. C-D. Growth curve in the absence and presence of 
tetracycline induction against TbRev3, after the exposure to different UV 
intensities. Error bars represent the standard deviation of the mean of three 
biological repetitions. 
 
3.4 Discussion  
This chapter provides a first analysis of the importance of three putative 
TLS DNA Pols in T. brucei BSF cells. Loss of TbPolN was shown to be severely 
detrimental to growth over 48 hours (approximately 8 generations), with an 
accumulation of cells showing aberrant nuclei, suggesting a critical role in 
nuclear genome maintenance. RNAi of TbPolZ, or at least the TbRev3 
polymerase catalytic subunit, did not impair growth, but resulted in increased 
sensitivity to methyl methanesulphonate (MMS) and, to a greater extent, UV 
radiation damage, phenotypes which were also observed after the depletion of 
TbPolN. Thus, both TLS pols provide a role in the response to alkylation and UV 
radiation effects. Unfortunately, targeted RNAi of a third factor, TbHelQ, was 
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unsuccessful. Taken together, these data reveal variant functions for two TLS 
DNA polymerases in T. brucei genome biology. 
 
 Bioinformatics and protein domain prediction 3.4.1
TbPolN, TbHelQ and TbRev3 were analysed using the SmartBlast software, 
with the aim of identifying related sequences in other organisms. The three 
proteins all recognized putative homologues in a common eukaryote, A. thaliana 
(Table 3-3); this plant is known to encode for orthologues of most proteins 
involved in genome maintenance in eukaryotes (Hays, 2002). A. thaliana encodes 
for four TLS pols, Polη, PolZ, Polκ and Rev1, polymerases that are also known to 
be present in  T. brucei (Hays, 2002; Passos-Silva et al., 2010). 
 
The single A. thaliana PolQ-like protein was a common match for TbPolN 
and TbHelQ.  The plant protein is composed of a C-terminal polymerase-like 
domain and an N-terminal helicase-like domain (Yousefzadeh and Wood, 2013), 
explaining its homology with TbPolN, which harbours a C-terminal A-family 
polymerase domain (Figure 3-1 A), and TbHelQ, which consist of a N-terminal 
helicase domain (Figure 3-1 C) (Delarue et al., 1990; Hall and Matson, 1999; 
Yousefzadeh and Wood, 2013). Additionally, the absence of an exonuclease 
domain in TbPolN suggests a possible role in the TLS pathway. The exonuclease 
domain is associated with the capacity of DNA polymerases for editing wrong 
nucleotides, an activity that is commonly found in replicative polymerases 
(Johansson and Dixon, 2013). The absence or alteration of this domain increases 
the possibility of spontaneous mutations, which was confirmed by alterations in 
the S. cerevisiae Polδ and Polε exonuclease domain resulting in frameshift and 
base substitution during synthesis (Tran, Gordenin and Resnick, 1999). It is 
known that polymerases involved in the TLS pathway are characterised by 
lacking 3’-5’ proofreading activity, impeding the excision of wrong nucleotides. 
Although this mechanism increases the probability of mutations, it is still 
essential for the survival of the cell (Goodman and Woodgate, 2013).  
 
SmartBlast analysis of TbPolN also identified the H. sapiens PolQ as a 
‘hit’, and, similar to A. thaliana, the human PolQ has a C-terminal A- family 
polymerase domain and an N-terminal SF2-helicase domain (Figure 3-1 E) 
111 
 
 
 
(Takata et al., 2010; Yousefzadeh and Wood, 2013). Surprisingly, H. sapiens 
PolN, the human protein that consists only of a C-terminal polymerase domain 
(Figure 3-1B), did not score as highly in searches with TbPolN. The polymerase 
domains of human PolQ and PolN are closely related (Yousefzadeh and Wood, 
2013), and previous studies suggest that PolN and PolQ diverged from one 
another before the origin of the vertebrate lineage  (Yousefzadeh and Wood, 
2013). Whether T. brucei had a PolQ dual domain protein that was discarded, 
leaving TbPolN and TbHelQ (below), or whether the two proteins were 
generated by separation of an ancestral PolQ is unknown. However, a true dual-
domain PolQ was not observed in any of the kinetoplastids examined, and 
detailed investigation of functional motifs suggests divergence between TbPolN 
and H. sapiens PolQ.  
 
When the protein sequences of TbPolN and TbHelQ were compared to the 
corresponding putative human homologues, the presence of several 
characteristic motifs in the polymerase and helicase domains could be 
identified. In the case of the polymerase domain, the aa sequence shown in 
Figure 3-3 was highly conserved across the functional motifs of the A family 
polymerase members, suggesting TbPolN is likely to be an active polymerase, 
though this remains to be tested. Studies performed in vertebrate and 
invertebrate PolQs indicate that these motifs are separated by three important 
inserts, all of which are characteristic of the PolQ polymerase domain (Hogg et 
al., 2011; Yousefzadeh and Wood, 2013). The first insert is located in the thumb 
domain, between the first and second motifs. The second insert resides in the 
palm domain between the second and third motifs, and the third insert is 
located in the palm domain, between the fifth and sixth motifs (Figure 3-3). 
Deletion of insert 1 affects the enzyme’s processivity. On the other hand, the 
deletion of inserts 2 and 3 affects the enzyme’s activity and its ability to bypass 
abasic sites (Hogg et al., 2011; Yousefzadeh and Wood, 2013; Wood and Doublié, 
2016). TbPolN lacks two of the three inserts that are characteristic of PolQ, 
whereas human PolN lacks all the inserts (Figure 3-3). This may suggest closer 
homology between TbPolN and vertebrate PolN homologues, but is not 
definitive. Indeed, it is unclear how any PolN activity is altered by the loss of 
these inserts, though activity of this TLS pol may be mediated by interaction 
with another protein. Further work will be needed to evaluate activity.  
112 
 
 
 
 
In contrast to TbPolN, TbHelQ appears to be more homologous in 
sequence to the human helicase HelQ than PolQ. HelQ shows clear sequence 
homology to the PolQ SF2-helicase domain (Takata et al., 2010; Yousefzadeh and 
Wood, 2013). From the alignment of the proteins (performed in section 3.2.3), 
TbHelQ also belongs to the SF2-family. Indeed, detailed analysis shows TbHelQ 
harbours specific motifs characteristic of this group of helicases (Figure 3-4)(Hall 
and Matson, 1999; Tanner and Linder, 2001; Fairman-Williams, Guenther and 
Jankowsky, 2010). The Q motif within this domain has been suggested to be 
involved in the DNA binding (Ding et al., 2015). Moreover, the motifs I, II and VI 
have been shown to be responsible for the binding and hydrolysis of nucleotide 
triphosphate (Fairman-Williams, Guenther and Jankowsky, 2010). Motifs Ia and 
IV are also involved in substrate binding (Tanner and Linder, 2001), while motifs 
III and V are involved in communication between the nucleoside triphosphate 
and the nucleic acid binding site (Tanner and Linder, 2001; Fairman-Williams, 
Guenther and Jankowsky, 2010). It seems, likely, therefore that the protein has 
helicase activity, given its homology with human HelQ. HelQ homologues are also 
found in archaea, where they are termed Hel308 (Northall et al., 2017).  
 
To date, the activity of the helicase domain of PolQ remains uncertain, 
considering the polymerase domain confers the functions of this protein 
(Yousefzadeh and Wood, 2013). Several roles for PolQ have been reported across 
a diverse range of eukaryotes. For instance, the enzyme has been shown to be 
involved in somatic hypermutation in chicken cells, since the absence of PolQ 
provokes a decrease in the immunoglobulin gene diversity in this organism 
(Yousefzadeh and Wood, 2013). Additionally, studies have shown that PolQ in 
eukaryotes is required during several repair pathways, such as microhomology 
mediated end joining (MMEJ), non-homologous end joining (NHEJ), homologous 
recombination (HR), base excision repair (BER) and translesion DNA synthesis 
(TLS) (Yousefzadeh and Wood, 2013; Wood and Doublié, 2016). To date, the PolQ 
related proteins, PolN and HelQ, have been shown to act during HR and crosslink 
repair, where they interact with proteins that are directly involved in this 
pathway. Immunoprecipitation analysis suggests a possible interaction between 
human PolN, Rad51 and FANCD2 (Moldovan et al., 2010). On the other hand, 
there is evidence of a possible interaction of mice HelQ and Rad51 paralogues 
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(Adelman et al., 2013). In the case of HelQ, it is suggested that the deficiency of 
this protein in mammalian cells affects the recruitment of RAD51 to the damage 
replication fork (Adelman et al., 2013; Takata et al., 2013). On the other hand it 
has been proposed that RAD51 stimulates the recruitment of PolN for the 
synthesis of the invaded strand (Moldovan et al., 2010). More recent data has 
suggested that human PolN may have a more restricted role in meiotic 
recombination (Takata et al., 2017), though this is incompatible with the 
pronounced phenotypes seen after PolN loss in T. brucei. Whether this is 
because TbPolN has assumed some of the functions of PolQ from other 
eukaryotes is unknown.  
 
One problem in assessing this is the fact that RNAi against TbHelQ did not 
work, and we cannot evaluate if the effects of its loss compare with or differ 
from TbPolN (discussed further below). For instance, it is unclear why the 
parasites encode two separate proteins instead of one protein with both 
activities. It is unknown if the separate expression of the proteins provides an 
advantage to the parasite, perhaps allowing the two separate proteins to work 
independently in diverse pathways. Moreover, the question still remains as to 
whether the two proteins interact with each other in order to compensate for 
the lack of a protein with both domains, or do TbPolN and TbHelQ provide 
completely different roles in the parasite?  
 
As described in section 3.2.2, the putative Rev3 component of TbPolZ was 
compared with the PolZ catalytic subunit of A. thaliana and H. sapiens. From 
this analysis, we could identify the presence of six conserved motifs 
characteristic of the B family of polymerases (Lin, Wu and Wang, 1999; Gan et 
al., 2008). The alignment of the sequences shows high homology across the 
motifs, suggesting that the Rev3 catalytic subunit is conserved between the 
three members of the B family of polymerases and that the T. brucei protein is 
likely active (see below). What is not known, however, is whether TbRev3 forms 
part of a conventional multisubunit PolZ, as interacting subunits have not been 
described.  
 
Domain predictions using Pfam and InterPro software  (Section 3.2.2) show 
a similarity between the domain organization of T. brucei, H. sapiens and A. 
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thaliana Rev3, with each constituted by a C-terminal polymerase domain, a C-
terminal multifunctional domain and an N-terminal exonuclease domain. In spite 
of the presence of the exonuclease domain in the three species, it has not been 
demonstrated that this domain provides a nuclease function (Vaisman and 
Woodgate, 2017). The presence of a conserved, dormant exonuclease domain 
suggests TbPolZ, through TbRev3, plays a role in a TLS pathway, though activity 
assays are necessary to test this prediction. The only difference between Rev3 in 
T. brucei and the other two species is the lack of the C-terminal zinc finger 
domain in the parasite catalytic subunit. The zinc finger domain has been 
associated with an interaction between PolZ and PCNA, regulating the binding of 
the polymerase to the DNA template (Vaisman and Woodgate, 2017). However, 
previous experiments performed in S. cerevisiae demonstrate that the absence 
of PCNA does not affect the recruitment of the protein to the DNA template 
(McVey et al., 2016; Waters et al., 2009). There is the possibility that in the 
parasite, as well as in S. cerevisiae, the recruitment of TbPolZ is regulated by 
another mechanism. The zinc finger domain has also been associated with the 
possible interaction of the PolZ catalytic subunit and Pol δ accessory subunits. A 
Fe-S cluster that localizes next to the zinc finger is known to coordinate the 
interaction between the two proteins (Baranovskiy et al., 2012). In humans it 
has been suggested that Polδ is able to regulate the TLS pathway by the 
recruitment of TLS polymerases that bind to the C-terminal domain (Tian et al., 
2016). Whether the lack of the zinc finger domain in the parasite protein 
interrupts the interaction between both proteins is unknown.  
 
 Cell cycle analysis after the depletion of TbPolN and TbRev3 3.4.2
DNA replication is characterized by its efficiency and high fidelity, 
ensuring the viability of cells (Sale, 2013). Under optimal conditions, most 
lesions are repaired during the G1 phase of the cell cycle, thus assuring 
replication can proceed in the presence of a damage free DNA template (Ziv et 
al., 2014). However, if DNA damage can escape the DNA repair machinery during 
G1 phase, or new lesions are formed during replication, the presence of a 
tolerance repair pathway to avoid the collapse of the cell is required (Ziv et al., 
2014). TLS pols play active roles during this process; these polymerases primarily 
function during S and early G2 phases of the cell cycle, thus ensuring the 
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culmination of replication (Ziv et al., 2014). Previous studies have shown that 
members of the Y family of polymerases are involved in the TLS pathway; other 
proteins, such as PolN, PolQ and PolZ, though they do not belong to the Y family 
of polymerases, play active roles during this tolerance process and in other 
repair mechanisms (Garcia-Diaz and Bebenek, 2007). 
 
TbPolN and TbRev3 were successfully depleted by RNAi with the aim of 
better understanding their role(s) in bloodstream from T. brucei cells. Foremost, 
the depletion of TbPolN resulted in a notable decrease in cell proliferation 
(Figure 3-10) and a rise in the number of aberrant cells in the population (Figure 
3-12). The aberrant cells contained multiple kinetoplasts and abnormal nuclear 
content, with this phenotype most pronounced at 48 hours, at which time ~60% 
of the cell population was comprised of aberrant cells. Furthermore, a 
significant decrease (~50%) of 1N1K cells occurred, thus suggesting an 
impairment of mitosis that may prevent cytokinesis.  
 
It was suggested that the replication of the kinetoplast is coordinated 
distinctly, and perhaps independently, from nuclear replication (Hammarton et 
al., 2003), where kinetoplast S phase starts before nuclear S phase, and 
kinetoplast segregation occurs in early G2 phase (Hammarton et al., 2003). 
Independent control of the two replication processes would explain the 
accumulation of cells with multiple kinetoplasts and abnormal nuclei, in that 
even in the absence of effective nuclear replication and division, TbPolN RNAi 
cells successfully complete the kinetoplast replication and segregation, and 
perhaps continue to replicate again. These data link TbPolN with nuclear 
functions.   
 
In S. cerevisiae it has been suggested that HR is essential for a successful 
cell division, since unrepaired DSBs affect chromosome segregation, impeding a 
proper division of the cell (Guirouilh-Barbat et al., 2014). As mentioned 
previously, it has been proposed that PolN has a role during HR (Moldovan et al., 
2010). Taken together, these data may suggest that TbPolN has a role during this 
repair process. However, what aspect of repair provided by TbPolN is so central 
to nuclear replication and division is unclear. Nonetheless, depletion of TbPolN 
leads to a transient and not terminal phenotype, since cells continued to 
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proliferate after 48 hours of RNAi, and the cell cycle impediments were reduced. 
One potential explanation is redundancy between TLS pols; in the absence of 
one polymerase, others may have the ability to take over the function of the 
absent enzyme (Friedberg, Wagner and Radman, 2002). Numerous studies in 
other organisms have indicated the activity of other TLS pols during this process; 
for example, in the case of multicellular eukaryotes, PolQ plays an important 
role in HR (Wood and Doublié, 2016). As previously mentioned, T. brucei lacks 
PolQ, but in other organisms, PolZ has an active role during HR (Sharma, 
Helchowski and Canman, 2013a); perhaps this is the reason why the phenotype 
of the cells begins to reverse after the depletion of TbPolN. One other TLS Pol 
that may contribute to such redundancy is PrimPol2, another nuclear factor 
(Rudd et al., 2013). RNAi against PrimPol2 also affects the cell cycle after G2 
phase, but here the effect is lethal, unlike TbPolN. In addition, localisation of 
PrimPol2 is modulated by MMS treatment, perhaps indicating a role in repair 
(Rudd et al., 2013). 
 
The catalytic subunit of PolZ has been linked to other processes; in mice, 
the depletion of this protein leads to embryonic lethality, suggesting an 
important role during cell development and embryogenesis (Vaisman & 
Woodgate, 2017). Due to this, we hypothesized depletion of TbPolZ might also 
affect T. brucei proliferation. However, in contrast to TbPolN, cell growth was 
not affected by RNAi of TbRev3, suggesting this protein does not have an 
essential role in this stage of the parasite’s life cycle. Generation of a TbRev3 
null mutant would confirm the non-essential nature of this enzyme for the in 
vitro survival of T. brucei, and this is explored in Chapter 4. 
  
 Cell Sensitivity against genotoxic stress 3.4.3
DNA damage sensitivity after RNAi was tested by the exposure of T. brucei 
cells to two damaging agents, UV radiation and MMS, with the aim to elucidate a 
possible role in the repair of cross-link and DSB lesions. The exposure to UV 
radiation results in the formation of cyclobutane pyrimidine dimers and 
pyrimidine (6-4) pyrimidine photoproducts. The main repair pathway for tackling 
these lesions is the NER pathway (Genois et al., 2014; Shah and He, 2015). 
Studies made in T. brucei have demonstrated the presence of this repair 
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machinery in the parasite, including its role in the removal of UV lesions 
(Machado et al., 2014).The helicase XPB-R has an important role during this 
process. The knockout of this gene results in an increase in the sensitivity of 
cells against UV radiation and cisplatin (Badjatia et al., 2013). It is proposed 
that XPB-R may have an important role in unwinding the site of damage, 
permitting the repair of the lesion (Badjatia et al., 2013).  In contrast, MMS, an 
alkylating agent, has the capacity to generate DNA breaks, including both single 
and DSBs (Wyatt and Pittman, 2006); this type of lesion is commonly tackled by 
HR (Lundin et al., 2005). In S. cerevisiae, it has been demonstrated that 
alteration of the HR pathway results in increased sensitivity of cells to alkylating 
agents (Lundin et al., 2005). Similar results have been observed in T. brucei in 
the absence of RAD51, RAD51 paralogues and BRCA2. An increase in the 
sensitivity to the alkylating agent MMS was observed in the absences of the 
Rad51 paralogues, RAD51-4 and RAD51-6 (Dobson et al., 2011). The same effect 
was detected in BRCA2 mutants and Rad51 mutants, associating this protein with 
the repair of DSB (McCulloch and Barry, 1999; Hartley and McCulloch, 2008). 
 
RNAi against TbPolN and TbRev3 showed sensitivity to both damaging 
agents. We hypothesized that we would observe a strong growth effect following 
depletion of TbRev3 after exposure to UV radiation, due to the active role that 
PolZ has in the repair of lesions caused by photoproducts, in collaboration with 
Polκ and ι, in other organisms (Zhu and Zhang, 2003; Shah and He, 2015). 
However, the T. brucei cells presented only a mild sensitivity, which suggests 
other TLS pols are more involved during the repair of UV induced lesions. An 
important TLS pol that plays a crucial role in this process in other organisms is 
Polη (Shah and He, 2015). This enzyme is able to repair UV lesions in an error-
free manner, being capable of both base insertion and template extension 
without requiring another polymerase (Shah and He, 2015). Due to the 
polymerase’s ability to complete synthesis without the help of other proteins, 
there is the potential that T. brucei Polη provides the predominant activity 
during the repair of UV lesions, with TbPolZ playing a lesser role. Polη has not 
been examined here, or by others, in T. brucei, so further experiments would be 
needed to test this prediction. It was, however, observed that TbPolN depleted 
cells show increased sensitivity to UV radiation compared toTbRev3 depleted 
cells (Section 3.3.3.2), suggesting PolN plays a pronounced role. Previous studies 
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have shown the activity of PolN during cross-link repair in avian cells (Moldovan 
et al., 2010). It has been proposed that the repair of DNA cross-links involves the 
action of three DNA repair pathways: NER, TLS and HR. Since NER mutants in T. 
brucei are also sensitive to UV, it is possible that NER is in charge of generating 
the incision at the lesion, and TLS bypass of the lesion, or HR, is in charge of 
later repair. As PolN functions within these pathways, its depletion may explain 
the increase in sensitivity to cross-link and DSB agents after its depletion in T. 
brucei, as in avian cells (Moldovan et al., 2010). Further support for this 
suggestion is that RNAi depletion of PolN also sensitises the cells to MMS, whose 
is known to generate DSBs, which are commonly repaired by HR (Lundin et al., 
2005; Wyatt and Pittman, 2006).  
 
Perhaps surprisingly, TbRev3 depleted cells showed greater sensitivity to 
MMS than TbPolN depleted cells, a result consistent with the readout of whole 
genome RITseq of putative MMS repair factors (Stortz et al., 2017). PolZ has 
been shown to function in the context of HR repair in other organisms (Sharma, 
Helchowski and Canman, 2013a): its deletion sensitises avian and mammalian 
cells to MMS and UV  (Van Sloun et al., 2002; Okada et al., 2005; Sharma, 
Helchowski and Canman, 2013a). In S. cerevisiae, an active role for PolZ during 
HR repair has been determined (Sharma et al., 2012). These studies propose that 
the ability of this TLS pol to extend mismatched primers plays an important role 
during the early stages of HR; here the polymerase has the capacity to extend 
mismatch primers in the 3’ invading strand, thereby facilitating the initiation of 
this pathway (Sharma et al., 2012). Whether such activities are shared by TbPolZ 
is currently unknown. 
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4 Understanding the function of DNA Polymerase 
Zeta in T. brucei 
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4.1 Introduction 
 DNA Polymerase Zeta in Eukaryotes 4.1.1
4.1.1.1 Structure and possible interactions 
DNA Polymerase Zeta (PolZ) is a member of the B family of DNA Pols. Yet 
unlike other members of this family, PolZ is characterized by its low fidelity due 
to the lack of 3’- 5’ proofreading activity (Sharma, Helchowski and Canman, 
2013a).  It is suggested that PolZ consists of a core, which contains the catalytic 
subunit Rev3 and the structural subunit Rev7 (Gan et al., 2008). There is also the 
presence of two accessory subunits that are known as Pol31/Pol32 in S. 
cerevisiae and P50/P66 in humans (Lee, Gregory and Yang, 2014).  
 
Interestingly, in S. cerevisiae it has been demonstrated that the 
accessory subunits, Pol31/Pol32, are shared with Pol δ (Baranovskiy et al., 2012; 
Lee, Gregory and Yang, 2014). Polymerase δ is a member of the B family 
polymerases, which are characterized by their high fidelity (Baranovskiy et al., 
2012) and  have an important role in replication of both the leading and lagging 
DNA strands (Johansson, Majka and Burgers, 2001). In yeast this polymerase is 
composed of three subunits, Pol3 (catalytic subunit), Pol31 and Pol32 
(Johansson, Majka and Burgers, 2001), the latter two of which are shared with 
PolZ (Makarova and Burgers, 2015). 
 
 It was suggested that when Polδ encounters a lesion within the DNA 
template, the replication fork stalls,  activating an unknown signal that in turn 
provokes the dissociation of Pol3 from Pol31 and Pol32 (Baranovskiy et al., 
2012). The last two subunits remain associated with the site of damage, forming 
a complex with Rev3 and Rev7 (Baranovskiy et al., 2012; Makarova and Burgers, 
2015). The Polδ catalytic subunit replaces Rev3 and Rev7 after PolZ bypasses the 
DNA lesion, allowing the culmination of the replication process (Baranovskiy et 
al., 2012). This interaction suggests a possible role of Polδ in the regulation of 
the TLS pathway (Baranovskiy et al., 2012).  
  
It has also been demonstrated that Rev3 and Rev7 interact with Rev1, 
another TLS pol member of the Y family of DNA pols. Together they are able to 
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extend through mismatched primers and DNA secondary structures (McVey et al., 
2016). It is believed that Rev1, similar to Polδ, is involved in the regulation of 
the TLS pathway, working as a platform protein recruiting TLS pols by 
interactions with its C-terminal domain (McVey et al., 2016). The TLS pols that 
are known to interact with Rev1, apart from PolZ (Rev3 and Rev7), are Polη, Polι 
and Polκ (McVey et al., 2016). Previous studies have suggested the interaction of 
PolZ with Polη, Polι and Polκ occurs during the error tolerance repair pathway. 
During this process  PolZ works like an extender and the other three TLS pols are 
in charge of the nucleotide insertion (Zhao & Washington 2017a). 
 
4.1.1.2 The role of DNA Polymerase Zeta 
PolZ is characterised by its ability to bypass through cyclobutane 
pyrimidine dimers (CPD), produced by UV irradiation, with a high probability of 
inserting mutations during the process (Zhao & Washington 2017a). This capacity 
has been demonstrated by the overexpression of Rev3, provoking an increase in 
spontaneous mutations (Singh et al., 2015). The repair of UV lesions is not the 
only role of PolZ, however. Deletion of the PolZ catalytic sub-unit (Rev3) results 
in embryonic lethality in mice (Sharma, Helchowski and Canman, 2013a; 
Makarova and Burgers, 2015; Singh et al., 2015), revealing that PolZ has an 
essential role during the early stage of mammalian embryonic development, 
which cannot be replaced by any other Pols (Sharma, Helchowski and Canman, 
2013a).  
 
There are also studies suggesting a role of PolZ during HR. Experiments 
performed in human and chicken cells, showed that the deletion of Rev1, Rev3 
or Rev7 provokes an increase in sensitivity to DNA cross-link and DNA DSBs 
(Sharma, Helchowski and Canman, 2013a). A decrease in HR by 50% was 
observed in mammals and Drosophila melanogaster in the absence of the PolZ 
catalytic subunit (Sharma et al., 2012; Sharma, Helchowski and Canman, 2013a). 
The depletion in mammalian cells of Rev1, Rev3 and Rev7 by siRNA, generates 
the accumulation of foci of Rad51, an essential protein involved in HR (Sharma 
et al., 2012). This suggests a relevant role of the three proteins during this 
repair pathway (Sharma et al., 2012). 
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It was proposed that PolZ (Rev3 and Rev7) works in association with Rev1 
during the initial step of the HR pathway (Sharma et al., 2012). Due to PolZ’s 
ability to extend mismatched primers, the complex Rev1/PolZ (Rev3 and Rev7) is 
able to proceed with the extension step in the presence of a 3’mismatch in the 
invading DNA strand (Sharma et al., 2012). 
 
Even though TLS Pols are known to be preferentially expressed in the 
nucleus, the presence of some of these proteins has also been documented in 
the mitochondria. Previous studies have shown the presence of Rev1, Rev3 and 
Rev7 in yeast mitochondria (Zhang, Chatterjee and Singh, 2006). Experiments 
performed in S. cerevisiae using single mutants of mtRev1, mtRev3 and mtRev7 
show a decrease of spontaneous mutations, proposing a role for these proteins in  
mitochondrial genome mutagenesis (Zhang, Chatterjee and Singh, 2006). On the 
other hand, in humans uniquely the catalytic subunit has been localized in the 
organelle (Singh et al., 2015). Here, the deletion of Rev3 is linked with the 
alteration of the oxidative phosphorylation system, suggesting a role in the 
regulation of the mitochondrial metabolic pathway (Singh et al., 2015). 
Interestingly, this is not the only possible role of mtRev3 in humans; chromatin 
immunoprecipitation analysis has shown a high affinity of PolZ catalytic subunit 
towards D-loop regions (Singh et al., 2015). These regions are known to be highly 
sensitive to UV radiation, proposing a role for PolZ in the maintenance of 
mitochondrial integrity (Singh et al., 2015). 
 
In T. brucei the presence of PolZ subunits in the mitochondria has not 
been reported. In the parasite, there are five polymerases that are involved in 
the maintenance of the organelle’s genome integrity: Polβ, Polβ PAK, PolIB, 
PolIC and PolID (Klingbeil, Motyka and Englund, 2002; David F Bruhn, Sammartino 
and Klingbeil, 2011). The first two polymerases are members of the X family of 
polymerases and are known to be involved in a late stage of the minicircle 
replication, during which they collaborate in the processing and gap filling of the 
Okazaki fragments (Saxowsky et al., 2003; David F. Bruhn, Sammartino and 
Klingbeil, 2011). The last three polymerases are members of the A family of 
polymerases and are known to be involved in kinetoplast replication (Klingbeil, 
Motyka and Englund, 2002; Chandler et al., 2008; Bruhn et al., 2010).   
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The aim of this chapter was to perform a more in-depth characterisation of 
TbPolZ, analyzing its subcellular localization, the effects seen after the loss of 
the protein and its link with damage repair, in order to have a better 
understanding of its function in the parasite. 
 
4.2 Intracellular localization of the catalytic subunit of 
Polymerase Zeta (TbRev3) 
 Verification of TbRev3 endogenous epitope tagging via 4.2.1
Western blot analysis 
As it was mentioned above, although  PolZ predominantly is localised in 
the nucleus it has also been detected in the mitochondria of S. cerevisiae and 
humans, suggesting a role in the maintenance of both organelles (Zhang, 
Chatterjee and Singh, 2006; Singh et al., 2015). Evaluation of the intracellular 
localisation of TbRev3 is of high importance, as this information will help the 
elucidation of a role for this protein in the parasite. For instance, does it play a 
role in the nucleus or kinetoplast, and does it display discrete or generalised 
localisation within an organelle?  
 
For this, the Rev3 component of TbPolZ was endogenously tagged, 
meaning that the Rev3 gene was modified in situ to express TbREV3 as a C-
terminal fusion with 12 copies of the myc epitope. This manipulation was 
achieved using the 12Myc pNAT BSD vector (Alsford and Horn, 2008),  inserting 
1592 bp of the C-terminal end of TbRev3 after PCR-amplification with the 
primers Fw-gcatgagctccagatggctattaaaatgct (SacI site) and Rv-
gcattctagagcgagtcgttacgtagtctt (XbaI site) (Figure 4-1 A). Plasmid and PCR 
fragment were digested with SacI and XbaI, followed by ligation. The resulting 
plasmid was sequenced to verify correct construction and then digested by HpaI 
and transformed into Lister 427 BSF T. brucei, allowing integration by ‘single 
crossover’ homologous recombination (2.5.1). To check if the TbRev3 variant 
was expressed as a fusion with the 12 myc tag, a Western blot was performed 
using an anti-myc antibody. A band of approximately ~231 kDa (216.8kDa for 
Rev3, 14.4 kDa for 12myc), was seen in cell extracts of two blasticidin resistant 
transformants (Figure 4-1 B). 
 
124 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1. C- terminal plasmid map and and confirmatory Western blot 
showing the correct fusion of the myc tag. A. Map of the C-terminal tagging 
vector containing a 12 Myc tag sequence (represented in yellow) and (in blue) 
the TbRev3 insert, derived from the C-terminus of the complete ORF. Cloning 
restriction sites are labelled in green and pink (SacI and XbaI) B.Western blot of 
whole cell extracts from two blasticidin resistant transformants and from a cell 
line expressing the protein kinase TbAUK2-12myc as a control (+C), detected 
using anti-myc antibody. The Wt untagged cell line is not shown in the Western 
blot. 
 
  TbREV3 localization in the absence and presence of DNA 4.2.2
damage 
Localisation of TbRev3-12myc was assessed by immunofluorescence of 
permeabilised cells, using an anti-myc antibody. The intracellular localisation of 
the protein was tested before and after exposure of the cells to the alkylating 
agent MMS (0.0003%) for 18 h. In both conditions, the predominant signal was 
present in the nucleus, though some extra-nuclear staining was also apparent 
(Figure 4-2). The extra-nuclear signal was considered as background staining, 
due to the fact that signal was also detected in WT (untagged) cells (Figure 4-3 
A). Surprisingly, a signal was also observed in the kinetoplast (Figure 4-2). The 
nuclear signal appeared to be present throughout the organelle and did not 
notably change when analysed inthe different cell cycle stages (Figure 4-3 B). In 
contrast, the kinetoplast staining was more pronounced after exposure to MMS 
(Figure 4-2), though it was still not seen in every cell, in common with the 
A. B. 
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nuclear signal.  The kinetoplast signal seems to predominate in the 1N1K cells, 
although it was also possible to detect a weak signal in other cell cycle stages 
(Figure 4-4). From a total of 50 cells, it was possible to detect the myc signal in 
the kinetoplast of 6% of undamaged cells and in 21% of damaged cells. These 
data may suggest that at least the TbRev3 component of TbPolZ may act in the 
kinetoplast.  
 
 
 
 
Figure 4-2. Immunolocalisation of C-terminally 12myc-tagged TbRev3 in the 
absence and presence of MMS damage. Immunolocalization of REV3-12myc in T. 
brucei BSF cells: first panel showing DAPI staining of the nucleus and kinetoplast, 
the second panel shows localization of Rev3-12myc using a conjugated Alexa 
Fluor® 488 anti-myc antibody, and the third panel is merged images of both 
signals. Cells are shown after culture without damage (-MMS) or after growth for 
18 hrs in the presence of 0.0003% methyl methanosulphonate (+MMS 18 h). 
Larger images of boxes show the nuclear and kinetoplastid signals. 
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Figure 4-3. Nuclear immunolocalisation of TbRev3-12myc throughout the 
different cell cycle stages. A. The top panels show representative field of view 
images from WT cells (Lister 427) stained with DAPI (to visualise the nDNA and 
kDNA) and conjugated Alexa Fluor® 488 anti-myc antibody. B. The lower panels 
show the detection of anti-myc signal throughout the three stages of the cell 
cycle in TbRev3-12myc expressing cells. The left panel shows DAPI staining of 
the nucleus and kinetoplast, the middle panel shows localisation of TbRev3-
12myc using a conjugated Alexa Fluor® 488 anti-myc antibody, and the right 
panel is merged images of both signals. Scale bar 5 µm. 
 
 
 
A. 
B. 
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Figure 4-4. Mitochondrial immunolocalisation of TbRev3-12myc throughout 
the different cell cycle stages after growth for 18 hrs in the presence of 
0.0003% methyl methanosulphonate. Detection of anti-myc signal throughout 
the three stages of the cell cycle in TbRev3-12myc expressing cells. The left 
panel shows DAPI staining of the nucleus and kinetoplast, the middle panel 
shows localisation of TbRev3-12myc using a conjugated Alexa Fluor® 488 anti-
myc antibody, and the right panel is merged images of both signals. Scale bar, 5 
µm. 
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4.3 Generation of TbRev3 knockout cell lines 
As discussed previously (section 3.3.1), depletion of TbPolZ by TbRev3 RNAi 
did not suggest an essential role in BSF cells. However, these data do not mean 
that TbPolZ does not have an important role in the parasite, or indeed are 
definitive. High stability of the protein could confound the effectiveness of RNAi 
knockdown, or the cellular function may require only a low concentration of the 
enzyme. For these reasons, a full knockout of TbRev3 was attempted to more 
rigorously test the prediction that TbRev3 is non-essential and ask if the 
complete absence of the gene affects the growth of the cells. Disruption of the 
TbRev3 gene was performed by two sequential rounds of transformation into 
wild type (WT) BSF cells (T. brucei Lister 427) using two constructs: one 
containing a BSD cassette (ΔPolZ:: BSD) (Figure 4-5 A) and the other a NEO 
cassette (ΔPolZ:: NEO) (Figure 4-5 B).  
 
A region of approximately 500 bp was PCR-amplified, which includes a part 
of the UTR and ORF of the gene of interest, from both the 5’and 3’ regions. The 
forward and reverse primers used for the amplification were designed to include 
a specific restriction site, important for the cloning step. In this specific case, 
two variations of the 5’ region forward primer were designed, one containing 
MluI and NotI restriction sites (gcatacgcgtgcggccgcttggaaactcggctattgga) and the 
other BamHI and NotI sites (gcatggatccgcggccgcttggaaactcggctattgga). The first 
primer was used for the amplification of the product that was ligated into the 
NEO vector and the second was used for the amplification of the insert cloned 
into the BSD vector. In the case of the 5’ reverse primer the XbaI restriction site 
was included (gcattctagattcccttcagtggttgtgta). The 3’ region forward primer 
contains SacI restriction site (gcatgagctcttttctatccagtcggaaga) and ClaI and NotI 
for the 3’ reverse primer (gcatatcgatgcggccgctcacgtttgccttgagacac).  
 
The PCR products and vectors were digested with MluI/BamHI+XbaI and 
SacI+ClaI allowing the correct ligation of the inserts into the BSD and NEO vector 
(Figure 4-6). The resulting plasmid constructs were checked by sequencing and 
linearised with NotI. The 5´and 3´UTRs in the constructs, flanking the drug 
resistance cassettes, allowed HR, replacing the ORF of the gene with the 
antibiotic resistance cassette (Figure 4-7). 
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Figure 4-5. Plasmid maps of the constructs used for the deletion of TbREV3.  
In grey are represented the BSD and NEO cassettes, encoding the drug resistance 
markers used for the selection of clones. Flanked by β-α tubulin and actin, 
represented in purple. In blue are represented sequences of approximately 200 
bp that have homology with the 5’and 3’ regions surrounding the REV3 ORF, 
respectively, which provide homology for  recombination and integration of the 
cassettes after transfection. 
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Figure 4-6. Schematic representation of the ligation of the 5’and 3’UTR PCR 
product into the BSD and NEO vector.The 5’and 3’ intergenic regions of the 
gene (UTR) are represented in blue, the ORF of the gene in white and the arrows 
show the amplification region. The drug resistance cassettes are represented in 
grey; the intergenic regions are represented in purple.  The diagram shows the 
cloning of the targeting regions (PCR product) into the vectors. 
 
  
 
 
Figure 4-7.Schematic representation of the replacement of the ORF of a gene 
of interest with the drug resistance cassette, mediated by homologous 
recombination.The targeting regions in the vector and the homology sequence 
in the gene are represented in blue.  The mediated HR is represented by the 
crosses, showing the replacement of the ORF (white) with the drug cassette 
(grey).  
 
 
131 
 
 
 
The ΔPolZ:: NEO construct was first transformed into WT cells, generating 
putative heterozygous mutants (TbRev3-/+). Though G418 (NEO)-resistant cells 
were recovered, it was noticed that the addition of the antibiotic provoked a 
slowed growth of the transformant cells relative to wild type (data not shown). 
The drug was therefore removed during growth and transformation of the 
putative TbRev3-/+ cells with the ΔRev3:: BSD construct. To test for the 
successful generation of the heterozygous and knockout cell lines, genomic DNA 
was extracted from putative TbRev3-/+ and TbRev3 -/- null mutants for use as a 
template in PCR analysis.  For the PCR, specific primers were used targeting the 
drug resistance cassettes and a region of the TbRev3 ORF (Table 2-1), testing for 
the presence of these genes (Figure 4-8 A). The clones were analysed by PCR, 
demonstrating the integration of the antibiotic resistance cassettes and the 
deletion of the ORF in the case of the null mutants to suggest the absence of 
TbRev3 and the successful generation of KO cell lines. Figure 4-8 B shows a 
comparison of the PCR products generated using WT, TbRev3-/+ and two 
TbRev3-/- clones, demonstrating the presence of the expected cassettes and the 
presence or absence of the TbRev3 ORF. 
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Figure 4-8. Confirmatory PCR of TbRev3 heterozygotes and null mutants. A. 
Schematic representation of expected fragment sizes amplified by PCR (bp), 
diagnostic primers used (black arrows) and their position in the genome. Primer 
sequences are available in Table 2-1. Not to scale. B. Agarose gels of diagnostic 
integration PCRs, testing the presence of TbRev3 ORF and integration of NEO or 
BSD cassette in wild type (Wt) cells, heterozygote +/- cells and null mutants -/-; 
ddH2O was used as a negative control.  All PCRs were performed on the same 
gDNA samples. 
 
 Loss of TbRev3 is associated with increased sensitivity of BSF 4.3.1
cells to DNA damage 
To ask if the loss of TbRev3 had any stronger effect than RNAi, the growth 
of the two TbRev3-/- clones was compared with WT (Figure 4-9A). No difference 
in population doubling time was apparent, suggesting that loss of TbRev3 had no 
A. 
B. 
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effect on the cells survival in culture. The growth of the TbRev3-/- mutants was 
compared with WT cells in the presence of three concentrations of MMS, asking 
if loss of TLS pol increases sensitivity of the cells to damage. Though the effect 
was not very pronounced, growth of the TbRev3-/- cells was notably slower than 
WT at the highest concentration of MMS (0.0003%) and perhaps slightly reduced 
at 0.0002% MMS (Figure 4-9 B), suggesting that TbPolZ is involved in the repair of 
MMS induced damage. To ask if this effect is only seen in the null mutants, 
growth of the TbRev3-/+ cell line was also compared with WT, though in a 
separate experiment. In this experiment greater slowing of WT growth was seen, 
perhaps due to pipetting differences during drug dilution, but it appeared that it 
was possible to observe a slightly increased growth reduction of the 
heterozygous mutants relative to WT at 0.0003% MMS (Figure 4-9 C). The results 
obtained, with TbRev3-/+ and TbRev3-/-, resemble the growth effect observed 
in the RNAi cell line against TbRev3 after MMS damage (section 3.3.3). Showing a 
growth effect after the exposure with the highest concentration of MMS.This 
appears to confirm a role for TbPolZ in MMS repair. 
 
 
 
 
Figure 4-9. Proliferation of TbRev3 +/- and TbRev3 -/- cell lines under 
different concentrations of MMS. A. Growth curve of Wt427 and TbRev3 -/- full 
knockout in the absence of damage, showing no effect on the growth of the cells 
after the deletion of both alleles. B. Growth curve of Wt427 and null mutant 
A. 
B. 
C. 
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TbRev3 -/- cell line under different concentrations of MMS; showing an increase 
of sensitivity, at the highest concentration of MMS after the loss of one allele. 
C.Growth curve of Wt427 and heterozygote TbRev3 +/- cell line under different 
concentrations of MMS; showing an increase of sensitivity, at the highest 
concentration of MMS after the loss of one allele. 
 
4.4  Identifying potential TbRev3 interaction partners 
  Immunoprecipitation and mass spectrometry using TbRev3-4.4.1
12myc 
 
PolZ in other eukaryotes is known to cooperate with diverse proteins 
facilitating the bypass of DNA lesions. An example is the interaction of S. 
cerevisiae and human Rev3 with the TLS pol Rev1 (Sharma et al., 2012). In S. 
cerevisiae, it has been demonstrated that Polδ shares accessory subunits with 
PolZ (Pol31/32), resulting in PolZ forming a four subunit complex  (Makarova and 
Burgers, 2015). 
 
In order to try and examine TbPolZ function further, we next sought to 
ask what factors TbRev3 might interact with. For instance, if TbPolZ is 
conserved as a four subunit complex in T. brucei, it might be predicted that 
TbRev3 interacts with proteins related to the three other factors, including some 
overlap with DNA Pol δ.  
 
To perform this analysis, extracts from WT cells and the cells expressing 
TbRev3-12myc were incubated with Dynabeads® (Invitrogen), magnetic beads 
coated with anti-myc antibody. After five washes with washing buffer (50 mM 
Hepes pH 7.55, 100 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, 10 % 
glycerol, 0.1 % Triton X-100, and 2x complete protease and phosphatase inhibitor 
cocktail; Roche) the eluate was collected and re-suspended in 15 μl of 1x protein 
loading buffer (duplicates for each sample were performed). One of the eluates 
from each WT and TbRev3-12myc, was separated on 10% Bis-Tris gel by SDS-
PAGE and stained with SYPRO®Ruby, revealing several bands that were only 
present in the tagged sample (Figure 4-10 A). With the second eluate, the 
specificity of the antibody of the two immunoprecipitations (IP) was confirmed 
by Western blot, detecting the presence of TbRev3-12myc exclusively in TbRev3-
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12myc IP (Figure 4-10 B). After assessing the proper performance of the IPs, the 
remaining eluates of the WT IP and TbRev3-12myc IP were analysed by mass 
spectrometry (Glasgow Polyomics Facility). 
 
 
 
 
 
 
     
 
Figure 4-10. Validation of TbrEV3-12Myc immunoprecipitation. A. Syrpo ruby 
stained gel of anti-myc immunoprecipitated proteins from WT427 (un-tagged cell 
line) and TbRev3-12myc lysates. Some specific bands in the TbRev3-myc are 
enclosed in the red box. B. Western blot on all fractions of the IP from WT and 
TbRev3-12myc cells. Fractions from left to right: prelysis, input, flow-through 
and eluate from TbRev3-12myc and WT, showing the absence of bands in the 
untagged cell line. Red box show bands corresponding to TbRev3-12myc.  
 
The mass spectrometry results show the immunoprecipitation of several 
possible interacting partners. Proteins were compared between the hits obtained 
with the WT cell line and the tagged cell line, in order to select only the 
proteins that were uniquely immunoprecipitated with the tagged cell line, 
ignoring those pulled down in both. In the WT immunoprecipitation, peptide hits 
were recovered for 87 proteins.  Any proteins recovered in both samples were 
excluded, which amounted to removing 45 proteins from the TbRev3-12myc IP 
and left a total of 49 hits for the tagged cell line (Table 4-1). Next, the available 
A. 
B. 
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genome annotations of the remaining 49 proteins were examined for the 
exclusion of possible contaminants such as VSG and ribosomal proteins. The rest 
of the hits were analysed by BLASTp and those with insufficient information 
were also excluded, leaving eight potential TbRev3 interaction partners (Table 
4-2). 
 
 
 
Table 4-1. Recovered proteins from TbRev3-12myc IP after Mass 
Spectrometry analysis. Proteins shown were only present in TbRev3 anti-myc IP; 
hits also identified in IP from WT cells were excluded. Interesting ‘hits’ are 
labelled in red. Samples were analysed using MASCOT software. 
Gene ID Annotation Score
Tb927.1.3180 40S ribosomal protein S11, putative 256
Tb10.389.0910 60S ribosomal protein L34, putative 183
Tb10.70.2170 ribosomal protein S27a, putative 156
Tb10.70.5650 TEF1 elongation factor 1-alpha 138
Tb927.2.450 retrotransposon hot spot (RHS) protein, putative 135
Tb10.70.1380 40S ribosomal protein S9, putative 126
Tb09.211.0540 FBPase fructose-1,6-bisphosphate, cytosolic 120
Tb11.01.6640 hypothetical protein, conserved 113
Tb09.244.2730 60S ribosomal protein L5 108
Tb927.7.7030 hypothetical protein, conserved 106
Tb10.61.1810 mitochondrial carrier protein, putative 104
Tb09.160.2490 1L12.125 ribosomal protein S7, putative 93
Tb10.70.1670 40S ribosomal protein S10, putative 93
Tb09.211.4850 60S ribosomal protein L26, putative 92
Tb927.1.710 PGKB phosphoglycerate kinase 89
Tb11.01.1790 60S ribosomal protein L29, putative 89
Tb09.211.4511 kinetoplastid membrane protein 85
Tb927.7.180 hypothetical protein 76
Tb927.5.2080 inosine-5'-monophosphate dehydrogenase, putative 75
Tb09.211.2650 60S ribosomal protein 69
Tb10.61.1390 40S ribosomal protein S13 62
Tb10.70.7020 RPS23 40S ribosomal protein S23, putative 62
Tb09.211.3680 HSP40 heat shock protein 60
Tb09.211.3830 Tb09.211.3830 hypothetical protein, conserved 60
Tb10.05.0060 hypothetical protein, conserved 54
Tb10.100.0080 40S ribosomal protein S6 53
Tb927.2.480 retrotransposon hot spot protein 50
Tb927.7.7460 hypothetical protein, conserved 48
Tb927.1.2430 histone H3, putative 43
Tb09.211.1150 hypothetical protein, conserved 41
Tb11.02.0740 60S ribosomal protein 40
Tb927.4.2070 antigenic protein 40
Tb927.4.1860 ribosomal protein S19 36
Tb927.4.3890 ATP-dependent RNA helicase, putative 35
Tb09.244.2720 ribosomal protein L15 35
Tb11.55.0013 cysteine desulfurase, putative 33
Tb927.6.2090 hypothetical protein, conserved 33
Tb09.160.4250 TRYP1 tryparedoxin peroxidase 28
Tb10.70.2465 nucleolar RNA-binding protein, putative 26
Tb09.v4.0057 variant surface glycoprotein (VSG, pseudogene) 25
Tb927.6.2210 hypothetical protein, conserved 23
Tb927.4.1390 hypothetical protein, conserved 23
Tb927.8.7260 kinetoplast-associated protein 23
Tb11.02.1566 variant surface glycoprotein (VSG)-related, putative 23
Tb927.3.1130 DNA polymerase delta subunit 2 22
Tb10.70.3290 DHH1 ATP-dependent DEAD-box RNA helicase 22
Tb09.160.5580 60S ribosomal protein L11 22
Tb11.02.5450 glucose-regulated protein 78, putative/Hsp70 19
Tb09.211.1750 mitochondrial carrier protein, putative 14
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Table 4-2. Potential TbRev3 interaction partners identified by Mass 
Spectrometry analysis. Proteins shown were only present in IP from TbRev3-
12myc. Proteins were analysed using MASCOT. Protein sequence for each ‘hit’ 
was examined by BLASTp.   
 
After excluding the possible contaminants, heat shock proteins, 
mitochondrial proteins and DNA polymerase δ subunit 2 were classified as 
potential interaction partners. The obtained hits have not been verified by 
further analysis and so must be considered as preliminary data.  
 
Blastp analysis of DNA polymerase delta subunit 2 (Tb927.3.1130) 
demonstrated homology (E- value of 2e-40 and 25% identity) with the S. 
cerevisiae Polδ subunit, Pol31 (Gene ID EEU05433.1).  In S. cerevisiae, the 
interaction between the accessory subunits of Polδ and the catalytic subunit of 
PolZ have been confirmed, showing an important role in the regulation of the 
TLS pathway (McVey et al., 2016).  Homologues of neither Pol32 nor Rev7, the 
other two subunits of S. cerevisiae PolZ, were found in the eluate of TbRev3-
12myc.  Blastp analysis of the yeast PolZ subunits Pol32 (NP_012577.1) and Rev7 
(Gene ID NP_012127.1) was performed revealing, interestingly, no homologues 
were found in T. brucei. These findings may suggest that TbPolZ is not a four 
unit complex and TbPolδ lacks one of the accessory subunits, differing from the 
yeast proteins  where PolZ consists of four subunits and Polδ is organized in 
three subunits (Figure 4-11). It will be important to elucidate if the possible 
absence of the accessory subunits (Rev7 and Pol32) affects the functions of 
TbPolZ and TbPolδ.  It should be noted that these are speculations and further 
analysis need to be performed to confirm the absence of Pol32 and Rev7 
homologues in T. brucei. 
 
Gene ID Annotation Predicted domains Score
Tb10.61.1810 mitochondrial carrier protein, putative ADP/ATP transporter on adenylate translocase 104
Tb09.211.3680HSP40 heat shock protein DnaJ-class molecular chaperone with C-terminal Zn finger domain 60
Tb11.55.0013 cysteine desulfurase, putative Aminotransferase class-V 33
Tb09.160.4250TRYP1 tryparedoxin peroxidase Peroxiredoxin (PRX) family, 28
Tb927.8.7260 kinetoplast-associated protein No putative conserved domains 23
Tb927.3.1130 DNA polymerase delta subunit 2 PolD2 (DNA polymerase delta, subunit 2), C-terminal domain 22
Tb11.02.5450 glucose-regulated protein 78, putative/Hsp70Heat shock protein 70kD (HSP70), peptide-binding domain 19
Tb09.211.1750mitochondrial carrier protein, putative Mitochondrial carrier protein 14
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On the other hand, the recovery of the heat shock proteins, HSP40 
(Tb09.211.3680) and HSP70 (Tb11.02.5450), is potentially interesting, as these 
have been suggested to be involved in the maintenance and replication of the 
mitochondrial DNA in T. brucei (Týč, Klingbeil and Lukeš, 2015). The interaction 
of TbPolZ with HSP40 and HSP70 is still uncertain, but if this interaction is 
proven, it will confirm a role of TbPolZ in the maintenance of the T. brucei 
mitochondria. Furthermore, the mitochondrial carriers (Tb10.61.1810, 
Tb09.211.1750, Tb11.55.0013) are of high relevance in T. brucei; previous 
studies have demonstrated that carriers allow the exchange of metabolites 
across the mitochondrial membrane for the proper function of different 
metabolic pathways (Colasante et al., 2009). The key question would be 
whether or not the parasite is using these carriers to enter to the mitochondria. 
TRYP1 is another potential interactor and is involved in the detoxification of 
peroxide, although its localisation in the mitochondria is still uncertain (Tetaud 
et al., 2001).  
 
 
 
 
 
Figure 4-11. Schematic representation of Polδ and PolZ in S. cerevisiae and 
T. brucei. A. Schematic representation S. cerevisiae and T. brucei PolZ. In blue 
is represented the catalytic subunit; in yellow, green and grey are represented 
the accessory subunits. B. Diagram of S. cerevisiae and T. brucei Delta. In purple 
is represented the catalytic subunit and in yellow and grey the accessory 
subunit. S. cerevisiae polymerase delta structure was based on (Makarova and 
Burgers, 2015).  
 
A. 
B. 
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4.5 Discussion  
Several interesting outcomes resulted from the analysis of the catalytic 
subunit of TbPolZ (TbRev3). First, TbRev3 is localized preferentially in the 
nucleus, but presents a mitochondrial signal in some cells, a localisation that  is 
more evident after the generation of damage with MMS.  TbRev3 double 
knockout cells show no growth effect, but there was an increase in sensitivity to 
MMS and UV damage, suggesting that this enzyme contributes to the repair of 
this type of DNA damage. Lastly, potential interaction partners were identified, 
suggesting that TbPolZ may have a role in mitochondrial maintenance.  
  TbRev3 displays both nuclear and mitochondrial localization 4.5.1
The mitochondrion is an important organelle in eukaryotes, having an 
essential role in the production of ATP by oxidative phosphorylation (Kaniak-
Golik and Skoneczna, 2015). Trypanosome mitochondria are uncommon as they 
are only found in a single copy in each parasite cell and are characterized by the 
presence of a uniquely unusual genome, which is composed of an interlinked 
lattice of few dozens of maxicircles and ~1000 minicircles, forming a specialized 
structure known as the kinetoplast (Lukes et al., 2002). Interestingly, in T. 
brucei the mitochondrion in the bloodstream stages is reduced in function and 
structural complexity, since glycolysis provides the main source of the 
generation of ATP (Fenn and Matthews, 2007; Cristodero, Seebeck and 
Schneider, 2010). On the other hand, during the insect stages, this organelle has 
an active role in the production of ATP (Cristodero, Seebeck and Schneider, 
2010).  
 
Studies have shown that in mammalian cells chemicals such as platinum-
based chemotherapy agents, cigarette components, the fungal toxin aflatoxin 
B1, and UV light result in mitochondrial DNA damage. Indeed, in the case of 
endogenous factors, it is well known that reactive oxygen species (ROS), which 
are generated during the synthesis of ATP, are the main source of mitochondrial 
DNA damage (Akhmedov & Marín-García, 2015; Cline, 2012). ROS are not the 
only endogenous factors that generate mitochondrial DNA damage, however, as 
spontaneous errors of the replication machinery can provoke point mutations 
and deletions (Akhmedov & Marín-García, 2015). Given all the above 
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considerations, it seems likely that active repair mechanisms must be present to 
protect the unusual genome of the single copy trypanosome mitochondrion. 
 
In T. brucei the presence of several mechanisms to protect the nucleus 
have been described (Passos-Silva et al., 2010), including base excision repair 
(BER), mismatch repair (MMR), nucleotide excision repair (NER), homologous 
recombination (HR) and microhomology-mediated end-joining. If trypanosomes 
follow the profile of other eukaryotes, the mitochondrion may have more 
restricted options for DNA repair (Cline, 2012).  In mammalian cells, BER appears 
to be the main mechanism involved in DNA repair in the mitochondria. In this 
pathway, DNA Pol β acts to fill short gaps in the DNA template (Lopes et al., 
2008; Sykora et al., 2017). T. cruzi and T. brucei have revealed two DNA Pol β 
variants, Polβ and Pol β-PAK, that are associated with mitochondrial DNA 
maintenance (Lopes et al., 2008), either acting in replication or repair 
(Saxowsky et al., 2003). Studies of Leishmania infantum have shown a nuclear 
localization for Polβ (Mejia et al., 2014). Interestingly, neither T. cruzi nor T. 
brucei shows the presence of this polymerase in the nucleus (Saxowsky et al., 
2003; Schamber-Reis et al., 2012). Like Polβ, T. brucei POLIB, POLIC and POLID, 
are targeted to the kinetoplast ( Bruhn et al. 2011).  
 
Interestingly the immunofluorescence assay performed with the TbPolZ 
catalytic subunit demonstrates nuclear and mitochondrial localization of this 
protein, which suggests that TbRev3 is the first polymerase in T. brucei to be 
localized in both organelles. In T. cruzi Pol κ, a TLS pol, has been examined and 
its main roles appear to be in the kinetoplast.  In vitro overexpression of Polκ, 
showed an increase in the cells resistance to hydrogen peroxide and gamma 
radiation (Rajão et al., 2009), revealing the ability of Polκ in bypassing 8-
oxoguanine lesions (lesion caused by oxidative agents) and in the repair of DSBs, 
indicating a possible function in HR (Rajão et al., 2009). If and how these 
activities are used in T. brucei are unknown. 
 
 Previous studies have demonstrated a mitochondrial localization of PolZ in 
S. cerevisiae and mammals. The specific role of the TLS polymerase in both 
organisms is still unclear, but it has been suggested that it may be involved in 
mitochondrial maintenance (Kaniak-Golik and Skoneczna, 2015; Singh et al., 
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2015). Recent studies in yeast have reported the interaction of yeast PolZ with 
Polη, another translesion polymerase, preventing the accumulation of mutations 
caused by UV-radiation (Kaniak-Golik and Skoneczna, 2015).  
 
In the case of mammalian cells, it has been possible to identify two 
isoforms of Rev3, the catalytic subunit of PolZ  (Singh et al., 2015). In the 
nucleus, it is feasible to detect both isoforms, while one is specifically seen in 
the mitochondria (Singh et al., 2015). It has been proposed that an interaction 
between Rev3 and Polγ in the mitochondria takes place, in order to maintain the 
integrity of the organelle (Singh et al., 2015). 
 
The data in this chapter provide indications that TbPolZ might also act in 
the nucleus and in the mitochondrion of T. brucei, since TbRev3-12myc showed 
a clear and robust nuclear signal as well as evidence for kinetoplast expression, 
especially after MMS treatment. It is uncertain if these data reflect dynamic 
relocalisation of a single isoform of TbRev3, or if the signals might be due to 
expression of more than one isoform, perhaps due to alternative start codon 
usage. In mammals Rev3 gene has two alternative translation sites (AUG). If 
translation initiates from the first start codon the result is a long isoform, and if 
it starts from the second AUG, a smaller isoform is generated (Singh et al., 
2015). There is evidence that shows that T. brucei also has differential splicing: 
the genes that encode for tRNA synthetases have two translational start codons, 
allowing the generation of a short and a long isoforms (Rettig et al., 2012).  
 
The basis for the observed stronger mitochondrial signal after the 
generation of damage with MMS is unclear, but could be explained by increased 
expression of a mitochondrial-targeted TbRev3 in the presence of damage or the 
migration of some of the nuclear TbRev3 to the kinetoplast. In the IFA 
performed with TbRev3-12 myc, the mitochondrial signal was present in some, 
but not all cells, regardless of the cell cycle phase. The lack of signal in some 
cases may simply be explained by low expression levels of the protein, making 
visualization of the signal in all the cells difficult. However, it is also 
conceivable that kinetoplast localisation only occurs in the cells in the 
population that reach a critical level of organellar genome damage or functional 
impairment. 
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Previous studies have suggested that PolZ in other eukaryotes is mainly 
involved in the repair of lesions provoked by UV (Zhao & Washington 2017b). It is 
unlikely that T. brucei is exposed to UV in natural conditions, but UV treatment 
in culture has been shown to cause both nuclear and kinetoplast damage (J.P da 
Rocha, personal communication). In the nucleus, UV damage is tackled by NER 
(Machado et al., 2014), but what route is used for kinetoplast repair is unknown. 
Recent studies in mammalian cells suggest the presence of BER, MMR and HR  in 
the mitochondrion (Akhmedov and Marin-Garcia, 2015),  but not the NER 
pathway, which is commonly in charge to repair UV induced lesions (Akhmedov 
and Marin-Garcia, 2015).  
 
PolZ’s role in HR has been demonstrated in humans and yeast, where it is  
seen as a key factor in the repair of DSBs (McVey et al., 2016). Though these 
studies considered the function of nuclear PolZ, there is a possibility that the 
polymerase plays a similar role in both the mitochondrion and nucleus. If so, the 
role of TbRev3, and perhaps TbPolZ, in providing HR activity in the kinetoplast is 
a feasible hypothesis, both for repair and perhaps during the recombination 
process the minicircles must undergo as part of the replication of the kinetoplast 
network (Rajão et al., 2009). This hypothesis needs further analysis, however, 
including tests to show that loss of TbRev3 leads to impaired integrity of the 
nuclear and mitochondrial genomes of T. brucei.   
 
 Increase in the cells sensitivity after partial and total 4.5.2
deletion of TbRev3 
As it was mentioned above, PolZ has been linked with several repair 
pathways such as cross-link repair and HR  (Gan et al., 2008; Makarova and 
Burgers, 2015). In mammalian cells this protein seems to have  a critical role 
during cell development, since the deletion of the gene leads embryonic 
lethality in mice (Esposito et al., 2000). It was suggested that this protein is 
essential during the early stages of cell development, by avoiding the stalling of 
the replication fork (Esposito et al., 2000; Makarova and Burgers, 2015). Studies 
in S. cerevisiae and D. melanogaster have demonstrated that mutations in the 
PolZ catalytic subunit result in an increase in sensitivity to UV radiation and 
alkylating agents (Eeken et al., 2001; Lawrence, 2002; Gan et al., 2008). In A. 
thaliana, mutations in a Rev3 homologues resulted in an increase in sensitivity to 
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UV radiation. However, AtRev3 mutants did not present sensitivity toward MMS 
damage (Takahashi et al., 2005).      
 
At the moment the role of this DNA polymerase in T. brucei remains 
uncertain, but based on the DNA damage sensitivity experiments performed 
after the depletion of the protein using RNAi, it is possible that the protein is 
involved in the repair of DNA lesions. In this chapter a Tbrev3-/- null mutant was 
generated, demonstrating that the protein, and probably TbPolZ, is not essential 
for BSF cell survival, at least in culture. Given a predicted function in repair, it 
may have been expected that the null mutants would display a stronger 
sensitivity to MMS in comparison to RNAi depletion and heterozygote deletion 
cell lines. Surprisingly, though there was some evidence for the strongest MMS 
sensitivity phenotype in the Tbrev3-/- mutants, this was rather mild. MMS 
damage sensitivity might be expected, as it is known this alkylating agent has 
the ability to generate base mispairing, replication blocks and DNA double strand 
breaks, most of which PolZ has been implicated in acting upon, including lesion 
repair by HR (Lawrence, 2002; Lundin et al., 2005).  
 
The relatively weak MMS sensitivity phenotype of the Tbrev3-/- cells 
could be explained by the redundancy that characterizes TLS Pols. It is well 
known that in multicellular organisms it is common to observe the exchange of 
roles between TLS Pols, where the loss of one can be easily replaced by another  
( Waters et al. 2009). There is a possibility that this could also happen in 
unicellular organisms, such as T. brucei. PolZ is known to interact with several 
TLS pols in order to repair lesions: Polη, Polι and PolƘ. During these interactions, 
the polymerases are normally in charge of inserting the nucleotides prior to  
PolZ performing the extension process (Zhao & Washington 2017a). However, it 
has also been documented that in the absence of Polη, Polι or PolƘ, PolZ has the 
ability to insert the nucleotides and complete the extension process (Johnson et 
al., 2000; Ziv et al., 2009; Stone et al., 2011). Thus, there is the possibility that 
in the absence of TbPolZ, or at least TbRev3, other polymerases can take over 
the role of this putative TLS Pol. Testing this is complicated by the lack of 
functional characterization of other TLS Pols in T. brucei.  
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An alternative explanation for the relatively mild MMS sensitivity 
phenotype of TbRev3 null mutants is that the putative TLS Pol plays a more 
pronounced role in tackling other forms of genome damage. Considering that T. 
brucei is a unicellular organism, the collapse of the replication fork may be 
lethal for the cell, which gives the possibility that in the absence of the protein, 
there is the action of an alternative repair pathway that is not mediated by 
TbPolZ.  In this regard, if there had been time it would have been valuable to 
assess growth of the mutants in the presence of, for example, UV or hydrogen 
peroxide. 
 
  Attempting to elucidate the role of PolZ in T. brucei 4.5.3
The immunoprecipitation of TbRev3-12myc was performed with the aim of 
beginning to understand the role of TbPolZ in T. brucei. However, given the 
complexity of the peptide hits obtained from the mass spectrometry analysis, it 
was not possible to clearly elucidate the pathway in which this protein is 
involved in in the parasite. Nonetheless, the recovery of several possible 
interaction partners suggests potential routes for future investigation.   
 
The strongest potential interactor recovered was a putative subunit of T. 
brucei Polδ, though it should be noted that functional or biochemical 
characterization of this replicative Pol has not been reported. As mentioned 
above, S. cerevisiae Polδ is composed of three subunits, the catalytic subunit 
(Pl3) and two accessories subunits (Pol31 and Pol32) (Johansson, Majka and 
Burgers, 2001). The C-terminal domain of the catalytic subunit is connected to 
the rest of the structure by a linker, providing the ability to dissociate from 
Pol31 and Pol32 and allowing the recruitment of Rev3 and Rev7, activating the 
TLS pathway (Baranovskiy et al., 2012). Thus the TbRev3-12myc IP suggests that 
TbPolZ might also be under the regulation of TbPolδ. However, at the moment 
this putative interaction needs to be confirmed, in particular as we did not 
recover proteins corresponding to Pol32 and Rev7 counterparts in TbPolZ, and no 
homologues were found with the Blastp analysis. Further studies are needed to 
understand the structure of TbPolZ. 
 
HSP40 was another protein that was recovered specifically in the TbRev3-
12myc IP and belongs to the heat shock protein family, which is activated during 
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cellular stress and localises both in the nucleus and in the mitochondrion (Deka 
et al., 2016). Studies have demonstrated that another member of the HSP family 
is involved in the regulation of TLS Pols: HSP90 regulates the activation of Polη 
and Rev1 by inhibiting the binding of the polymerases to PCNA (Yamashita, Oda 
and Sekimoto, 2012). It is, therefore, a possibility that HSP40 plays a similar role 
in the parasite, but further studies are required. As it was mentioned in section 
3.5.1, TbPolZ lacks the zinc finger domain, which is associated with the 
interaction with the proliferating cell nuclear antigen (PCNA) and with Polδ 
accessory subunits. The question is how HSP40 may regulate TbPolZ activity if 
there is no evidence of interaction between the TLS pol and the PCNA. Despite 
the lack of this structure, the immunoprecipitation results suggest that there is 
an interaction between TbPolZ and TbPolδ accessory subunit 2. Studies in S. 
cerevisiae have shown that the PCNA binding motif (PIP box) is localised in the 
C-terminal domain of the Pol32 subunit (accessory subunit) (Acharya et al., 
2011). Even though T. brucei seems to lack a Polδ Pol32 homologue, there is the 
possibility that Polδ subunit 2 is the one interacting with the PCNA. Though the 
general sequence of the PIP box (Q-x-x-(L,V,I,M)-x-x(Y,F)) is missing in TbPolδ 
subunit 2, this could be explained by a mutation of the motif, changing the 
sequence of the PIP box without affecting the interaction with the PCNA. This 
could mean that HSP40 could be regulating the activity of TbPolZ only if the TLS 
pol is interacting with the accessory subunit of TbPolδ. Further studies are 
needed in order to confirm this hypothesis. 
 
Given the demonstration of TbRev3-12myc localisation in the kinetoplast, 
it was intriguing that a number of mitochondrial proteins were recovered in the 
IP. Amongst these were mitochondrial carrier proteins, which have an important 
role in the cell due to their ability to transport molecules into this organelle. 
Several proteins involved in the organization, regulation and replication of the 
mitochondrion are synthesized in the nucleus and transported into the 
mitochondria using the carrier proteins (Bailey and Doherty, 2017).  It may be 
possible that TbRev3 (and TbPolZ) interacts with these carriers to be mobilized 
from the nucleus to the mitochondrion. It is known that during the replication of 
the kinetoplast, the minicircles need to close the gaps that are left during the 
process (Klingbeil and Englund, 2004). The possibility that TbRev3 might have a 
function during this process is raised by the IP of a kinetoplast binding protein 
146 
 
 
 
(Tb927.8.726), which preferentially binds to the minicircles and is also involved 
in the compaction of the structure (Pfam domain prediction). In other 
kinetoplastids such as Chrithidia fasciculata, the kinetoplast binding protein 
(UMSBP) has an important role during the replication of the minicircles by 
recognizing and binding to the replication origins. The interaction of the 
kinetoplast binding protein and TbRev3, may suggest that TbRev3 repair activity 
may be involved during the replication process. Of course, the recovery of 
mitochondrial proteins after TbRev3-12myc IP may simply reflect artefactual 
localisation of the protein to the organelle, and therefore further tests are 
needed. It can be noted, however, that myc-tagging of no other T. brucei repair 
protein has so far caused artefactual kinetoplast localisation, and further TLS 
Pol IPs described here have not recovered mitochondrial carrier proteins 
(chapter 5, see section 5.7.1).  
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5 Understanding the function of DNA Polymerase 
Nu (PolN) in T. brucei 
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5.1 Introduction 
The eukaryotic DNA polymerase Nu (PolN) is a member of the A family 
polymerases. These polymerases are known to be involved in both DNA 
replication and repair (Garcia-Diaz and Bebenek, 2007). They are characterized 
by their high fidelity, due to the presence of 3’-5’exonuclease proofreading 
activity (Garcia-Diaz and Bebenek, 2007). PolN, together with PolQ, are the only 
members of the A family of polymerases that lack such exonuclease activity 
(Arana et al., 2007; Garcia-Diaz and Bebenek, 2007). PolN has been associated 
with several genome maintenance pathways such as TLS, cross-link repair and 
homologous recombination (HR) (Arana et al., 2007; Moldovan et al., 2010; 
Gowda, Moldovan and Spratt, 2015). Studies in human cells have suggested an 
important role of PolN during the repair of cross-link lesions by HR (Moldovan et 
al., 2010). It has been proposed that Rad51 stimulates PolN in order to initiate 
DNA synthesis after strand invasion (Moldovan et al., 2010). In Leishmania 
infantum LiPolθ (PolN) has TLS activity, permitting the bypass of oxidative 
lesions such as 8-oxoguanine, thymidine glycol and abasic sites (Fernández-
Orgiler et al., 2016). However, functional analysis of the consequences of loss of 
PolN has not been reported in any kinetoplastid. 
 
Previous studies have shown high homology between PolN and the 
polymerase domain of PolQ (Li, Gao and Wang, 2011). PolQ is a highly conserved 
polymerase among multicellular eukaryotes and consists of a C-terminal 
polymerase domain and an N-terminal helicase domain (Bebenek and Kunkel, 
2004). Although the helicase activity is still uncertain, in some organisms, such 
as D. melanogaster, the PolQ (Mus308) polymerase domain has been associated 
with cross-link repair (Moldovan et al., 2010). Biochemical analyses have shown 
the ability of PolQ to add nucleotides opposite abasic sites and bypass thymidine 
glycol lesions (Li, Gao and Wang, 2011).  PolQ has also been associated with 
other repair pathways such as HR, microhomology-mediated end joining (MMEJ) 
and base excision repair (BER) (Beagan et al., 2017). Interestingly, a helicase 
(HelQ) has been found that shares high homology with the PolQ helicase domain. 
In vitro experiments demonstrated the ability of the protein to unwind the DNA 
duplex, confirming its helicase activity (Beagan and McVey, 2016). Recent 
studies in human cells proposed a role for HelQ in DSB repair (Wu et al., 2001). 
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Due to the high sequence homology PolN and HelQ share with  PolQ’s polymerase 
and helicase domains, respectively, it has been suggested that there is a possible 
interaction between PolN and HelQ (Beagan and McVey, 2016).  
 
In T. brucei, the role of PolN (TbPolN) and its possible interaction with 
HelQ (TbHelQ) is still uncertain. Chapter 3 revealed that RNAi of TbPolN had a 
transient, severe impact on growth, but similar RNAi against TbHelQ was 
ineffective. Unpublished data suggests that in T. brucei TbHelQ in procyclic form 
cells interacts with BRCA2, a regulator of homologous recombination (Prorocic 
and McCulloch, unpublished), but this has not been evaluated in bloodstream 
form cells, where the RNAi studies were performed (Chapter 3). Due to the lack 
of information about these proteins, the aim of this chapter was to make a more 
in-depth characterisation of the effects of TbPolN loss, in order to have a better 
understanding of the function that the protein plays in the parasite and, 
perhaps, to ask how this compares with PolN and PolQ in other eukaryotes, given 
that there is no evidence that T. brucei encodes a PolQ homologue.  
 
5.2 Cell structural analysis after RNAi depletion of TbPolN 
It was shown in Chapter 3, section 3.4.1, that RNAi depletion of TbPolN 
results in significant changes in cell morphology, especially at 48 hours post 
induction, and the accumulation of aberrant cells with abnormal nuclei and 
multiple kinetoplasts. In order to evaluate these observations further, two 
electron microscopy imaging methods were employed: transmission electron 
microscopy (TEM) and scanning electron microscopy (SEM).  These techniques 
have already been used successfully in T. brucei and L. mexicana, permitting 
analysis of the flagellum architecture, for instance (Gluenz et al., 2015).  
 
TEM was performed in order to examine the ultrastructure of TbPolN RNAi 
depleted cells relative to uninduced controls, facilitating the visualization of the 
nucleus, kinetoplast and flagellar pocket. SEM allowed the 3D visualization of 
the external architecture of BSF cells, following the loss of TbPolN, to try and 
reveal possible changes in the body shape. The fixation and imaging of the cells 
is described in section 2.11. The below images were taken by L. Lemgruber-
Soares after RNAi induction for 48 hours by the addition of tetracycline, since 
this was when the most severe defects were observed. 
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 Transmission electron microscopy and scanning electron 5.2.1
microscopy 
Due to the cross-sectioning that is performed before imaging with TEM, not 
all structures are visible in each sample. For this reason, four images of RNAi 
induced cells were chosen, from a total of thirteen examined, in which it was 
possible to observe the main internal structures. Upon depletion of TbPolN, 
significant alterations were observed in the internal morphology of the cell 
(Figure 5-1). Unlike in uninduced cells (Figure 5-1), the kinetoplast could not 
clearly be detected in the images of the TbPolN RNAi depleted cells, even 
though DAPI staining suggested this DNA was present (chapter 3). However, 
there were cells with multiple flagellar pockets (Figure 5-2 B). In T. brucei the 
kinetoplast is connected to the flagellum basal body (Sunter and Gull, 2016). 
Due to this, the number of kinetoplasts is directly related with the number of 
flagellar pockets, corroborating the IFA images showing the accumulation of 
multiple kinetoplasts after the depletion of TbPolN (Figure 3-12). The SEM 
images support this observation, with the presence of cells with multiple flagella 
(Figure 5-3), suggesting that TbPolN may be involved in cell division. Why, given 
these observations, the kinetoplast DNA was undetectable in the TEM is unclear.  
 
RNAi cells also presented an irregular nucleus (Figure 5-2 A).Though this 
phenotype was not detected in all cells, it is consistent with the aberrant 
nuclear staining after DAPI (chapter 3) and suggests problems associated with 
replication or division of the nucleus. In addition, swollen ‘vacuole-like’ 
structures were identified in a few of the cells (Figure 5-2 B). These structures 
seem to be lacking any content and how they arose is unclear.  SEM analysis 
revealed that the aberrant cells previously visualized by light microscopy had, in 
addition to multiple flagella, a contorted body shape, consistent with an 
impediment in completing cell division (Figure 5-3). 
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Figure 5-1. Internal cellular architecture with and without TbPolN RNAi. The 
first panel shows a cell with a regular architecture, before the depletion of 
TbPolN (Tet-). The other four panels show representative images of aberrant 
cells 48 h post RNAi induction (Tet+), presenting abnormal internal architecture. 
Important features of the cells are indicated in red (n-nucleus; fp- flagellar 
pocket; and v-vacuole). Images were captured on a Tecnai T20 transmission 
electron microscope and processed by L.Lemgruber-Soares. Scale bars 5-10 μm. 
 
 
 
 
 
Figure 5-2. Abnormal cellular structures associated with the RNAi depletion 
of TbPolN. A. Cell showing irregular nucleus 48 hours after the depletion of 
TbPolN. B. Cell showing the presence of multiple flagellar pockets and an 
A. 
B. 
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enlarged vacuole-like structure, 48 hours post induction. Important features of 
the cells are indicated in red (n-nucleus; fp- flagellar pocket; and v-vacuole). 
Scale bars 2-10 μm. 
 
 
Figure 5-3. TbPolN loss is associated with aberrant cell morphology. The left 
panel shows a BSF T. brucei cell before RNAi induction (Tet-). The other three 
panels show representative images of aberrant cells, presenting two flagella, 48 
h post RNAi induction of TbPolN (Tet+). Images were captured on a Jeol 6400 
scanning electron microscope and processed by L.Lemgruber-Soares. Scale bars: 
5 - 2 μm. 
 
5.3 Intracellular localisation of Polymerase Nu in T. brucei 
 Verification of TbPolN endogenous epitope tagging via 5.3.1
Western blot analysis 
Previous studies in human cells have shown that GFP-tagged PolN localises 
to the nucleus (Marini et al., 2003). To ask if this is also true in the parasite, the 
TbPolN gene was modified in situ in BSF cells in order to express the protein as a 
C-terminal fusion with 12 copies of the myc epitope. This manipulation was 
achieved using the 12Myc pNAT BSD vector (Figure 5-4) (Alsford & Horn 2008), 
inserting 686 bp coding for the C-terminal end of TbPolN, generated by PCR-
amplification with the primers Fw- gcatgagctcacgagttgctcattaagcac (SacI site) 
and Rv-gcattctagaaggaacatcaagtttctcga (XbaI site) (Figure 5-4 A), into the 
construct. Plasmid and PCR fragment were digested with SacI and XbaI, followed 
by ligation. The cloning strategy was employed as described in section 2.3, and 
the construct was checked by sequencing. The construct was then linearised 
with PstI and transformed into wild type (WT) Lister 427 BSF cells. 
Transformants were selected with blasticidin (10 µg/ml).  
 
To check if the TbPolN variant was expressed as a fusion to the 12 myc 
tag, a Western blot was performed using an anti-myc antibody.  A band of 
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approximately 113 kDa (98.8kDa for TbPolN, 14.4 kDa for 12Myc), was seen in a 
whole cell extract of one blasticidin resistant transformant (Figure 5-4 B). 
 
 
 
 
 
Figure 5-4. Expression of TbPolN as a 12myc C-terminal fusion variant. A. Map 
of the C-terminal tagging vector pNAT BSD containing a 12 Myc tag sequence 
(represented in yellow) and (in blue) the TbPolN insert, derived from the C-
terminus of the complete ORF. Cloning restriction sites are labelled in pink (SacI 
and XbaI). B. Western blot of whole cell extracts from a blasticidin resistant 
transformant (cl1), wild type (WT, untransformed)  cells and from a cell line 
expressing  CRK11-12 myc kinase as a control (+C). The blot was probed with 
anti-myc antibody. 
 
 TbPolN localisation in the absence and presence of damage 5.3.2
Localisation of TbPolN-12myc was assessed with immunofluorescence of 
permeabilised cells, using a conjugated Alexa Fluor® 488 anti-myc antibody. The 
intracellular localisation of the protein was tested with and without growth of 
the cells in the presence of the alkylating agent MMS (0.0003%) for 18 hours. 
Images were captured on an Axioscope 2 (Figure 5-5). 
 
The anti-myc signal was strongest in the nucleus in the absence of MMS, 
with a less intense signal in the cytoplasm, suggesting TbPolN-12myc 
predominantly localises to the nucleus in the absence of damage. After 
treatment with MMS, the nuclear signal appeared to be more intense, but 
retained the non-uniform distribution seen before damage (Figure 5-5). The 
A. 
B. 
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nuclear signal appeared to be present throughout the different cell cycle stages 
Figure 5-6.  
 
 
 
Figure 5-5.Immunolocalisation of C-terminally 12myc-tagged TbPolN in the 
absence and presence of MMS damage. Immunolocalisation of TbPolN-12myc in 
T. brucei BSF cells: the left panel shows DAPI staining of the nucleus and 
kinetoplast, the middle panel shows localisation of TbPolN-12myc using a 
conjugated Alexa Fluor® 488 anti-myc antibody, and the right panel is merged 
images of both signals. Cells are shown after culture without damage (-MMS) or 
after growth for 18 hrs in the presence of 0.0003% methyl methanosulphonate 
(+MMS 18 h). Images were captured on an Axioscope 2. Scale bar represents 5 
μm. 
 
155 
 
 
 
 
 
Figure 5-6. Immunolocalisation of TbPolN-12myc throughout the different 
cell cycle stages. The left panel shows DAPI staining of the nucleus and 
kinetoplast, the middle panel shows localisation of TbPolN-12myc using a 
conjugated Alexa Fluor® 488 anti-myc antibody, and the right panel is merged 
images of both signals. Cells are shown after culture without damage (-MMS) or 
after growth for 18 hrs in the presence of 0.0003% methyl methanosulphonate 
(+MMS 18 h). Images were captured on an Axioscope 2. Scale bar represents 5 
μm. 
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Because the TbPolN-myc localisation in the nucleus seen using the 
Axioscope microscope appeared non-uniform, high resolution images were 
captured on a Delta Vision RT deconvolution microscope (Figure 5-7) and Zeiss 
Elyra Super Resolution Microscope (Figure 5-8). In the absence of MMS 
treatment, localisation of the anti-myc signal was predominantly at the nuclear 
periphery, and was normally composed of intense puncta (Figure 5-7 A). In the 
case of the Elyra images a pattern composed of two distinct puncta was 
observed (Figure 5-8 A).  After growth in MMS, greater subnuclear signal was 
seen throughout the nucleoplasm (Figure 5-7 B, Figure 5-8 B), suggesting 
redistribution of TbPolN-myc in the presence of damage. What features of the 
nuclear genome are localised in the periphery of the nucleus and might coincide 
with TbPolN-myc localisation in undamaged cells, still unclear. On the other 
hand the rearrangement of the signal inside the nucleus after MMS damage may 
indicate that the putative TLS pol migrates from its predominant sites of action 
to sites of exogenously generated damage in order to repair the resulting 
lesions.  
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Figure 5-7. TbPolN-12myc nuclear loicalisation throughout the different cell 
cycle stages in the absence and presence of MMS damage.  Immunolocalisation 
of TbPolN-12myc in T. brucei BSF cells: the left panel shows DAPI staining of the 
nucleus and kinetoplast, the middle panel shows localisation of TbPolN-12myc 
using a conjugated Alexa Fluor® 488 anti-myc antibody, and the right panel is 
merged images of both signals. A. Cells are shown after culture without damage 
(-MMS) or B. after growth for 18 hrs in the presence of 0.0003% methyl 
methanosulphonate (+MMS 18 h). Images were captured on a Delta Vision RT 
deconvolution microscope. Scale bar represents 2 μm. 
 
A. 
B. 
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Figure 5-8. High resolution images of TbPolN-12myc localisation. 
Immunolocalisation of TbPolN-12myc in T. brucei BSF cells: left panels show 
DAPI staining of the nucleus and kinetoplast, the middle panels shows 
localisation of TbPolN-12myc using a conjugated Alexa Fluor® 488 anti-myc 
antibody, and the right panels are merged images of both signals. A. Cells are 
shown after culture without damage (-MMS) or B. after growth for 18 hrs in the 
presence of 0.0003% methyl methanosulphonate (+MMS 18 h). Images were 
captured on a Zeiss Elyra Super Resolution Microscope. Arrows show the 
agglomeration of TbPolN-12myc signal in the periphery of the nucleus, forming 
two distinct puncta.  Scale bar represents 2 μm 
 
 
 
 
A. 
B. 
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5.4 TbPolN depletion is associated with damage 
accumulation and replication impairment 
As described in chapter 3, the depletion of TbPolN by RNAi provokes a 
decrease of proliferating cells and the rise of aberrant cells. In studies in other 
eukaryotes, PolN has been associated with the repair of different lesions, such 
as DSBs and lesions caused by oxidative agents (Moldovan et al., 2010; 
Fernández-Orgiler et al., 2016). To ask if similar roles might be provided by 
TbPolN, expression of the DNA damage marker γH2A was determined after RNAi, 
asking if loss of the putative TLS resulted in nuclear DNA damage. In addition, 
incorporation of 5-ethynyl-2’-deoxyuridine (EdU), a thymidine analogue, was 
tested at the same time, asking if loss of the protein impedes genome 
replication.  
 
 Analysis of γH2A expression in TbPolN depleted cells. 5.4.1
The eukaryotic nucleosome consists of four core histones: H2A, H2B, H3 
and H4. Histone post-translational modification is a widespread strategy to alter 
chromatin, in order to prepare chromatin for the repair machinery. In T. brucei 
it has been demonstrated that phosphorylation of H2AThr130 occurs in the 
presence of diverse types of damage, suggesting this histone modification is the 
kinetoplastid variant of serine phosphorylation of either H2A or the H2Ax variant 
in other eukaryotes (Glover and Horn, 2012). Indeed, elevated levels of γH2A are 
seen in T. brucei following RNAi of a range of protein kinases, and in Leishmania 
major after mutation of components of the 9-1-1 repair complex (Damasceno et 
al., 2016; Stortz et al., 2017), indicating abundance of the modified histone is a 
marker of levels of nuclear damage. 
 
Two techniques were used for the analysis of γH2A levels after TbPolN 
RNAi:  IFA imaging and Western blot. In the case of the IFA, uninduced and RNAi 
induced cells were collected after 24 hours, 48 hour and 72 hours growth and 
the cells prepared as described in section 2.10. In the case of the Western blot, 
cell lysates of uninduced and RNAi induced cells were collected at 24 hours and 
48 hours; detailed explanation of the lysate preparation can be found in section 
2.12 .  For this assay, WT cells in the absence of damage or after the addition of 
160 
 
 
 
phleomycin (1 µg/ml) for 24 hours were used as negative and positive controls, 
respectively. Phleomycin is known to cause DBS breaks, which induces the 
phosphorylation of γH2A making possible its detection.  For both approaches 
anti-γH2A antibody (provided by Dr. Tiago D. Serafim), which recognised the 
phosphorylated γH2A,  was diluted to a concentration of 1:1000 and detected 
with α-rabbit HRP conjugate (1:3000) for the Western blot and Alexa Fluor® 594 
α- rabbit (1:1000) for the immunofluorescence.  
In both the IFA and Western blot experiments, it was possible to observe 
an increase in the expression of γH2A after TbPolN RNAi (Figure 5-9). In the 
Western blot an increase of γH2A expression levels was seen at both 24 hours 
and 48 hours post RNAi induction relative to the uninduced cells (Figure 5-9 A). 
Unlike the IFA results (see below), there was not a visible difference between 
the γH2A levels at 24 hours and 48 hours post RNAi induction. In the case of the 
IFA (Figure 5-9 B), a small amount of γH2A signal was seen in most uninduced 
cells, and this did not alter over the time course, though was variable within 
individual cells in the populations. After RNAi, a modest increase in γH2A signal 
was seen in some cells after 24 hrs, and this signal was substantially stronger at 
48 hours post RNAi induction. At 72 hour the expression levels of γH2A appeared 
to decrease relative to the 48 hours RNAi induced cells and appeared more 
comparable with the increased signal seen after 24 hrs. The fluorescence 
intensity was quantified by calculating the corrected total cell fluorescence 
(CTCF) (section 2.10.3), supporting the results obtained in the IFA. At 24 hours 
the γH2A intensity levels were close to zero. At 48 hours the γH2A intensity was 
stronger, showing a wider distribution along the Y-axis. Meanwhile, at 72h the 
cells show a decrease in γH2A intensity. Intriguingly, the IFA results closely 
mirror the cell cycle analysis in section 3.3.1, in which the strongest 
accumulation of aberrant cells was seen 48 hours post RNAi induction and 
diminished by 72 hrs. The results obtained in both assays suggest that loss of 
TbPolN results in an accumulation of nuclear DNA damage, suggesting the 
protein contributes to genome maintenance. 
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Figure 5-9. Acummulation of DNA damage after RNAi of TbPolN. A. Western 
blot showing γH2A expression levels after the RNAi depletion of TbPolN relative 
to uninduced cells. Signal is shown after 24 h and 48 h of growth and detected 
with anti-γH2A antiserum. WT cells in the absence and presence of phleomycin 
(2.5 µg/ml) were used as negative (-C) and positive (+C) control respectively. 
Anti-Ef1α antiserum was used as a loading control. Size markers (kDa) are 
shown. B. Immunolocalisation of T. brucei γH2A: left panels show DAPI staining 
of the nucleus and kinetoplast, the middle panel shows γH2A, detected with 
anti-γH2A antiserum, and the right panels are merged images of both signals. 
Cells are shown 24 hours, 48 hours and 72 hours with (Tet+) and without (Tet-) 
RNAi induction. Images were captured on an Axioscope 2. Scale bar represents 5 
μm. C. Quantitative measurement of fluorescence intensity of γH2A after 24h, 
48h and 72h RNAi induction. The fluorescence was measured by calculating the 
corrected total cell fluorescence (CTCF). Dots represent the signal obtained for 
each individual cell. A total of 20 cells were analysed for each group.   
 
 Possible role of TbPolN in DNA repair 5.4.2
Increased expression of γH2A in the cell following the depletion of TbPolN 
suggests an accumulation of DNA damage after the loss of the protein. To ask if 
TbPolN associates with DNA lesions, a double immunofluorescence assay was 
A.  B. 
C. 
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performed assessing a possible co-localisation of the modified histone γH2A and 
TbPolN-12Myc after the generation of damage.  
For the assay, the TbPolN-12 myc tagged cell line was used. Signal co-
localisation was tested in the absence and presence of the alkylating agent MMS 
(0.0003%) for 18 hours. Permeabilised cells were incubated in a mixture of two 
primary antibodies, rabbit anti- γH2A (1:1,000 dilution) and mouse unconjugated 
anti-Myc (1:1,000).  The signal was detected with Alexa Fluor® 488 α- rabbit 
(1:1,000) and Alexa Fluor® 594 α- mouse (1:1,000), respectively. 
Some overlap of the fluorescent signals was seen after the addition of 
MMS. As described before, the TbPolN-myc signal after MMS treatment was 
spread throughout the cells, whereas the γH2A signal was seen as a discrete 
focus in some cells, or not at all in others. After MMS treatment, γH2A signal was 
much more widespread in the nucleus and the overlap of both fluorescent signals 
was modest (Figure 5-10). The partial co-localisation of TbPolN and γH2A 
suggests a putative role of TbPolN during the repair of MMS damage.  
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Figure 5-10. Co-localisation of TbPolN-12myc and γH2A. Immunolocalisation of 
T. brucei γH2A and TbPolN-12myc: first (left to right) panel shows DAPI staining 
of the nucleus and kinetoplast, the second panel shows TbPoN-12myc using a 
unconjugated anti-myc antibody, third panel shows γH2A signal and the fourth 
panel is merged images of the three signals. Cells are shown before (Tet-) and 
after (Tet+) RNAi induction in the presence of 0.0003% of MMS. Images were 
captured on a Delta Vision RT deconvolution microscope. Scale bar represents 2 
μm.  
 
 Analysis of EdU incorporation in TbPolN depleted cells 5.4.3
Damage accumulation, increase of aberrant cells and decrease of cell 
proliferation are all the result of RNAi depletion of TbPolN. One explanation for 
this range of phenotypes is a role of TbPolN during nuclear genome replication, 
which results in genome instability when the protein is lost. 
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 To assess a possible role of TbPolN during replication, uptake of EdU, 
which has the capacity to incorporate into the DNA of proliferating cells (Salic 
and Mitchison, 2008), was assessed. This synthetic nucleoside is characterized by 
the replacement of the terminal methyl group by an alkaline group. The alkaline 
group can form a covalent bond with a fluorescent azide using a copper Cu(I) 
catalyzed-[3+2] cycloaddition (‘Click’) reaction, facilitating the detection of EdU 
inside the cell (Salic and Mitchison, 2008). 
 
 In order to test if the depletion of TbPolN affects DNA replication, EdU 
incorporation was tested in cells after 12 hours, 24 hours, 36 hours and 48 hours 
growth, in the absence (Tet-) or presence (Tet+) of tetracycline RNAi induction. 
In procyclic forms, nuclear S phase has a duration of 1.5 hours (Woodward and 
Gull, 1990). Assuming that the nuclear DNA synthesis timing is similar or slightly 
shorter in blood stream forms, it was decided to incubate the cells with EdU for 
a period of four hours. The cells used in this assay were not synchronized. For 
this reason, the four hour incubation period was considered optimal to ensure 
the labeling of the majority of cells undergoing DNA synthesis. Previous work, in 
both procyclic from and bloodstream form T. brucei, has shown that RNAi 
depletion of components of the origin recognition complex (ORC), which initiates 
DNA replication, leads to loss of EdU uptake (Marques et al., 2016). In all cases, 
the timing of EdU uptake loss preceded further growth and cell cycle 
impairment, suggesting ORC loss led to DNA replication reduction, which then 
led to growth defects (Marques et al., 2016). 
 
IFA imaging of EdU positive cells was performed for both uninduced and 
RNAi induced cells after 12 hours, 24 hours, 36 hours and 48 hours growth. In 
these conditions, the proportion of uninduced cells that displayed nuclear EdU 
signal was 90%. To allow comparison with EdU uptake after RNAi, the proportion 
of Tet- EdU positive cells at each time point were considered to be a 100% and 
the proportion of the Tet+ EdU positive cells were calculated relative to the Tet- 
value. 2T1 cells, which do not induce RNAi, were used as a control.  
 
A small decrease in the number of EdU stained cells, 5% and 6%, was 
observed 12 hours and 24 hours post induction, respectively (Figure 5-11). A 
decrease in the number of EdU stained cells (22%) was also detected 36 hours 
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after RNAi induction (Figure 5-12), suggesting that replication impairment starts 
before the most pronounced cell cycle defects were seen at 48 hours (section 
3.3.1, 3.3.2). At 48 hours post-RNAi induction, when there was a very 
pronounced decrease of 1N1K cells and an accumulation of aberrant cells, 45% of 
the population stopped incorporating EdU (Figure 5-12). Closer examination of 
the EdU positive and EdU negative cells 48 hours after RNAi, suggested a possible 
connection between a lack of EdU incorporation and aberrant cells. In the 
damage accumulation assay (Section 5.3.2), aberrant cells commonly presented 
γH2A signal. Thus, we decided to ask if the defect in replication and damage 
accumulation phenotypes were also connected. 
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Figure 5-11. EDU labelling to determine the effect on nuclear DNA replication 
at 12 hours and 24 hours of TbPolN loss. A. Left panels shows DAPI staining of 
the nucleus and kinetoplast, middle panels show EdU signal, and right panels 
show the cell outline by DIC. B. EdU stained cells in the absence (Tet-) and 
presence (Tet+) of tetracycline induction at 12 hours and 24 hours are shown, 
with the graph depicting the  percentage of the total population after induction 
relative to uninduced control at the same time points (set at 100%). A minimum 
of 100 cells were analysed per time point.  
 
A. 
B. 
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Figure 5-12. EdU labelling to determine the effect of TbPolN RNAi on nuclear 
DNA replication. A. Left panels shows DAPI staining of the nucleus and 
kinetoplast, middle panels show EdU signal, and right panels show the cell 
outline by DIC. B. EdU stained cells in the absence (Tet-) and presence (Tet+) of 
tetracycline induction at 36 hours and 48 hours are shown, with the graph 
depicting the  percentage of the total population after induction relative to 
B. 
A. 
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uninduced control at the same time point (set at 100%). A minimum of 100 cells 
were analysed per time point.  
 
 In order to test for a correlation between damage accumulation and the 
decrease of EdU incorporation at 48 hours post induction, a double 
immunofluorescence was performed using permeabilised cells. The cells where 
first stained for EdU (section 2.8) and subsequently stained for γH2A (1:1,000).  
 
This experiment suggests an association between damage accumulation and 
lack of EdU incorporation. In the uninduced population most cells that had 
nuclear EdU signal did not display γH2A signal (Figure 5-13 A). In contrast, many 
cells could be detected after RNAi against TbPolN that did not display EdU signal 
and had γH2A signal; indeed, this was commonly observed in aberrant cells 
(Figure 5-13(1)). This appears consistent with stalling of nuclear replication in 
the absence of TbPolN leading to damage. Cells were also detected, though less 
often, which were positive for EdU and γH2A, as well as healthy cells that 
appeared to be incorporating EdU and had no γH2A (Figure 5-13 (2-3)). These 
latter events suggest that not all cells lacking TbPolN suffer this fate, which may 
be explained by redundancy of TLS pols, with the role of TbPolN being assumed 
by another TLS pol. Alternatively, the levels of TbPolN loss after RNAi are 
variable in the cells of the population, or the features of the genome that need 
to be tackled by TbPolN are at variable levels in individual cells.  
 
The results were confirmed by performing a quantitative measurement of 
EdU and γH2A fluorescence intensity by calculating the corrected total cell 
fluorescence (CTCF) with the software Fiji (ImageJ) (section 2.10.3). The CTCF 
was calculated separately for each fluorescent channel.  The measurement of 
the intensity of EdU and γH2A signal, in uninduced cells, resembles the data 
obtained in the IFA, where the γH2A signal in the majority of the analysed cells 
was limited, suggesting the absence of damage accumulation in most cells. In 
the same cells, the EdU fluorescence intensity ranged between ~ 50 – 100 pixels, 
meaning that the cells were incorporating EdU, and therefore showing evidence 
of ongoing replication (Figure 5-13 B). On the other hand, the 48 hours induced 
cells show EdU intensity levels closer to zero, suggesting replication stalling. At 
the same time, a much larger proportion of the RNAi induced cells displayed 
γH2A signal (which was more distributed along the Y-axis), suggesting 
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accumulation of damage after the depletion of the protein. It was also possible 
to observe an overlap of both signals, which support the data obtained in the 
IFA, where few cells accumulate damage and incorporate EdU (Figure 5-13). 
 
 
 
 
 
 
 
 
Figure 5-13. Double staining immunofluorescence of γH2A and EdU before 
and after TbPolN RNAi. Cells are shown after 48 h growth in the absence (Tet-) 
or presence (Tet+) of tetracycline. A. The first panels (left to right) show DAPI 
staining of the nucleus and kinetoplast, second panels show γH2A signal 
detected with anti- γH2A antiserum, third panels show EdU signal, the fourth 
panels show a merge of the γH2A and EdU signals, and the fifth panels show the 
cell outline by DIC. Larger images of boxes show three different scenarios: (1) 
cells lacking EdU signal but showing accumulation of damage; (2) cells 
presenting γH2A and EdU signal; and (3) cells incorporating EdU and not showing 
A. 
B. 
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γH2A signal. Scale bar 5 µm. B.  Quantitative measurement of fluorescence 
intensity of EdU and γH2A by calculating the corrected total cell fluorescence 
(CTCF). The CTCF was calculated separately for each fluorescent channel (ROI -
21x21 pixels). Dots represent the signal obtained for each individual cell. A total 
of 50 cells were analysed for each group   
 
 Association of TbPolN with chromosome integrity  5.4.4
Although PolN has not been associated with chromosomal rearrangements 
in other organisms, the severe phenotype shown after the depletion of the 
protein suggested this was a possibility in T. brucei after RNAi. Previous studies 
have demonstrated a link between polymerases and chromosomal segregation; 
for instance, S. cerevisiae trf4/polymerase σ, a member of X family of 
polymerases, is associated with the sister chromatid cohesion complex, and loss 
of the protein affects the assembly of the complex and the subsequent transition 
from metaphase to anaphase  (Wang et al., 2002; Haracska et al., 2005).   
In order to test for a role for TbPolN and the maintenance of chromosome 
integrity in BSF parasites, a telomere-fluorescence in situ hybridisation (Telo-
Fish) assay was performed using a telomeric probe recognizing the TTAGGG 
repeats in T. brucei. The assay was performed with the TbPolN RNAi cell line in 
the presence and absence of tetracycline at 24 hours and 48 hours. 2x106 cells 
were collected and fixed (section 2.9); subsequently the probe was applied to 
the cells and incubated for 16 hours. Several washes were performed in order to 
remove unhybridized probes (section 2.9). Images were taken using the Delta 
Vision RT Epifluorescence Imaging System. Because mini-chromosomes are more 
abundant than megabase-chromosomes, it is likely that most Telo-FISH signal 
corresponds to the former. As seen in previous work (DuBois et al., 2012), in 
uninduced RNAi cells, telomeres are localised diffusely around the nucleus 
during interphase, with a stronger signal towards the nuclear envelope 
(Ogbadoyi et al., 2000) (Figure 5-14). During metaphase the telomeres were 
detected in the centre of the nucleus and later in mitosis (anaphase) the 
telomeres were localised towards the nucleus poles (Figure 5-14)(Ogbadoyi et 
al., 2000; DuBois et al., 2012). It appears that the telomere distribution 24 hours 
post RNAi induction was mainly not affected (Figure 5-15), resembling the 
telomere segregation of the uninduced cells. 
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Figure 5-14. Fluorescence in situ hybridisation analysis of the distribution of 
telomeres during the cell cycle in T. brucei. Schematic representation of 
chromosome distribution. Chromatids are represented in green, kinetochores in 
purple and nuclear membrane, spindle and microtubules in black. 
Representative images of uninduced cells (Tet-), which were captured on a Delta 
Vision RT. DNA (blue) is stained with DAPI and telomere signal is in green. Scale, 
2 µm. 
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Figure 5-15.Fluorescence in situ hybridisation analysis of telomere 
distribution 24 hours post RNAi induction against TbPolN. Fluorescence in situ 
hybridization using telomeres as a probe (green), in the presence (Tet+) of 
tetracycline for 24 hours. Top three panels show telomere distribution during 
interphase, middle panels show telomere localisation during metaphase and 
bottom panels show telomere distribution during anaphase. Images captured on 
a Delta Vision RT. Scale bar 2 µm.  
 
On the other hand, after 48 hours of TbPolN RNAi it was possible to 
observe potentially aberrant chromosome segregation.  In cells that appeared to 
be going through mitosis, the typical telomere distribution during metaphase 
could be lost, with cells presenting an abnormal alignment at the equator of the 
nucleus. During anaphase the ordered segregation of the telomeres into each of 
the two progeny cells could be seen to be compromised, with unequal 
distribution in the nuclei (Figure 5-16 A). In interphase cells the telomere signal 
resembles the localisation of uninduced cells, with a large part of the signal 
localised to the nuclear periphery (Figure 5-16 A)(Ogbadoyi et al., 2000). Finally, 
defective telomere distribution was also observed in aberrant cells, which could 
be the result of anomalous nucleus architecture or of previous inaccurate 
chromosome segregation events during mitosis (Figure 5-16 B). 
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Figure 5-16. Fluorescence in situ hybridization of telomeres after the 
depletion of TbPolN. Fluorescence in situ hybridization using telomeres as a 
probe (green), in the absence (Tet-) and presence (Tet+) of tetracycline for     
48h. A. Top panels show telomere distribution during interphase, middle panels 
show telomere distribution during metaphase and bottom panels show telomere 
localisation during anaphase. B.  Aberrant cells, such as with abnormal nuclei or 
increased kinetoplast numbers, showing examples of telomere distribution. 
Images captured on Delta Vision RT. Scale bar 2 µm.  
 
A. 
B. 
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5.5 Depletion of TbPolN is associated with deregulation of 
silent VSG expression sites 
It was shown above that TbPolN may be associated with chromosome 
stability, with depletion of the protein resulting in alteration of chromosome 
segregation during metaphase and anaphase. As in other eukaryotes, T. brucei 
regulates the transition from metaphase to anaphase through the cohesin 
complex (Gluenz et al., 2008). Earlier studies in T. brucei suggest that 
alterations in the cohesin complex result in activation of silent VSG expression 
sites (ESs) (Landeira and Navarro, 2007). Thus, it was considered a possibility 
that loss of TbPolN might also result in an alteration in VSG expression controls. 
Previous studies have identified the presence of 15 unique bloodstream ESs 
(BESs) in Lister 427 (Figure 5-17) (Hertz-Fowler et al., 2008; Landeira et al., 
2009). The cell lines used for this assay predominantly express VSG221, which is 
localised in BES1 (the ‘active’ expression site). In order to investigate whether 
the loss of TbPolN resulted in the increase in transcription of silent VSGs RT-
qPCR was performed; 48 hours post induction of TbPolN RNAi, to assess levels of 
RNA for four silent ES genes (VSG13, VSG800, VSG224 and VSGVO2). The RNA 
extraction and its conversion to cDNA, prior to the RT-qPCR analysis, was 
performed as per section 2.3.4. The primers used for the assay are described in 
Table 2-2. 
An increase in VSG transcript levels from the silent ESs could be detected 
48 hours after TbPolN RNAi relative to the uninduced cells. In the case of VSG13, 
VSGVO2 and VSG224 an increase, ranging from ~2-3 fold was seen (Figure 5-18), 
with a smaller increase for VSG800. Although the changes are modest, the data 
suggest that the depletion of TbPolN results in activation of silenced VSG ESs. 
Similar results were obtained after the depletion of the cohesin complex 
subunit, TbSCC1 (Landeira et al., 2009). However, a small increase in VSG221 
RNA, to a similar extent to that of VSG800, was also seen. This observation may 
suggest subtly different effects to that of TbSCC1 RNAi, but may also suggest 
that these preliminary observations need to be validated by further 
experimental repeats. 
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Figure 5-17. Schematic representation of bloodstream VSG expression sites in 
T. brucei Lister 427. The diagram shows the bloodstream expression sites (BESs) 
annotated in the T. brucei Lister 427 genome following TAR (transformation-
associated recombination) cloning. ESAGs (expression site associated genes), 
VSGs (variant surface glycoprotein), pseudogenes and other ES features are 
represented above. Figure reproduced in full from (Hertz-Fowler et al. 2008) (all 
rights reserved). 
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Figure 5-18. Loss of TbPolN is associated with the increase in transcription of 
silent ES VSGs. Levels of RNA were assessed by RT-qPCR of TbPolN RNAi cell line 
after growth for 48 hour in the presence or absence of tetracycline induction. 
The CT values for each sample were calculated by averaging the CT values 
across the triplicate technical repeats. The relative fold change for each gene 
examined was determined by calculating the ΔΔCT value (equation shown in 
section RT-qPCR) for each gene normalised to an endogenous control (actin). The 
levels of RNA for the uninduced samples were set to 1 (represented by the black 
line), and the levels in the RNAi induced expressed relative that control. The 
following VSGs were examined: VSG221, VSG13, VSGVO2, VSG224 and VSG800 
(named as detailed in Hertz-Fowler et al. 2008).  
 
5.6 Generation of TbPolN knockout cell lines 
As discussed previously (section 3.3.1), depletion of TbPolN by RNAi results 
in a decrease in cell proliferation. Interestingly, however, the defects observed 
during reduced growth represent transient phenotypes, with less aberrant cells 
and less nuclear damage beyond 48 hour post induction.  
 
For these reasons, a full knockout of TbPolN was attempted in order to ask 
if TbPolN is truly essential. In order to accomplish this, a disruption of the 
TbPolN gene was attempted by two sequential rounds of transformation into 
wild type (WT) BSF cells (T. brucei Lister 427) using two constructs: one 
containing a blasticidin resistance cassette (ΔPolN::BSD) and the other a G418 
resistance cassette (ΔPolN:: NEO) (Figure 5-19).  
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A region of approximately 500 bp was amplified, which includes a part of 
the UTR and ORF of the TbPolN gene, from both the 5’and 3’ regions. The 
forward and reverse primers used for the amplification were designed to include 
a specific restriction site. For the 5’ region, the forward primer contains HindIII 
and NotI sites (gcataagcttgcggccgcaaacatgcttatgtttttgt) and the reverse primer 
contains an XbaI restriction (gcattctagattcccttcagtggttgtgta). The 3’ region 
forward primer contains a SacI restriction site 
(gcatgagctcttcacgaaaggcgtcacgac), and ClaI and NotI were included in the 
reverse primer (gcatatcgatgcggccgcccccacaacaataacaacaa). 
  
 
 
Figure 5-19. Plasmid maps of the constructs used for the deletion of 
TbPolN.In grey are the BSD and NEO cassettes, encoding the drug resistance 
markers used for the selection of transformant clones. Β-α tubulin and actin 
represented in purple, flanking the drug cassette.In blue are represented 
sequences of approximately 200 bp that have homology with the 5’ and 3’ 
regions surrounding the TbPolN ORF, respectively, which provide homology for 
recombination and integration of the cassettes after transformation. 
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The PCR products and the ΔPolN::BSD and ΔPolN::NEO plasmid were 
digested (HindIII+XbaI and SacI+ClaI) and ligated as described in section 2.3.8. 
The resulting knockout constructs were checked by sequencing prior to 
transfection, after the DNA fragment was liberated from the plasmid with NotI. 
If successful, two rounds of transformation in WT cells should replace both 
alleles of the gene with the antibiotic resistance cassettes (Chapter 4, Section 
4.3).  
 
ΔPolN:: NEO was first transformed into WT cells, generating putative 
heterozygous mutants (TbPolN-/+). As mentioned in section 4.3, the addition of 
the antibiotic G418 caused slowed growth of the transformant cells in 
comparison to WT (data not shown). As in the case of TbRev3 -/+ transformants, 
the drug was removed after clonal selection, permitting optimal outgrowth of 
the cells for transformation of the putative TbPolN-/+ cells with the ΔPolN:: BSD 
construct. 
 
The first transformation with the ΔPolN::NEO construct was successful, 
recovering two G418 resistant transformant clones. For the verification of the 
heterozygous cell line, two PCRs were performed: the first PCR targeting the 
drug resistance cassette, and the second PCR targeting a region of the TbPolN 
ORF (Figure 5-20). For both clones, the PCRs confirmed the presence of 
integrated NEO and retention of the ORF, as expected for a heterozygous cell 
line (-/+)(Figure 5-20).  
 
Having generated TbPolN-/+ cells, a second transformation with the 
ΔPolN::BSD construct was attempted, but no blasticidin resistant transformants 
were recovered. Further attempts were performed to obtain null mutants, 
reducing the drug concentration from 10 µg/ml to 7 µg/ml and 5 µg/ml. Before 
changing the drug concentration a titration was performed to ensure the drug 
concentration was still optimal for the selection of positive clones (data not 
shown). The retrieval of null mutants was not successful, suggesting that TbPolN 
protein may have an essential role in survival of the parasite.  
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Figure 5-20. Confirmatory PCR of TbPolN heterozygote mutants.Schematic 
representation of expected fragment sizes amplified by PCR (bp), including 
diagnostic primers used (black arrows) and their position in the genome or 
construct (not to scale). Primer sequences are available in Chapter2, Table 2-1. 
Agarose gels of diagnostic PCRs, testing the presence of TbPolN ORF and 
integration of the NEO cassette. WT cells and ddH2O were used as negative 
controls.  All PCRs were performed on the same gDNA samples. Size markers (bp) 
are shown. 
 
5.7 Identifying TbPolN potential interaction partners 
To attempt to further understand the functions of TbPolN, it was decided 
to search for possible interaction partners. To do this, immunoprecipitation (IP) 
of TbPolN-myc was performed with anti-myc antiserum. For this purpose, the 
TbPolN-/+ cell line was transformed with C-terminal myc-tag construct as 
described in section 5.3.1. The expression of TbPolN-myc was verified by 
Western blot of cell extracts with anti-myc antiserum (Figure 5-21 A). 
 Immunoprecipitation 5.7.1
In order to perform the IP, extracts from WT (1x108) and TbPolN-
/+::12myc cells (1x108) were incubated with Dynabeads® (Invitrogen) coated 
with anti-myc antibody. After five washes with washing buffer (50 mM Hepes pH 
7.55, 100 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, 10 % glycerol, 0.1 % 
Triton X-100, and 2x complete protease and phosphatase inhibitor cocktail; 
Roche), the eluate was collected and re-suspended in 15 μl of 1X NuPAGE® LDS 
Sample Buffer (described in chapter 2, section 2.12.2). For both WT and TbPolN-
/+::12myc duplicate IPs were performed. One of the eluates from each of the 
WT and TbPolN-/+::12myc cells was separated on a 10% Bis-Tris SDS-PAGE gel 
and stained with SYPRO® Ruby. It was not possible to differentiate specific 
bands when comparing the WT control and TbPolN-/+::12myc IPs (Figure 5-21 B). 
180 
 
 
 
However, using the second eluate, specific IP of TbPolN-myc was confirmed by 
Western blot (1μl of eluate, 9μl of protein loading buffer), where the presence 
of tagged protein was exclusively detected in the TbPolN-/+::12myc IP eluate 
and not WT (Figure 5-21 C). Thus, the remaining eluate of both the WT and 
TbPolN-/+::12Myc IPs were analysed by mass spectrometry (Glasgow Polyomics 
Facility). 
 
  
Figure 5-21. Immunoprecipitation of TbPolN-12Myc. A. Western blot of whole 
cell extracts from WT, a blasticidin resistant transformants and from a cell line 
expressing CRK11-12 myc as a control (+C), detected using anti-myc antibody.  
B. Sypro ruby stained gel of anti-myc immunoprecipitated proteins from WT427 
(un-tagged cell line) and TbPolN+/-12myc lysates. C. Western blot on all 
fractions of the IP from TbPolN-12myc and WT. Fractions from left to right: 
prelysis, input, flow-through and eluate from TbPolN-12myc and WT, showing 
the absence of bands in the untagged cell line. 
 
The mass spectrometry data revealed the IP of several possible TbPolN-
myc interacting partners. In order to evaluate the data, TbPolN -/+::12Myc IP 
‘hits’ were compared against WT ‘hits’, excluding common proteins. From a 
total of 59 proteins identified by MS in the TbPolN -/+::12Myc IP, four proteins 
were shared with the WT control IP (which identified 36 proteins), leaving 55 
proteins specific to the former (Table 5-1). These 55 proteins were assessed for 
possible contaminants (e.g. VSGs, ESAGs and ribosomal proteins), which were 
A. B. 
C. 
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excluded, leaving 34 proteins. All of these hits were analysed by BLASTp, in an 
attempt to derive potential functional information beyond the existing 
TriTrypDB annotations. For many proteins no further information could be 
discerned beyond that provided by existing annotations, and for others, 
annotated as ‘hypothetical’, the Blast and conserved domain predictions gave 
only very weak homologies. However, four potential proteins were revealed as 
potentially of interest (Table 5-2). Three of the four possible interaction 
partners are annotated in TriTrypDB as hypothetical proteins (Tb927.5.3280, 
Tb927.2.3990 and Tb11.01.3060), but BLASTp revealed each to have putative 
domains conserved with structural maintenance of chromosome (SMC) proteins, 
perhaps suggesting roles in chromosomal condensation or cohesion (Harvey, 
Krien and O’Connell, 2002). The other ‘hit’ was a putative Poly(A) polymerase 
(putative Polσ), which has been suggested to have a role in DNA repair (Garcia-
Diaz and Bebenek, 2007) in other eukaryotes. It has also been associated with 
chromosome cohesion in yeast (Edwards et al., 2003b). Thus, though the IP is 
highly unspecific, a cohort of proteins potentially associated with genome 
transmission were specifically recovered in the TbPolN-12myc IP, perhaps 
consistent with the impaired genome maintenance functions seen after TbPolN 
RNAi.  
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Table 5-1. Recovered proteins from TbPolN-12myc IP after mass 
spectrometry analysis. Proteins shown were only present in TbPolN anti-myc IP; 
hits also identified in IP from WT cells were excluded. Interesting ‘hits’ are 
labelled in red. Samples were analysed using MASCOT software. 
 
 
Gene ID Annotation Score
 Tb927.8.7590  receptor-type adenylate cyclase GRESAG 4, putative 33
 Tb927.6.1130  hypothetical protein, conserved 33
 Tb927.1.2330 beta tubulin 570482:571810 forward 33
 Tb927.5.3280  hypothetical protein, conserved 31
 Tb11.01.3980  hypothetical protein, conserved 30
 Tb927.4.5610  variant surface glycoprotein (VSG, pseudogene), 29
 Tb927.7.1140  GPX3 trypanothione/tryparedoxin dependent peroxidase 29
 Tb11.30.0013  variant surface glycoprotein (VSG, pseudogene) 29
 Tb927.2.2340  hypothetical protein, conserved 26
 Tb11.01.4960  Tb11.01.4960 regulator of nonsense transcripts 1, putative (pseudogene) 25
 Tb927.8.5200 hypothetical protein, conserved 25
 Tb927.8.7260  kinetoplast-associated protein, putative 25
 Tb927.5.3250  hypothetical protein, conserved 25
 Tb927.8.5700  hypothetical protein, conserved 25
 Tb927.5.2800 hypothetical protein, conserved 25
 Tb927.4.5650 variant surface glycoprotein (VSG, pseudogene) 24
 Tb927.2.6050 beta prime COP protein 24
 Tb10.70.0070  tyrosine specific protein phosphatase, putative 22
 Tb927.8.4230  hypothetical protein, conserved 22
 Tb11.01.2440  glycosyl hydrolase, putative 22
 Tb927.8.7800 hypothetical protein, conserved 20
 Tb11.03.0970  receptor-type adenylate cyclase GRESAG 4, putative 20
 Tb927.8.3830  ATP-dependent DEAD/H RNA helicase, putative 19
 Tb927.8.600  hypothetical protein, conserved 19
 Tb05.5K5.310  expression site-associated gene (ESAG) protein, putative 19
 Tb927.5.4660 expression site-associated gene (ESAG, pseudogene), putative 19
 Tb11.03.0670 transcription factor, putative; transcription factor IIIb, putative 18
 Tb927.2.3990  hypothetical protein, conserved 18
 Tb10.6k15.1200 hypothetical protein, conserved 18
 Tb927.4.1700  protein kinase, putative 17
 Tb11.01.0300  hypothetical protein, conserved 17
 Tb927.1.2670 axoneme central apparatus protein, putative 16
 Tb09.211.2310  Bem46-like serine peptidase 16
 Tb05.5K5.540  variant surface glycoprotein (VSG, pseudogene), putative 16
 Tb927.3.5850  variant surface glycoprotein (VSG, pseudogene), putative 15
 Tb09.160.1290 hypothetical protein, conserved 15
 Tb11.01.3730  hypothetical protein, conserved 15
 Tb927.6.5830  variant surface glycoprotein (VSG, pseudogene), putative 15
 Tb09.211.4580  hypothetical protein, conserved 14
 Tb11.01.2490  hypothetical protein, conserved 14
 Tb09.244.0750  variant surface glycoprotein (VSG, pseudogene), putative 14
 Tb09.160.3240  hypothetical protein, conserved 14
 Tb10.v4.0092  variant surface glycoprotein (VSG, pseudogene), putative 13
 Tb11.02.1370  katanin, putative; 13
 Tb927.8.7310  hypothetical protein 13
 Tb10.70.7360 hypothetical protein, conserved 13
 Tb09.244.0190  hypothetical protein, unlikely 13
 Tb927.6.1220 hypothetical protein, conserved 13
 Tb927.8.1090  DNA polymerase sigma, putative 13
 Tb09.244.1250 variant surface glycoprotein (VSG, pseudogene), putative 13
 Tb927.4.1090  endosomal integral membrane protein, putative 13
 Tb11.01.3060  hypothetical protein, conserved 13
 Tb11.01.0200  katanin, putative 13
 Tb927.8.6120 hypothetical protein, conserved 13
 Tb10.61.3120 hypothetical protein, conserved 13
 Tb927.7.2160  hypothetical protein, conserved 13
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Table 5-2. Potential TbPolN interaction partners identified by Mass 
Spectrometry and homology analyses. Proteins shown were only present in IP 
from TbPolN-12Myc. Proteins were analysed using MASCOT. Proteins sequence 
for each ‘hit’ was examined by BLASTp.  
 
 Co-Immunoprecipitation and Co-localisation of TbPolN and 5.7.2
putative Poly(A) polymerase (putative Polσ) 
 
To evaluate the possible TbPolN interaction partners further, one of the 
candidates, a putative Pol σ homologue, was chosen for further study as it has 
been characterised to some extent in T. brucei (Cristodero and Clayton, 2007). 
The potential role of Polσ in RNA degradation was tested, showing  no clear 
interaction with MTr4. In S. cerevisiae, Mtr4 forms part of the TRAMP complex 
together with a Poly-A polymerase (Cristodero and Clayton, 2007; Callahan and 
Butler, 2010). This complex is known to be involved in the degradation of RNA in 
the nucleus (Callahan and Butler, 2010). Interestingly it was possible to detect a 
growth effect after the depletion of Pol σ by RNAi (Cristodero and Clayton, 
2007).     
 
In order to test the predicted interaction, a double-tagged cell line was 
generated, in which TbPolN was tagged with a myc epitope and TbPolσ with six 
copies of the HA tag. In order to create the double-labelled cell line, the 
TbPolN-/+::12 Myc cell line was used as the parental line (section 5.7.1). To tag 
TbPolσ a 620 bp DNA fragment of the C-terminal end of the putative Polσ ORF 
was inserted into the 6 HA pNAT Phl vector (Alsford and Horn, 2008)(Figure 5-22 
A). The fragment was amplified using the following primers: Fw- 
gcatgagctcagatgctttaaacgtacgga (SacI site) and Rv- 
gcattctagaacgtcgggtcaatgaccgag (XbaI site). The construct was digested with 
HpaI and transformed into TbPolN-/+::12 Myc cells and transformants selected 
with phleomycin (2.5 µg/ml). The cloning strategy is described in section 2.5.1. 
 
To check if TbPolN and TbPolσ were expressed as fusions with 12 Myc and 
6 HA tags, respectively, a Western blot was performed.  A band of approximately 
Gene ID Annotation Predicted domains Potential Function Protein Score
 Tb927.5.3280  hypothetical protein Structural maintenance of chromosomes (SMC) domain chromosome segregation 31
 Tb927.2.3990  hypothetical protein SMC domain chromosome segregation 18
 Tb927.8.1090  DNA polymerase sigma putative Poly A polymerase domain repair,sister chromatin cohesion 13
 Tb11.01.3060  hypothetical protein SMC domain chromosome partition 13
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113 kDa (98.8kDa for TbPolN, 14.4 kDa for 12Myc) for TbPolN-myc and a band of 
approximately 88 kDa for putative Polσ-HA (81.6 kDa for Polσ, 6.6 kDa 6HA) 
were expected. Two bands of the expected size were seen in a cell extract of 
one transformant, confirming a successful double tagged cell line (Figure 5-22 
B). 
 
 
 
 
Figure 5-22. Expression of TbPolσ as a 6HA C-terminal fusion variant A. Map 
of the C-terminal tagging vector containing a 12 Myc tag sequence (represented 
in yellow) and (in blue) the TbPolσ insert, derived from the C-terminus of the 
complete ORF. B.Western blot of whole cell extracts from a blasticidin and 
phleomycin resistant individual transformant, Polσ-6HA and PolN-12myc 
transformants as controls (+C), detected using anti-myc and anti HA antibody. 
WT, untagged cell line is not present in the gel.  
 
To test interaction between TbPolN and TbPolσ, co-localisation of TbPolN-myc 
and TbPolσ-HA was first assessed by a double immunofluorescence assay. For 
this approach, permeabilised cells were incubated in a mixture of two primary 
antibodies:  conjugated Alexa Fluor® 488 mouse anti-myc (1:500 dilution) and 
mouse anti- HA (1:1,000), detected with Alexa Fluor® 594 α- mouse (1:1,000). 
Images were captured on a Delta Vision RT deconvolution microscope (Figure 
5-23 A) and on a super-resolution Elyra microscope (Figure 5-23B).  
 
Both sets of images suggest some co-localisation of the proteins, 
presenting as an overlap of staining inside the nucleus (Figure 5-23 A-B). Though 
A. B. 
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the anti-HA signal for TbPolσ-HA was more widespread in the nucleoplasm, loci 
of discrete overlap with TbPolN-myc were apparent, and overlay of the signals 
(Myc and HA) could be seen by the generation of a fluorescence intensity graph, 
using the super-resolution images (Figure 5-23 B). However, in spite of the 
overlap, the interaction still needed to be confirmed as the broad distribution of 
TbPolσ-HA across the nucleus may result in false-positive co-localisatio.
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Figure 5-23.  Co-localisation of TbPolN and TbPolσ. A. First panels (left to right) shows DAPI staining of the nucleus and kinetoplast, 
second panels show anti-myc  signal, third panels show anti-HA signal, and fourth panels are a merge of the three signals. B. First panels 
show putative Pol σ signal, second panels show PolN-/+::12myc signal, third panels show DAPI staining of the nucleus and kinetoplast 
and fourth panels are a merge of the three signals. Diagrams show fluorescence intensity for the DAPI (red), anti-HA (green) and anti-
myc (blue) signals. The white box represents the area from which the fluorescence intensity was measured in order to elaborate the 
graph (using image J). Fluorescence intensity is plotted (X-axis) over distance (μm; Y-axis). Scale bar = 5 μm
B. 
A. 
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To more directly test for interaction of TbPolN and TbPolσ, a co-
immunoprecipitation (co-IP) was performed. The co-IP methodology is an 
extension of the IP method, the conditions used for this assay are those 
described for the IP in section 5.7.1. 
 
The co-immunoprecipitation was assessed by Western blot, using anti-myc 
and anti-HA to IP proteins from the TbPolN-myc and TbPolσ-HA double tagged 
cells, as well as from cells expressing only TbPolN-myc or TbPolσ-HA. In the 
eluate of the double tagged cell line, anti-myc IP revealed a band of ~88kDa 
recognized by the anti-HA antibody, confirming recovery of Polσ-HA (Figure 5-24 
A) . In addition, in the eluate of the double tag cell line after anti-HA IP, a band 
of ~113 kDa was recognized by the anti-myc antibody, confirming the presence 
of TbPolN-myc (Figure 5-24 B). To check that the co-IPs were not false positives, 
controls were performed to test the specificity of the antibodies. While both 
TbPolN12-myc and TbPolσ-6 HA are successfully detected by anti-myc and anti-
HA antibodies after anti-myc and anti-HA IPs, respectively, from cells expressing 
only TbPolN12-myc or TbPolσ-6 HA, IPs of the same cells with anti-HA or anti-
myc, respectively, did not recover the same proteins (Figure 5-24 C,D).  Thus, 
the antibodies uniquely bind to the target epitopes and the coIP in the double 
tagged cells is because of TbPolN12-myc and TbPolσ-6 HA interaction.  
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Figure 5-24. TbPolN and TbPolσ co-immunoprecipitation. A. Western blot 
showing anti-myc IP from  cell line expressing TbPolN12-myc and TbPolσ-6 HA , 
detected using anti-HA antibody. B. Western blot showing anti-HA IP from the 
same double tagged cells, detected using anti-Myc antibody. C. Western blot of 
anti-Myc and anti-HA IPs from a PolN+/-12Myc lysate, detected using anti-Myc 
antibody. D. Western blot of anti-Myc and anti-HA IPs from a TbPolσ-6HA lysate, 
detected using anti-HA antibody. In each blot the prelysis, input, flow through 
and eluate samples are shown. 
 
 Possible interaction partners of Polymerase theta (helicase 5.7.3
domain) 
In higher eukaryotes a possible interaction between the helicase domain-
containing protein  HelQ and the polymerase domain protein PolN has been 
suggested (Bebenek and Kunkel, 2004). For this reason, it was decided to ask if 
the two putative T. brucei homologues interact, in particular because RNAi 
against TbHelQ was ineffective. Though the results obtained from the TbPolN-
myc IP and MS analysis did not reveal TbHelQ as a possible interaction partner, it 
is possible it was not efficiently recovered. Therefore, a reverse IP was 
performed, this time using TbHelQ-HA as the target protein. 
For the analysis, TbHelQ was tagged using the 6 HA pNAT vector (Alsford 
and Horn, 2008) containing 1160 bp of the C-terminal end of the TbHelQ ORF 
A. B. 
C. D. 
189 
 
 
 
(Figure 5-25 A). The insert was amplified using the following primers: Fw- 
gcatgagctcctggagtttgtcgcgattgg (SacI site) and Rv- 
gcattctagagtaggttgaagattggaggg (XbaI site). Plasmid and fragment were digested 
with SacI and XbaI, followed by a ligation process.  The vector was linearised 
with XhoI and transformed into WT Lister 427 BSF (section 2.3.7, 2.3.8).  The 
cloning strategy is described in detail in section 2.5.1. To verify if TbHelQ was 
expressed as a fusion with the 6 HA tag, a Western blot was performed, where a 
band of approximately 121.6 kDa (115 kDa TbHelQ, 6.6 kDa HA tag) was observed 
(Figure 5-25 B). 
 
 
 
 
 
 
 
Figure 5-25. Expression of TbPolQ as a 6HA C-terminal fusion variant. A. Map 
of the C-terminal tagging vector containing a 6 HA tag sequence (represented in 
yellow) and (in blue) the TbHelQ insert, derived from the C-terminus of the 
complete ORF.  B. Western blot of whole cell extracts from four phleomycin 
resistant transformants (cl1-4) and from a cell line expressing Polσ-6HA as a 
control (+C). The blot was probed with anti-HA antibody. WT untagged cell line 
was not loaded in the gel.  
 
The IP conditions used for this assay are the same as those described for 
the TbPolN-myc IP in section 5.7.1, but using anti-HA antiserum. The 
SYPRO®Ruby gel did not show any specific bands in TbHelQ-HA IP in relation to 
the control WT IP (Figure 5-26 A). However, IP of the HA-tagged protein was 
confirmed by Western blot, detecting the presence of TbHelQ-HA uniquely in the 
TbHelQ-HA IP (Figure 5-26 B). The eluates from both the WT and TbHelQ IPs 
were analysed by mass spectrometry (Glasgow Polyomics Facility). 
 
B. A. 
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Figure 5-26. Validation of TbHelQ immunoprecipitation.A.Sypro ruby stained 
gel of anti-myc immunoprecipitated proteins from WT427 (un-tagged cell line) 
and TbHelQ-6HA lysates. B. Western blot on all fractions of the IP from TbHelQ-
HA and WT. Fractions from left to right: prelysis, flow-through, input and eluate 
from WT and TbHelQ, showing the absence of bands in the untagged cell line. 
The extra bands represent the heavy chain of the antibody.  
 
As for TbPolN-myc IP, the TbHelQ-HA IP mass spectrometry results were 
analysed against WT (which identified 143 proteins), excluding common 
proteins, leaving a total of 49 possible interaction partners (Table 5-3). None of 
these proteins corresponded to TbPolN. After the elimination of possible 
contaminants and proteins with insufficient information, 4 possible TbHelQ 
interactors were highlighted as potentially worthy of further analysis (Table 
5-4). Three of these proteins, Rad50 (Tb11.01.0340), Rad51 (Tb09.211.1210), 
and BRCA2 (Tb927.1.640), are known to play an important role during HR in the 
parasite. BRCA2 is of particular interest, because it is known to be essential for 
the regulation of Rad51 in T. brucei (Trenaman et al., 2013) and previous work 
in which IP was used against procyclic form T. brucei cells expressing BRCA2-myc 
recovered TbHelQ (Prorocic and McCulloch, unpublished). Though Rad50 and 
Rad51, which also act during the repair of DSBs (Passos-Silva et al., 2010), were 
not recovered in the BRCA2-myc IP, selected bands, rather than a whole eluate, 
were analyzed by MS in that approach. One further repair protein, T. brucei 
A. 
B. 
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PMS1 (Tb09.211.4840), was also recovered by TbHelQ-HA IP and is known to have 
an important role in mismatch repair (Passos-Silva et al., 2010).  
 
 
Table 5-3.Recovered proteins from the TbHelQ-6HA IP after mass 
spectrometry analysis. Proteins shown were only present in TbHelQ anti-HA IP; 
hits also identified in IP from WT cells were excluded. Interesting ‘hits’ are 
labelled in red. Samples were analysed using MASCOT software. 
Gene ID Protein Score
 Tb927.1.710  PGKB phosphoglycerate kinase 356
 Tb09.160.2550 ribosomal protein S7, putative 322
 Tb09.160.0700  60S ribosomal protein L35, putative 181
 Tb927.4.1860 ribosomal protein S19, putative 83
 Tb10.70.4800  ribosomal protein S25, putative 83
 Tb10.61.2090  60S ribosomal protein L17, putative 80
 Tb927.7.2820  histone H2A, putative 79
 Tb09.211.3270  60S ribosomal subunit protein L31, putative 78
 Tb11.01.7535  60S ribosomal protein L27, putative 77
 Tb11.02.0740  60S ribosomal protein 75
 Tb11.01.0355  ribosomal protein S26, putative 73
 Tb09.211.0865 60S ribosomal protein L37, putative 65
 Tb927.8.1330 60S ribosomal protein L7a, putative 56
 Tb09.v4.0067 retrotransposon hot spot protein, pseudogene 34
 Tb927.4.2180  60S ribosomal protein L35A, putative 33
 Tb10.70.4700  TSR1IP splicing factor PTSR1 interacting protein 41
 Tb927.5.940 NADH-dependent fumarate reductase 31
 Tb11.02.1630 hypothetical protein 31
 Tb10.70.4680 hypothetical protein, conserved 30
 Tb927.6.150  retrotransposon hot spot protein (RHS, pseudogene), putative 30
 Tb927.7.3050 hypothetical protein, conserved 29
 Tb09.244.2760  cytosolic coat protein, putative 28
 Tb11.13.0006  variant surface glycoprotein (VSG, pseudogene), putative 27
 Tb927.4.3160 dihydroxyacetone phosphate acyltransferase, putative 26
 Tb11.14.0008  variant surface glycoprotein (VSG, atypical), putative 25
 Tb09.160.5400  expression site-associated gene 9 (ESAG9) protein, putative 25
 Tb09.160.0010 variant surface glycoprotein (VSG, pseudogene), putative 24
 Tb927.3.3620  hypothetical protein, conserved 24
 Tb10.v4.0231  variant surface glycoprotein (VSG, pseudogene), putative 23
 Tb09.v4.0057 variant surface glycoprotein (VSG, pseudogene), putative 23
 Tb10.v4.0004  variant surface glycoprotein (VSG, pseudogene), putative 23
 Tb09.160.1290  hypothetical protein, conserved 23
 Tb927.5.2140 regulator of nonsense transcripts 1, putative 22
 Tb927.4.1730  hypothetical protein, conserved 21
 Tb05.5K5.530 variant surface glycoprotein (VSG), putative 19
 Tb09.v4.0114  variant surface glycoprotein (VSG, atypical), putative 18
 Tb11.52.0008 hypothetical protein, conserved 33
 Tb927.3.1850  hypothetical protein, conserved 33
 Tb927.8.1840 hypothetical protein, conserved 29
 Tb927.7.3160 dynein heavy chain, cytosolic, putative 28
 Tb11.01.4210 hypothetical protein, conserved 18
 Tb927.6.4070   hypothetical protein, conserved 18
 Tb927.7.1200  hypothetical protein, conserved 18
 Tb11.02.1340  AMP deaminase, putative 18
 Tb11.01.2310  hypothetical protein, conserved 17
 Tb09.211.1210 RAD51/dmc1 protein, putative 48
 Tb11.01.0340 RAD50 DNA repair-like protein 16
 Tb09.211.4840 mismatch repair protein PMS1, putative 15
 Tb927.1.640 hypothetical protein, conserved (BRCA2) 13
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Table 5-4.Potential TbHelQ interaction partners identified by Mass 
Spectroscopy and homology analyses. Proteins shown were only present in IP 
from TbPHelQ-HA. Proteins were analysed using MASCOT. Proteins sequence for 
each ‘hit’ was examined by BLASTp for predicted domains. 
 
 A possible role for HelQ during Homologous Recombination 5.7.4
BRCA2 was chosen for further analysis to try and elucidate a possible role 
for TbHelQ. In order to assess a possible interaction, a double tagged BSF cell 
line expressing TbHelQ-HA and BRCA2-Myc was generated. The generation of the 
double tagged cell line was performed by using a BRAC2-12 Myc cell line (kindly 
provided by A. Trenaman) as the parental cell line, into which the TbHelQ-6HA 
pNAT Phl vector was transformed ( section 2.3.9). To verify if both tagged 
proteins were expressed, a Western blot was performed and probed with anti-
myc and anti-HA antisera, revealing bands of ~120 kDa (115 kDa TbHelQ, 6.6 kDa 
HA tag) and ~200 kDa (181.28 kDa BRCA2, 14.4 kDa Myc) (Figure 5-27).  
 
For immunofluorescence, permeabilised cells were incubated in a mixture 
of two primary antibodies, conjugated Alexa Fluor® 488 mouse anti-Myc (1:500 
dilution) and mouse anti- HA (1:1000), which was detected with Alexa Fluor® 
594 α- mouse (1:1000). The images were captured on a Delta Vision RT 
deconvolution microscope. It was possible to observe a very substantial overlap 
of the anti-HA and anti-myc signals, suggesting TbHelQ-HA and BRCA2-myc co-
localise in the same regions of the nucleus (Figure 5-27). Indeed, the pattern of 
BRCA2-myc localisation is highly similar to previous studies, with the protein 
present in multiple puncta across the nucleus in the absence of damage 
(Trenaman et al., 2013). 
 
Gene ID Annotation Predicted domain Score
 Tb09.211.1210 RAD51/dmc1 protein, putative NTP binding domain, Rad51 48
 Tb11.01.0340 RAD50 DNA repair-like protein ATP-binding domain,  exonuclease domain,AAA domain 16
 Tb09.211.4840 mismatch repair protein PMS1, putative MutL dimerisation domain 15
 Tb927.1.640 hypothetical protein, conserved (BRCA2) BRCA2, oligonucleotide/oligosaccharide-binding, domain 1 13
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Figure 5-27. TbHelQ and BRCA2 nuclear co-localisation. A. Western blot of whole cell extracts from 3 blasticidin and phleomycin 
resistant transformants (cl3, 4, 5), and from a cell line expressing only TbHelQ-6HA as a control (+C), detected using anti-myc and anti- 
HA antibody. B. First panel show DAPI staining of the nucleus and kinetoplast, second panel show anti -HA signal, third panel show anti-
myc signal, and fourth panel is a merge of the three signals. Images captured on a Delta Vision RT deconvolution microscope. Scale bar 
5μm.
A. 
B. 
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 In order to ensure the putative co-localisation of TbHelQ and BRCA2 did 
not result from antibody cross-reaction in the IFA, the TbHelQ 6HA pNAT Phl 
vector was transformed into a WT Lister 427 cell line (Section 5.7.3). For the 
immunofluorescence assay, permeabilised cells were incubated in a conjugated 
mouse anti-HA (1:500 dilution) antibody and images were taken on a Delta Vision 
RT deconvolution microscope. The anti-HA signal was detected along the nucleus 
(Figure 5-28), resembling the localisation observed in the co-localisation assay 
(Figure 5-27). 
 
 
 
Figure 5-28. TbHelQ nuclear localisation. First panel shows DAPI staining of the 
nucleus and kinetoplast, second panel shows TbHelQ-6HA signal and third panel 
is a merge of the two signals. Images captured on a Delta Vision RT 
deconvolution microscope. Scale bar 5μm. 
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5.8 Discussion 
This section describes the activity of the putative TLS Pol, Tb Pol Nu (PolN) 
in bloodstream form T. brucei cells. Epitope tagging demonstrates that TbPolN 
localises in discrete sites at the periphery of the nucleus in the absence of DNA 
damage, with a more widespread, but non-uniform localisation after MMS 
damage. Morphological defects arise ~48 hours post RNAi induction, with the 
appearance of multiple flagellar pockets and aberrant nuclei. EdU labelling and 
γH2A analysis after TbPolN knockdown reveal a decrease in proliferating cells, 
which accumulate nuclear DNA damage. The depletion of TbPolN is also 
associated with aberrant chromosome segregation. Finally, we show that TbPolN 
interacts with a nuclear putative non-canonical PolyA polymerase (putative 
Polσ).  
In addition to the above data on TbPolN, IP and colocalisation analysis 
indicate that TbHelQ provides a quite distinct function in T. brucei to TbPolN. 
TbHelQ appears not to interact with TbPolN, but to interact with TbBRCA2, and 
perhaps further repair factors, suggesting a role in HR.  
 
 Possible roles of Polymerase theta (helicase domain) in T. 5.8.1
brucei 
 
Helicases are known for their ability to catalyse the separation of double-
stranded nucleic acids in an ATP dependent manner (Byrd and Raney, 2012). The 
resulting substrate - single-stranded nucleic acids - play important roles during 
cellular reactions (Byrd and Raney, 2012). The helicase members of the Sf1 and 
Sf2 superfamilies are known to have important roles in  DNA and RNA metabolism 
(Fairman-Williams, Guenther and Jankowsky, 2010; Byrd and Raney, 2012). The 
members of the SF2 superfamily (RecQ-like, RecG-like, DEAH/RHA box and 
DEAD-box) are active during replication, transcription, DNA repair and chromatin 
rearrangement (Byrd and Raney, 2012). Alterations of the SF2 helicases are 
associated with  mental retardation, immunodeficiency, premature aging and 
predisposition to cancer in humans (Byrd and Raney, 2012).  
 
As it was shown in chapter 3, TbHelQ belongs to the SF2 superfamily, 
suggesting a role in DNA metabolism, with the possibility of being involved in 
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DNA repair. TbHelQ-HA immunoprecipitation revealed that BRCA2, and perhaps 
RAD51, are interaction partners of TbHelQ (section 5.7.3). These two molecules 
are known to be involved in repair of double strand breaks (DSB) in eukaryotes 
(Jasin and Rothstein, 2013). An important question, therefore, is if and how this 
helicase might act in HR. 
 
Several members of the SF2 superfamily have been linked with the repair of 
DSBs. For instance, mutation in the BLM helicase, a member of the RecQ family, 
has been associated with Bloom’s disorder. This disorder is responsible for 
growth delay, facial sun sensitivity, immunodeficiency, fertility problems and 
cancer  (Wu et al., 2001). It is suggested that this is provoked by an inefficient 
HR pathway (Wu et al., 2001). The interaction was tested by 
immunofluorescence, which confirmed co-localisation of BLM and Rad51 in 
response to ionizing radiation (resulting in interstrand cross-links (ICL)) (Wu et 
al., 2001). It has been proposed that BLM activity is important for impeding the 
crossover of the DNA strands, facilitating the recruitment of Rad51 (Wu et al., 
2001). T. brucei RecQ2, a putative BLM homologue, shows a role during DNA 
repair and VSG switching. The loss of TbRecQ2 in the parasite impairs the 
survival of the cells in the presence of DSB (Devlin et al., 2016). In addition, Co-
localisation of TbRecQ and TbRad51 was detected after inducing damage with 
phleomycin (generates DSBs) and loss of TbRecQ results in an increase in VSG 
switching, which is a consequence of altered recombination pathways (Devlin et 
al., 2016).  
 
In contrast to a clear role for RecQ helicases in Rad51-mediated HR, the 
human HelQ helicase has only so far been related to ICL repair in cancer, since 
HelQ heterozygous cells show increased sensitivity to ICL inducing agents 
(Takata et al., 2013). In addition, immunoprecipitation of  HelQ revealed 
interaction with ATR and Rad51 paralogs (Rad51B, Rad51C and Rad51D), not 
Rad51 or BRCA2 (Takata et al., 2013). CL lesions are highly lethal for the cell, 
impeding the pass of the replication and transcription machinery by blocking 
DNA strand separation (Takata et al., 2013). Tackling these lesions involves 
different pathways such as NER, TLS and HR. These pathways work together in 
order to excise, bypass and homologously pair the resulting strand (Zhang et al., 
2009; Moldovan et al., 2010). Interestingly, several genes that are known to be 
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involved in CL repair by HR are present in the Fanconi anemia (FA) pathway 
(Moldovan and D’Andrea, 2009; Moldovan et al., 2010; Michl, Zimmer and 
Tarsounas, 2016). FA is a recessive disorder, which is characterized by the 
inability to repair CL lesions, provoking bone marrow failure, genomic instability 
and predisposition to cancer (Moldovan and D’Andrea, 2009). In humans, 13 
genes have been shown to be involved in this pathway, and are conserved among 
vertebrates (Zhang et al., 2009). In contrast to humans, trypanosomes have only 
been described as having one FA gene conserved; this is FANCDI, also known as 
BRCA2 (Zhang et al., 2009). In the parasite, BRCA2 is involved in HR, which is 
critical for the repair of DSBs (Hartley and McCulloch, 2008; Trenaman et al., 
2013). BRCA2 interacts with Rad51 through the BRC repeats, and an expanded 
number of BRC repeats in TbBRCA2 appears to regulate RAD51 nuclear 
redistribution after damage (Trenaman et al., 2013).  
 
Studies have suggested that the signaling of the stress checkpoint, involving 
ATR, is necessary for the activation of the FA pathway (Collis et al., 2008; 
Takata et al., 2013). The ATR kinase responds to a variety of lesions, including 
DSBs and SSBs (Maréchal and Zou, 2013; Takata et al., 2013). In C. elegans Hel-
308, the likely homologue of HelQ, has recently been suggested to be involved in 
the FA pathway. Analysis has shown that the deletion of Hel-308 followed by the 
mutation of Brc-1 (BRCA-1 homologue) is lethal for the worm after crosslinking 
treatment (Muzzini et al., 2008). Nontheless, a specific role of the helicase 
during the FA pathway is still uncertain (Muzzini et al., 2008). Together, these 
data suggest a possible interaction between HelQ and the checkpoint machinery, 
but to date a direct link with Rad51 and BRCA2 during HR, as potentially 
observed in T. brucei, has not been seen. Whether TbHelQ works with TbATR to 
activate checkpoint signaling and recruitment of the repair machinery is also 
unknown.  
 
Taken together, the available data from other eukaryotes suggest TbHelQ 
interaction and co-localisation with BRCA2 is either novel, or so far undetected. 
The pronounced overlap of signals for the two proteins was of particular 
interest, suggesting almost exactly matching distributions of the proteins across 
the nucleus (Section 5.7.4). Though BRCA2 is known to interact with Rad51, a 
key molecule in the HR pathway in the parasite, the co-localisation of RAD51 and 
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BRCA2 is not nearly as extensive (Trenaman et al., 2013). Thus, though the 
potential interaction of TbHelQ and TbRad51 revealed by IP is of interest, it will 
be necessary to test this further, since the data to date suggest a more 
pronounced co-ordination with BRCA2, for reasons that are unclear. Whether this 
relates to possible interaction with Rad50 is also unclear. In eukaryotes, Rad50 is 
part of the MRN complex (Mre11/Rad50/Nbs1), which is essential for the initial 
recognition of a DSB (Lamarche, Orazio and Weitzman, 2010), subsequently 
activating the HR repair pathway, including Rad51. In T. brucei, all MRN 
homologous proteins have been found (Passos-Silva et al., 2010), but to date 
only MRE11 has been analysed (Robinson et al., 2002; Tan, Leal and Cross, 
2002). Intriguingly, loss of MRE11, like loss of BRCA2, leads to attrition of the 
VSG archive (Robinson et al., 2002; Hartley and McCulloch, 2008; Trenaman et 
al., 2013); it would be valuable to test if TbHelQ acted in the same way.  
 
 Possible role of T. brucei Polymerase Nu 5.8.2
Despite work in other eukaryotes suggesting a role for PolN in HR,  unlike 
TbHelQ (Moldovan et al., 2010; Gowda, Moldovan and Spratt, 2015), 
immunoprecipitation of TbPolN-12myc did not reveal proteins involved in the HR 
pathway. Instead, four proteins associated with chromosome integrity, including 
three hypothetical proteins (Tb927.5.3280, Tb927.2.3990, Tb11.01.3060) that 
contain putative conserved domains belonging to structural maintenance of 
chromosomes proteins (SMC) (Harvey, Krien and O’Connell, 2002), were 
highlighted. Interaction with a fourth protein that provides similar roles was 
validated by targeted coIP. The fourth potential interaction partner is a putative 
homologue of Pol σ. In yeast Trf4/Trf5, also known as Pol σ, is encoded by two 
redundant genes (Trf4 or Trf5), and is known to have Poly(A) activity (Edwards 
et al., 2003b; Haracska et al., 2005). In this organism, Polσ is involved in 
chromosome condensation and sister chromatid cohesion (Haracska et al., 2005), 
activities similar to SMC proteins (Harvey, Krien and O’Connell, 2002). Indeed, 
studies have suggested that Pol σ directly interacts with SMC1 and SMC2 in order 
to accomplish the cohesion of sister chromatids (Haracska et al., 2005).  
 
Recent studies in S. cerevisiae have also shown a possible interaction of 
Pol σ and Polε. Polε is a high fidelity polymerase, involved in replicative strand 
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synthesis. However, it has been suggested that this polymerase may also have an 
alternative role, apart from the polymerase activity (Edwards et al., 2003b). A 
co-immunoprecipitation of Trf4-6His and Pol2 (catalytic subunit of Polε)-Flag 
cells was performed, confirming the interaction between these two polymerases 
(Edwards et al., 2003b). This was further studied by mutating the Polε binding 
domain of Polσ (trf4), showing deficient sister chromatid cohesion in the 
absences of the Polσ-Pol2 interaction. Hence, Polε may also have a role in 
chromatid cohesion (Edwards et al., 2003b). Although TbPolσ has not been 
implicated in such a role, and neither has PolN in any eukaryote, their co-
immunoprecipitation may reveal a role for both in similar strategies of 
chromosome cohesion.  
 
In yeast and metazoans, SSC1 is associated with SMC1 and SMC3, forming 
the chromosome cohesin complex, whose role is to maintain the chromosomes 
together through S phase until anaphase (Gluenz et al., 2008). The cleavage of 
SSC1 allows the separation of sister chromatids during anaphase, preparing the 
cell for division (Gluenz et al., 2008).  
 
SSC1 (Tb927.7.6900) has been studied in T. brucei in order to understand 
the cohesion mechanism in the parasite. Mutants were generated by depleting 
SSC1 by RNAi. The depletion of the protein in BSF cells lead to a decrease of 
proliferating cells, a decrease of 1N1K cells and an increase of 1N2K, 24 hours 
post induction (Gluenz et al., 2008). Intriguingly, a similar effect was observed 
after TbPolN depletion.  Moreover, depletion of SSC1 also results in 
accumulation of aberrant cells, which consist of an irregular nucleus, multiple 
kinetoplasts and multiple flagella, a phenotype more obvious 48 hours post 
induction (Gluenz et al., 2008). Interestingly, the cells appear to recover from 
the phenotype after three days,  though through reappearance of the protein 
(Gluenz et al., 2008). In the case of TbPolN, depletion of the protein also 
resulted in an accumulation of aberrant cells, which was also a transient 
phenotype. Unlike SSC1, however, the TbPolN depletion was maintained through 
the 72 hours after RNAi activation. This either suggests that the parasites have 
the ability to compensate the loss of TbPolN or part of the population escapes 
the RNAi mechanism, since we have not yet detected re-expression of the 
putative TLS pol.  
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Loss of SSC1 is responsible for aberrant chromosome distribution, 
impeding the separation of the sister chromatids and generating an arrest in 
anaphase (Gluenz et al., 2008). Depletion of TbPolN also results in an irregular 
chromosome distribution, as suggested by telo-FISH, which indicated an 
abnormal distribution of DNA in cells going through metaphase and anaphase. It 
would be valuable to investigate if the correct separation of sister chromatids is 
impaired after TbPolN loss, as this would more closely link the two sets of data.  
 
Studies in yeast have linked SSC1 with the release of CDC14 phosphatase 
from the nucleus, a protein necessary for mitotic exit. For this reason, absence 
of SSC1 affects the culmination of mitosis, impeding cell division (Gluenz et al., 
2008). This may explain the presence of an enlarged aberrant nucleus after the 
depletion of TbPolN. All these data raise the possibility that TbPolN is part of 
the cohesin complex, and its absence in this context would explain the effect of 
TbPolN loss on  mitosis in T. brucei, resulting in the inability of the parasite to 
correctly conclude cytokinesis (Hammarton et al., 2003).   
 
Interestingly, studies in yeast have shown that the cohesin complex is not 
only involved in sister chromatid cohesion, but may also affect the repair of DSB 
during S phase (Sjogren and Nasmyth, 2001).  It has been proposed that this 
complex is essential during post-replication repair by maintaining chromatids 
close together. In this way, the complex facilitates homologous pairing and 
preventing chromosome fragmentation (Sjogren & Nasmyth 2001). This 
hypothesis was tested with SSC1 deficient mutants, where the loss of the protein 
results in mutants incapable of repairing γ irradiation damage (Sjogren and 
Nasmyth, 2001). This may explain the data obtained after the depletion of 
TbPolN, where the cells show sensitivity to UV and MMS exposure, accumulation 
of damage, decrease of EdU incorporation and redistribution of the protein in 
the presence of damage. This suggests that in the presence of DNA damage, 
TbPolN is redistributed in order to facilitate damage repair by maintaining 
chromosome integrity.  The cohesion complex has also been associated with VSG 
switching in T. brucei. The depletion of SSC1 by RNAi was shown to lead to an 
increase in the expression levels of inactive VSG genes, which was also observed 
after the depletion of TbPolN. It was suggested that alteration of the cohesin 
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complex may alter the monoallelic VSG expression mechanism (Landeira and 
Navarro, 2007). 
These data propose a new role for TbPolN in the maintenance of 
chromosome integrity and DNA repair, where TbPolN interacts with SMC-related 
proteins and a putative Polσ. As it was shown in yeast, the complex may be 
involved in the repair of DSB and maintenance of chromosomal integrity by 
promoting sister chromatid cohesion. How exactly the coordination of such 
interactions compares between T. brucei and yeast is, however, currently 
unknown.   
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6 Conclusion 
Cells are constantly exposed to DNA damage, which can arise from sources 
such as UV light, genotoxic agents and reactive oxygen species (ROS), to name 
just a few (Giglia-Mari, Zotter and Vermeulen, 2011). In order to maintain 
genome integrity, cells have developed diverse repair mechanisms that are 
capable of tackling the resulting lesions (Iyama and Wilson, 2013; Gao et al., 
2017). Although these mechanisms are highly efficient, they are not always able 
to completely resolve the damage. In order to avoid collapse of the DNA 
replication fork when a DNA lesion is encountered, the translesion synthesis 
pathway (TLS) has the ability to bypass through damage, ensuring complete 
replication and the survival of the cell (Goodman and Woodgate, 2013). 
Translesion polymerases play an important role in this error tolerance 
mechanism and so eukaryotes possess several TLS polymerases (pols), such as 
PolZ, PolN, PolQ, Polι, Polη, PolƘ and Rev1 (Goodman, 2002). 
 
TLS is known as a low fidelity pathway due to the absence of proofreading 
activity by the TLS pols involved in this process, increasing the probability of the 
insertion of mutations (Sale, 2013). Despite the fact that TLS is prone to 
insertion of mutations, it has been conserved throughout evolution, suggesting a 
critical role for the process in the maintenance of eukaryotic genome integrity 
(Rosenberg, 2001; Friedberg, Wagner and Radman, 2002). For example, the loss 
of PolZ results in embryonic lethality in mice, suggesting that PolZ cannot be 
replaced by any other polymerase during early development (Esposito et al., 
2000). TLS pols are not only involved in the error tolerance repair pathway. It 
has also been demonstrated that they have an active role in diverse repair 
mechanisms such as homologous (HR) recombination, base excision repair (BER), 
nucleotide excision repair (NER) and mismatch repair (MMR) (Goodman, 2002; 
Lange, Takata and Wood, 2011). For instance, in humans, PolN has been 
associated with crosslink repair by HR  (Moldovan et al., 2010). Meanwhile, PolZ 
has been linked with TLS in S. cerevisiae and in HR in human cells  (Gibbs et al., 
2005; Lange, Wittschieben and Wood, 2012; Sharma, Helchowski and Canman, 
2013a).  
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T. brucei encodes ~15 TLS pols, only two of which have been analysed at 
all. A single recent study demonstrated that two related proteins, termed PPL1 
and PPL2, have TLS activity and that PPL2 is essential for the survival of the cell. 
PPL2 has a critical role in cell cycle progression, where the protein is involved in 
the transition from late S-phase into mitosis, since depletion of the protein was 
found to result in arrest in the G2 phase of the cell cycle (Rudd et al., 2013). 
The unconventional structure of PPL1 and PPL2 has meant that they are 
frequently overlooked as TLS pols, and instead are classified as members of the 
archaeo-eukaryotic primase superfamily, though in common with other factors in 
this class they can synthesise DNA (Iyer et al., 2005). 
 
At the start of this work, no other functional data was available for TLS 
pols in T. brucei. In order to have a better understanding of the function of TLS 
pols in T. brucei, TbPolN, TbPolZ’s catalytic subunit (TbRev3) and a putative 
TbPolQ helicase domain protein (TbHelQ) were studied. The first step was the 
analysis of the protein sequences, showing that TbRev3 and TbPolN are highly 
conserved when compared to human and A. thaliana homologues. Each harbours 
motifs which characterise them as members of the B and A family of 
polymerases, respectively. On the other hand, TbPolQ (HelQ) resembles the 
structure of helicase HelQ, rather than the translesion polymerase PolQ: rather 
than encoding both a polymerase and helicase domain, the T. brucei protein 
only harbours a helicase domain. Thus, the protein is unlikely to be a TLS pol. 
Despite this, TbHelQ maintains the conserved motifs corresponding to the SF2 
helicase superfamily, which are also found in the helicase domain of PolQ in 
other eukaryotes (Fairman-Williams, Guenther and Jankowsky, 2010). These 
sequence comparisons indicate a separation of activities found in PolQ into two 
proteins in T. brucei, which led to the question of whether the function of T. 
brucei TLS pols is conserved.  
 
In order to answer the above question, RNAi analysis was performed for 
each gene. The loss of TbPolN appeared to slow growth after ~24 hours, which 
was associated with observable phenotypic changes in which the cells lose their 
regular structure and accumulate aberrant DNA content, with these phenotypic 
effects being most pronounced at 48 hours post RNAi induction. The timing of 
the growth effect seen after TbPolN RNAi also coincided with increased 
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sensitivity of the cells after exposure to MMS and UV light. EdU labelling and 
γH2A analysis after TbPolN knockdown revealed a decrease in proliferating cells, 
which accumulate nuclear DNA damage. In addition, irregular chromosome 
segregation was detected after the loss of the protein. Localisation of TbPolN-
myc revealed a pronounced and localised signal in the nucleus periphery, with 
some redistribution after the generation of damage. To understand these 
observations further an immunoprecipitation (IP) assay was performed, which 
revealed putative interaction with a putative Polσ and several further 
hypothetical proteins that harbour structural maintenance of chromosome (SMC) 
domain homology.  SMC proteins are involved in chromosome segregation, 
forming part of the cohesin complex which holds sister chromatids together until 
the cell cycle transitions to anaphase (Harvey, Krien and O’Connell, 2002; 
Haracska et al., 2005). Interestingly, the TbPolN cell cycle phenotype after RNAi 
resembles the phenotypes obtained after the depletion of SCC1 by RNAi, a 
molecule that forms part of the cohesin complex (Gluenz et al., 2008). However, 
this is not the only role which has been conferred to the cohesion complex, as it 
has also been suggested that the complex is involved in the repair of DSBs, also 
by maintaining the sister chromatids close together, permitting homologous 
pairing (Sjogren and Nasmyth, 2001). All the data together may suggest that 
TbPolN interacts with the cohesin-like complex and be involved in chromosome 
segregation and promoting HR. However, only interaction with Polσ was 
confirmed, and the remaining factors are not canonical cohesin factors, meaning 
further work is needed to explore this hypothesis and to understand the roles 
played by each factor. In addition, what feature of the nucleus or genome is 
bound by TbPolN in undamaged cells remains unclear, though this may provide 
important insight. Finally, at this time it remains somewhat speculative that 
TbPolN is a TLS Pol, since no enzymatic activity of the protein was tested, 
though the syntenic gene in L. infantum encodes a protein that does display TLS 
Pol activity (Fernández-Orgiler et al., 2016). 
 
In higher eukaryotes an interaction between PolN and HelQ has been 
proposed (Bebenek and Kunkel, 2004). The results obtained from the IPs of 
TbPolN and TbHelQ, suggest that there is no such interaction between these 
proteins in the parasite. Instead, TbHelQ was confirmed to interact and 
colocalise with BRCA2, which is involved in HR. Further, as yet unconfirmed, 
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proteins were recovered from the TbHelQ IP that are also involved in HR, 
including Rad51 and Rad50. These data suggest a role for TbHelQ in the HR 
pathway, but this is complicated by the differing subnuclear localisations of 
TbBRCA2 and TbRAD51 (Trenaman et al., 2013), with TbHelQ more closely 
resembling the former. Thus, it will be important to evaluate further if TbHelQ 
acts in HR, and wider roles in the DNA damage response might be considered. In 
humans HelQ appears to activate the checkpoint via ATR, allowing recruitment 
of the repair machinery (Takata et al., 2013). Further studies to test for an 
interaction between TbHelQ and TbATR in T. brucei may therefore be valuable.   
 
A damage sensitivity effect was observed after the growth of TbRev3 RNAi 
and TbRev3 KO cells in the presence of MMS and UV radiation, suggesting a role 
of the protein in DNA damage repair. Interestingly, the growth effect after UV 
exposure was not as severe as expected, considering PolZ has been characterised 
by its ability to repair UV damage (Zhao & Washington 2017b; Gueranger et al. 
2008). The data might therefore suggest that UV damage is tackled by another 
repair mechanism that does not involve TbRev3, and that TbRev3 may mainly act 
in another pathway. TbRev3-12myc immunolocalisation reveals both nuclear and 
mitochondrial signals, which became stronger after the generation of damage. In 
mammals and yeast, the PolZ catalytic subunit has also been detected in the 
mitochondrion, suggesting a role in the maintenance of this organelle (Kaniak-
Golik and Skoneczna, 2015; Singh et al., 2015). TbRev3 mitochondrial 
localisation was supported by IP, where mitochondrial proteins were recovered 
as potential interaction partners. All these findings, taken together, suggest a 
possible role for TbPolZ in the maintenance of both the mitochondrion and 
nucleus in T. brucei. In both cases, however, the precise roles played by the 
factor need to be further evaluated. 
 
Taken as a whole, the work in this thesis reveals widespread and variant 
functions for TbPolN, TbRev3 and TbHelQ in T. brucei genome biology. It might 
be anticipated that the functions provided by the other putative T. brucei TLS 
pols, TbPolK and TbPolH, which were not examined here, will reveal yet further 
activities. 
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